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A. General abbreviations  
 
 delta 
°C Degrees Celsius 
µg microgram 
A alanine 
AAM Alternatively activated macrophage 
Ab antibody 
ABM Abomasal mucosa 
ALN Abomasal lymph node 
Amp Ampicillin 
ANOVA Analysis of Variance 
APC Antigen presenting cell 
AR Anthelmintic resistance 
ATP Adenosine triphosphate 
BLAST Basic Local Alignment Search Tool 
bp base pairs 
BSA Bovine serum albumin 
CD Crohn's Disease 
CD Cluster of differentiation 
cDNA complementary DNA 
cDNA Complementary deoxyribonucleic acid 
Ch Chromosome 
CIP Calf intestinal phosphatase 
CMI Cell-mediated immunity  
Cq Quantifiable cycle 
Ct Threshold cycle 
dATP Deoxyadenosine triphosphate 
DC Dendritic cell 
dCTP Deoxycytidine triphosphate 




dGTP Deoxyguanosine triphosphate 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTP Deoxynucleotide triphosphate 
DTT Dithiothreitol 
dTTP Deoxythymidine triphosphate 
dUTP Deoxyuridine triphosphate 
E/S  excretions/secretions 
EB Elution buffer 
EDN Eosinophil-derived neurotoxin 
EDTA Ethylenediamenetetracetic acid 
ELISA Enzyme linked immunosorbent assay 
FACS Fluorescence-activated cell sorting 
FEC Faecal egg count 
g Gram 
G Guanine 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GC Guanine or cytosine  
gDNA Genomic deoxyribonucleic acid 
GI Gastrointestinal 
GSP Gene-specific primers 
H&E Hematoxylin and eosin 
HCl Hydrochloric acid 
HPRT Hypoxanthine-phosphoribosyltransferase  
HRM High resolution melt analysis 
IBD Inflammatory bowel disease 
IEC Intestinal epithelial cell 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
LB Luria-Bertani broth 
LPS Lipopolysaccharide 




MgCl2 Magnesium chloride 
MgSO4 Magnesium phosphate 
MHC  Major histocompatibility complex  
min Minute (s) 
ml Millilitre 
mM Millimolar 
MMC Mucosal  mast cell 
mRNA Messenger ribonucleic acid 
MS Multiple sclerosis 
NaOH Sodium hydroxide 
ND Not done 
ng Nanogram 
NK Natural killer 
nm Nanomole 
NO Nitric oxide 
NTC Non-template control 
PBMC Peripheral blood mononuclear cell 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
pDNA Plasmid deoxyribonucleic acid 
PI Post infection 
QTL Quantitative trait loci 
RFLP Restriction fragment length polymorphism 
RIN Ribonucleic acid integrity number 
RLM-RACE 
RNA Ligase-mediated Rapid amplification of 
cDNA ends 
RNA Ribonucleic acid 
RT Reverse transcriptase/transcription 
RT-qPCR 
Reverse transcriptase- quantitative polymerase 
chain reaction 
SD Standard deviation 
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SDS Sodium dodecyl sulphate 
sec second (s) 
SMI Sequence manipulation suite 
SNP Single nucleotide polymorphism 
SYBR Synergy Brands 
T Thymine 
TAP Tobacco acid pyrophosphatase 
Taq Thermophilus aquaticus 
TH1 T Helper 1 
TH17 T Helper 17 
TH2 T Helper 2 
Tm Melting temperature 
Treg Regulatory T cell 
TSLP Thymic stromal lymphopoietin 
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Epstein_Barr virus induced 3 
 
EBI3 
FOXP3 Forkhead box P3  
GAPDH Glyceraldehyde 3 phosphate dehydrogenase  
GATA 3 GATA binding protein 3 GATA3 
IFNγ Interferon gamma IFNG 
IgA Immunoglobulin A IGHA1 
IgE Immunoglobulin E IGHE 
IgG  Immunoglobulin G IGHG 
IgM Immunoglobulin M IGHM 
IL-10 Interleukin 10 IL10 
IL-12p40 Interleukin 12 p40 IL12B 
IL-17A Interleukin 17A  
IL-2 Interleukin 2 IL2 
IL-4 Interleukin 4 IL4 
IL-5 Interleukin 5 IL5 
IL-6 Interleukin 6 IL6 
IL-7 Interleukin 7 IL7 
IL-7R Interleukin 7 receptor IL7R 
IL-21 Interleukin 21 IL21 
IL-21R Interleukin 21 receptor IL23A 
IL-22 Interleukin 22 IL22 
IL-23A Interleukin 23A IL23A 
IL-27p28 Interleukin 27p28 IL27p28 
J chain J chain IGJ 
PIGR Secretory component / poly Ig receptor  
RORt 

















Retinoic acid receptor-related orphan 
receptor C 
 
SDHA Succinate dehydrogenase complex subunit A  
SOCS Suppressor of cytokine signalling proteins  
STAT1 




















Signal transducer and activator of 
transcription 6 
 
TGFβ Transforming growth factor, beta 1 TGFB1 
TLR Toll-like receptor  
TNFα  Tumour necrosis factor alpha TNF 
YWHAZ 
tyrosine 3-monooxygenase/tryptophan 5-













Control strategies against the parasitic nematode Teladorsagia circumcincta are 
problematic under current sheep management systems.  Infection with the parasite, 
particularly in young lambs, results in significant production losses therefore 
sustainable worm control is being sought.  It has been established that variation in 
resistance to T. circumcincta is under genetic control and the development of 
resistance is an acquired characteristic and has an immunological basis.  This project 
investigated the immunological response to infection, of lambs with predicted 
resistance or susceptibility to T. circumcincta. Specifically, the study aimed to 
identify immune response-associated genes that were differentially-expressed in 
resistant and susceptible lambs and attempted to identify mutations in these genes.  
This study was part of a long term project that aims to identify genetic marker/s to 
aid in marker-assisted selection (MAS) for resistance to T. circumcincta.   
Real time reverse transcription-quantitative polymerase chain reaction (real time RT-
qPCR) was performed on abomasal mucosa and lymph nodes from 55 lambs used in 
a previous experiment.  The lambs had been either trickle-infected with 2,300 
infective larvae every two days over three months (infected resistant/susceptible, 
n=45) or sham-dosed (non-infected control, n=10). Lambs were ranked in relation to 
faecal egg count (FEC) and adult worm count (AWC) at post mortem; zero or low 
FEC (resistant) to high FEC (susceptible).  Histopathology showed only mild 
pathological changes in the abomasal mucosa of resistant lambs but heavy 
lymphocytic inflammatory infiltration in the mucosa and submucosa of infected 
susceptible animals.  Measurements of a range of cytokine transcripts and cell 
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markers associated with the four major CD4+ T cell subsets identified IL6, IL21, and 
IL23A as significantly increased by at least two-fold in abomasal lymph nodes and 
abomasal mucosa of susceptible lambs in comparison to resistant animals.  Highly 
significant (P<0.02) positive correlations were found between IL6 (ρ=0.35), IL21 
(ρ=0.54) and IL23A (ρ=0.38) transcript levels and AWC. Similarly, there were 
highly significant (P<0.01) positive correlations between FEC and IL6 (ρ=0.41), 
IL21 (ρ=0.65) and IL23A (ρ=0.31). In contrast, significant negative correlation 
(P<0.04) between IL23A with IgA antibody levels (ρ=-0.31) was found.  There was 
also a significant positive correlation (P<0.03) of TGFB1 levels with AWC (ρ=0.42) 
and FEC (ρ=0.32) in the abomasal mucosa. 
These data suggests that susceptibility to T. circumcincta is linked to the activation 
of the inflammatory TH17 T cell subset and that this chronic inflammatory response 
was inappropriate to clear worm infection. High resolution melt analysis failed to 
identify single nucleotide polymorphisms in the coding regions of IL21 and IL21R.  
This is the first report of the involvement of TH17 response in GI worm infection in 
sheep.  Similar gene expression studies involving the known upstream and 
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1.1 Gastrointestinal (GI) parasitism  
Gastrointestinal parasite infection is a major burden to the small ruminant industry.  
Higher demand for meat and diminishing pasture lands has led farmers to increase 
their stocking density (Taylor,  2012) whilst employing tactical approach in worm 
control with chemical anthelmintics.  The consequent scenario is higher risk of 
infection especially in susceptible animals and ineffective worm control measures. 
Sheep are infected with several species of GI nematodes but generally the most 
important species in terms of prevalence, pathogenicity, and economic importance 
are Haemonchus contortus, Trichostrongylus colubriformis, and Teladorsagia 
circumcincta.  Haemonchus and Trichostrongylus species are prevalent in warm, 
Mediterranean and sub-tropical and tropical regions while T. circumcincta is found 
in cool, temperate areas (Craig et al., 2006; Larsen and Anderson, 2009; Taylor,  
2012; Wilson et al., 2008).  Adult T. colubriformis reside in the small intestine while 
H. contortus and T. circumcincta are both found in the abomasum.  All three species 
undergo a typical direct life cycle (Figure 1.1) with no tissue migration apart from 
the temporary lodgement of the pre-adult stages in the GI mucosa.  H. contortus 
feeds voraciously on blood while T. colubriformis and T. circumcincta nourishes on 
cellular secretions (Soulsby and Mönnig, 1982; Urquhart, 1996).   
The economic impact of GI nematode parasites in sheep is related to increased 
anthelmintic treatments, increased labour for sheep management and production 
losses in terms of decreased live weight, and reduced survival in lambs (McLeod,  
1995; Newton and Meeusen, 2003).  Mortality is not uncommon particularly in 
young, susceptible lambs.  However, morbidity is high and the associated pathology 
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results in significant production losses in meat, milk and wool (Taylor et al.,  2007; 
Urquhart, 1996).  Continuous reinfection with ubiquitous GI nematode parasites and 
their high rate of establishment can reduce weight gain b up to 50% (Sargison, 2008). 
GI parasitism also causes losses associated with repeated treatments and reduced 
animal performance valued annually at £84M in the UK (Nieuwhof and Bishop,  
2005) and $1.5 billion in the US (Newton and Meeusen, 2003). 
1.2 Teladorsagia circumcincta 
Teladorsagia circumcincta (previously known as Ostertagia circumcincta) is the 
most common GI nematode parasite in sheep in cool temperate areas. The adult 
worm, which measures 712 mm, lodges in the lumen of the abomasal mucosa and 
feeds on mucosal tissues and cellular secretions (Dunn, 1978; Soulsby and Mönnig,  
1982). 
1.2.1 Life cycle 
T. circumcincta follows a direct life cycle (Figure 1.1) with no tissue migratory 
stage, which is typical of most strongyle1 species (Soulsby and Mönnig,  1982).  
Their pre-parasitic developmental stages have greater resistance to desiccation and 
lower temperature.  Temperature of 410C is required for the eggs to hatch in 48 
hours (McKenna, 1998; Jasmer et al., 1986).  Development from L1 to L3 could be 
as short as two weeks at 11C or could extend up to 10 weeks at 7C  (Gibson and 
Everett, 1972).  However, high temperature of 30C is still favourable for their 
development (Salih and Grainger, 1982). The higher tolerance of T. circumcincta to 
lower temperature enables them to survive over winter.  The pre-infective larval 
                                                            
1 Strongyle – nematode worms of the Order Stronglylida 
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stages feed on microorganisms in the faeces on soil until they reach the third stage 
infective larva (L3).  The optimal faecal moisture content for T. circumcincta to 
develop through to L3 is 60% (Rossanigo and Gruner, 1995).  Infection is acquired 
by ingestion of the infective L3 by grazing sheep.  Early fourth stage larvae may 
cease development (hypobiosis 2 ) and remain inactive in tissues as a result of 
unfavourable environmental conditions or host immune response (Soulsby and 
Mönnig, 1982; Urquhart, 1987).  Larvae penetrate the abomasal gastric glands in 23 
days after ingestion and develop into pre-adult stages (L4 and L5) before they mature 
into sexually active adults 1721 days post-infection.  The rate by which larvae 







2 Hypobiosis – cessation of development of nematode larvae in the gut of the definitive host 




Figure 1.1  Life cycle of Teladorsagia circumcincta.  Adults lodge in the abomasal 
mucosa and lay eggs, which are passed out with the faeces.  Eggs hatch into the first 
larval stage (L1) within 1-2 days, then moult and develop onto L2 in 23 days.  
These stages feed on microorganisms in the faeces while they are trapped in the 
faecal pellet until they reach the infective larval stage (L3).  L3 develops from 7 days 
to 3 months depending on the prevailing environment and may remain viable for 
several months.  They climb up on blades of grasses to be ingested by ruminant host.  
The L3 enters the gastric glands where they moult again to become L4 then L5.  
They remain in the glands for 23 days and emerge into the lumen as adults.  
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1.2.2 Pathogenesis and clinical signs 
T. circumcincta is a ubiquitous, persistent parasite that is responsible for seasonal 
outbreaks of parasitic gastroenteritis in weaned lambs (Gruner et al., 1994; Taylor et 
al.,  2007; Urquhart, 1996; Sargison, 2008).  The pathogenesis and associated clinical 
effects of T. circumcincta are attributed largely to the host immunologic response to 
clear infection (Houdijk et al., 2003; Jackson et al., 2009; Kyriazakis and Houdijk, 
2006).   Surveillance on the seasonal patterns of T. circumcincta infection suggests 
that fewer larvae survive the winter at pasture (van Dijk et al.,  2008). However, 
large numbers of ingested infective larvae undergo hypobiosis and remain as early 
L4 during winter and develop only to adult stages in spring (Sargison et al.,  2007; 
Waller et al.,  2004a).  Hence, there is markedly reduced infection early in the year 
particularly for weaned lambs in their first grazing season.  This pattern allows 
highly susceptible lambs to cause high build-up of pasture contamination later in the 
year increasing the risk of reinfection.  High level of infection in spring may also be 
attributed to periparturient rise in faecal egg counts3 by ewes.     
The primary pathology of T. circumcincta infection is associated with larvae 
developing within the gastric glands.  The host response to the invading L3 damages 
the tight junctions and this stretches the mucosal lining leading to hyperplastic 
abomasal mucosa (Gruner et al., 1994; McKellar, 1993).  Formation of nodules 
associated with larval development may be evident along with mucous cell 
hyperplasia.   (Miller and Horohov, 2006; Scott et al., 1998).  These changes result in 
reduced or no production of digestive enzymes and leakage of macromolecules and 
                                                            
3 Periparturient rise (PPR) in faecal egg counts or “Spring rise” is an increase in the number of 
nematode eggs in the faeces around parturition which is associated with relaxation of immunity 
resulting in more fecund females and resumed development of hypobiotic larvae (Urquhart, 1996). 
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proteins across the damaged mucosa resulting in hypoproteinemia, hypoalbuminemia 
and increased plasma pepsinogen (Lawton et al., 1996; Simpson et al., 2009).   The 
disease is characterised by anorexia, intermittent diarrhoea, dehydration and 
weakness which may lead to emaciation and death if left untreated (Aitken,  2007; 
Kyriazakis et al., 1998; Stear et al.,  2003; Sargison et al., 2008).  
1.3  Development of anthelmintic resistance (AR) 
The use of chemical anthelmintics for common GI nematodes of sheep has been the 
preferred method of worm control due to availability, cost, convenience and high 
efficacy.  However, for the past 40 years resistance to one or multiple classes of 
anthelmintics, notably benzimidazoles, levamisoles, and ivermectin have been 
reported worldwide, and the incidence of resistance rising steadily (Gopal et al.,  
1999;J ackson et al., 2009; Kaplan, 2004; Waller et al., 1995).  In the UK, several 
reports of AR in sheep (Bartley et al., 2003; Burgess et al., 2012; Taylor and Hunt,  
1989; Wilson and Sargison, 2007) have been recorded following its first account in 
1982 (Britt, 1982).  Several isolates of T. circumcincta have been shown to have 
multiple AR (Bartley et al., 2004; Martinez-Valladares et al., 2011; Sargison et al.,  
2001; Sargison et al., 2010; Sargison et al.,  2007; Sutherland et al., 2008; Traversa 
et al., 2007) such that even combination drenches were found to be ineffective 
(Wrigley et al., 2006). The above discussion suggests that the use of chemical 
anthelmintics may not be a sustainable method of worm control.  
It takes longer to discover, test and commercialize a new chemical anthelmintic than 
it is to maintain its efficacy.   It was not until 20 years after the discovery of 
Ivermectin that a new class of synthetic anthelmintic amino-acetonitrile derivatives 
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(AADs) was introduced (Kaminsky et al., 2008).  Resistance to anthelmintics for 
sheep helminths may develop as early as three years after the initial drug use 
(Kaplan,  2004).  It is therefore imminent that resistance to new drugs may develop 
after some time and integration of judicious anthelmintic use with non-chemical 
based worm control may be a sustainable approach.   
1.4 Alternative strategies in worm control 
The increasing worldwide problem of AR in sheep nematodes stimulates the 
development of non-chemical and sustainable methods of worm control.  Work on 
these approaches has been the subject of several reviews (Hoste and Torres-Acosta,  
2011; Jackson et al., 2009; Molento, 2007; Stear et al., 2006b) that are aimed at 
reducing worm infection by limiting host-parasite contact, enhancing the host 
immune response to reduce worm establishment and persistence, and removing adult 
worms in the host.   
Protective immunity to GI nematode infections can be acquired after some time with 
repeated infections (Seaton et al., 1989).  Hence, it seems practical to employ 
management interventions targeted at boosting the immunological status of animals 
to prevent or reduce the effects of worm infection.  There are three current strategies 
being tested to manipulate the immunological response of sheep to GI infections: 
nutrition boosting, vaccination and selection for resistance4 and/or resilience5.   
                                                            
4 Resistance – ability to suppress the establishment and/or subsequent development of a parasite 
infection Bisset, S. A. & Morris, C. A. 1996. Feasibility and implications of breeding sheep for 
resilience to nematode challenge. Int J Parasitol, 26, 857-868.   
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1.4.1 Improved nutrition 
High level of nutrition optimizes animal productivity and also the immune response 
to parasites.  Parasitized lambs become weak and grow slowly because the nutrients 
required for their growth are reallocated to sustain energy required in the complex 
effector and immune-regulatory response mechanisms in parasite infection (Houdijk 
et al., 2003; Jackson et al., 2009; Kyriazakis and Houdijk, 2006).  Indeed, lambs with 
continued milk supply improved resistance and resilience to experimental T. 
circumcincta infection compared to their twin weaned counterparts (Iposu et al.,  
2008).  This suggests that improved nutrition is an effective strategy to reduce the 
debilitating effects of parasite infection.  While no cost analysis has been made to 
determine the actual benefits of improved nutrition enhancing resistance/resilience to 
worm infection, this strategy has high potential if adopted in combination with other 
options.   
1.4.2 Pasture and grazing management 
The basic concept of adopting grazing schemes for worm control is to reduce or 
prevent host contact with the infective stages of the parasite (Barger, 1999).  
Rotational grazing involves movement of animals from one paddock to another 
considering the supposed non-viability of L3 (Burke et al., 2009); infective L3 larvae 
remain viable on pasture for up to a year in warm, humid areas (Barger et al.,  1994).  
This grazing method seems to work well in tropical (Barger et al., 1994) but not so in 
sub-tropical and temperate regions (Eysker et al., 2005) with decreased larval 
                                                                                                                                                                        
5 Resilience – the ability to maintain relatively un-depressed production while subjected to parasite 
challenge. Ibid. 
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challenge resulting in reduced worm load (Colvin et al., 2012).  Moving lambs to 
clean pastures is a practical anthelminthic treatment (Githigia et al., 2001).  
However, there are practical implications with this approach, like provision of 
sufficient fodder and grass with limited area available for grazing and the initial cost 
of setting up the paddock divisions.  Another scheme is to isolate the high egg 
shedders i.e. animals with high faecal egg count (FEC) from the flock, reducing 
worm burdens on the pasture. 
Other interventions include the use of nematophagous fungi (Chandrawathani et al.,  
2004; Waghorn et al., 2002), surface-feeding earthworms (d'Alexis et al., 2009) and 
physico-chemical agents (Bang et al., 1990; Torres-Acosta and Hoste, 2008) on the 
pasture to prevent the development of larvae through the infective L3 stage.  Aside 
from reducing host contact to the infective larval stage, boosting the host’s ability to 
limit infections or cope with the harmful effects of parasite infection is another 
strategy for worm control (Hoste and Torres-Acosta, 2011; Knox et al., 2012).  
1.4.3 Development of vaccines 
The development of vaccines including its strategic implementation has been a 
recognized immunological approach in worm control; however effective vaccines for 
GI nematodes remain elusive.  To date, the only vaccine against a commercially-
relevant ruminant nematode parasite is against the bovine lungworm, Dictyocaulus 
viviparus, where irradiated larvae give clinically effective protection.  Studies on 
vaccine candidates for GI  parasites have focused on directing immune responses 
toward possible targets on somatic, or secreted parasite molecules (Knox et al.,  
2003; Smith and Zarlenga, 2006). 
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Less work has been done on vaccine development for T. circumcincta than with H. 
contortus.  Why gut antigens protect against blood-feeding Haemonchus and 
mucosal browser Ostertagia, but not for Teladorsagia (Morton et al., 1995) is not yet 
known (Smith, 2008).  The immunogenic component of T. circumcincta has not been 
identified but candidate antigens have been located on the larval cuticle surface 
(Nisbet et al., 2009), and in excretions/secretions (E/S) mixture (Nisbet et al., 2011; 
Redmond et al., 2006).  However, vaccine trials using larval extracts (Halliday and 
Smith, 2011) and membrane glycoproteins (Smith et al., 2001) have failed to 
establish effective protection against T. circumcincta.    
Attempts have also been made to develop molecular vaccines, with recombinant 
versions such as H11 and H-gal-GP candidates for H. contortus but have failed to 
reproduce protection (Newton and Meeusen, 2003; Smith et al., 2009a).  Promising 
results on the potential use of nucleic acid vaccines has been demonstrated in H. 
contortus (Muleke et al., 2007; Zhao et al., 2012) but this work is still at a 
preliminary stage.   
1.4.4 Breeding for resistance  
Resistance is defined as the ability of a host to initiate and maintain responses to 
suppress the establishment of parasites and /or eliminate the parasite load (Woolaston 
and Baker,  1996).  Utilizing genetic variation to select for sheep that are resistant to 
nematode parasites has been the subject of several reviews covering related work in 
the last three decades (Albers et al., 1987; Bishop and Morris, 2007; Davies et al.,  
2005; Gray, 1997; Stear et al., 2009; Woolaston and Baker, 1996).  To develop 
breeds that are selected for resistance to GI parasites seems to be the most promising 
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of all alternative worm control method.  Improved resistance to nematodes translates 
to reduced costs incurred for anthelmintic treatments and diminished production 
losses attributed to worm infection.  The breeding for resistance programme which 
primarily involved the use of phenotypic marker has been adopted successfully in 
Australia and New Zealand (Davies et al., 2006; Gray, 1997; Windon, 1996).  The 
major setback in the sustainability of its implementation is that some production 
traits are compromised in favor of low worm load.  Development of phenotype 
markers to select for resistance to worms requires at least 6-7 years, not to mention 
the maintenance cost involved in keeping the animals.   
1.4.4.1 Phenotypic traits as indicators of GI resistance 
Selection for resistance has traditionally been based on quantitative measurements of 
phenotypic traits.  The practical use of indicator traits for important GI nematodes is 
best exemplified by the FAMACHA scoring system.  This is a scheme to assess the 
degree of anaemia as clinical manifestation of H. contortus infection in small 
ruminants.  The method involves comparing the colour of the eye conjunctiva against 
an eye colour chart (Gauly et al., 2004; Kaplan et al., 2004), then marking a score 
that corresponds to the need to administer anthelmintic to the affected animal.  
Through this method, sheep resistant/resilient to H. contortus infection can be 
identified.  Evaluation of estimated breeding values for FAMACHA scores indicate 
its heritability (Riley and Van Wyk, 2009) and has now been used as a phenotypic 
marker for selection in some farms in Brazil (Molento, 2007).  
Most sheep breeding programmes for reduced egg production performed in New 
Zealand and Australia use FEC as the parameter for selection of resistance to GI 
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parasites (Windon, 1996;Woolaston, 1992).  FEC has been the most widely-used 
parameter in identifying nematode resistance (Davies et al., 2005; Gill, 1991; Gruner 
et al., 2004; Smith et al., 1984).  Heritability values vary from 0.30  0.48 in T. 
circumcincta (Stear et al.,  2009), T. colubriformis (Douch et al., 1996; Sreter et al., 
1994) and H. contortus (Gruner et al., 2004) making it a viable indicator trait for 
selection.  Its genetic component is further evidenced by its association with three 
different genotypes at the diallelic adenosine deaminase locus (Gulland et al., 1993) 
and Major histocompatibility complex (MHC)-linked microsatellites in a wild 
population of Soay sheep (Beraldi et al., 2007).  Moreover, FEC  is repeatable over 
time and heritable by six months (Bishop et al., 1996; Davies et al., 2005).   
There are other potential phenotypic indicator traits in addition to FEC that could be 
selected for breeding sheep for resistance to nematodes.  These include 
parasitological, immunological, and pathological characteristics (Beh and Maddox,  
1996; Dominik, 2005).  Examples are adult worm count and worm length of T. 
circumcincta with reported heritability of 0.14 and 0.62 respectively (Stear and 
Bishop, 1999).  Plasma immunoglobulin A (IgA) is an immunological trait that has 
been found to have high heritability and repeatability (Strain et al., 2002).  
Furthermore, some studies have claimed that eosinophil levels are useful, with 
estimated heritability in 45 month old lambs of 0.430.48 (Henderson and Stear,  
2006).  However, the reliability of this trait is debatable as high variability was 
observed in Australian sheep breeds (Douch et al.,  1996).  
There are several challenges in the identification and development of phenotypic 
marker for resistance.  The process involves carrying out in vivo studies under 
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condition when exposure and intensity of infection are critical to obtain statistically 
robust associations.  In addition, environmental factors and physiological factors 
such as age, season and health status influence phenotypic markers (Jackson et al.,  
2009; Stear et al.,  2007).  Hence, phenotypic index of trait heritability warrants 
careful assessment and interpretation.  
1.4.4.2 Development of genetic markers for resistance 
Identification of molecular markers is a more reliable approach in selection for 
resistance or against susceptibility when direct association between the gene and the 
trait is determined.  The genetic approach in breeding for resistance to worms 
involves identification of gene(s) that are linked to the trait to be selected.  Genetic 
markers can only be defined with prior association to a quantitative trait such as FEC 
(Douch et al.,  1996).  There are two general approaches in identifying causal 
mutation effect for quantitative traits: quantitative trait locus (QTL) mapping and 
candidate gene analysis (Carta and Scala, 2004; Pemberton et al., 2012).  The main 
differences between the two methods are described in Figure 1.2.  Each has its own 














Figure 1.2 Approaches in identifying DNA marker for quantitative traits.  The basic 
features of candidate gene analysis and quantitative trait loci (QTL) mapping are 
presented highlighting the advantages and disadvantages of both approaches.  The 
work flow in detecting the gene that could be associated with a particular trait and 
the tools required in the process is shown.  
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1.4.4.2.1 Quantitative trait locus (QTL) mapping 
QTL identification involves mapping a gene for a trait on genome region with the 
use of known DNA markers such as a microsatellite marker or single nucleotide 
polymorphism (SNP) (Beh et al., 2002).  SNP is a variation in the DNA sequence 
occurring when a single nucleotide in the genome (or other shared sequence) differs 
between members of a biological species.  Microsatellite markers are repeating 
sequences of 26 base pairs of DNA which vary in number in any individual.  The 
causal mutation associated with phenotypic traits found in that region is termed as 
QTL.  The association between phenotypic value and known DNA markers is 
investigated to detect a QTL by using recombination6 or linkage disequilibrium7 
information.  The direct effect of QTL on an objective trait is then investigated by 
comparing to a DNA database of genes with known functions or gene expression 
analysis.   
The traditional strategy of QTL mapping was to use linkage analysis to map a QTL 
with microsatellite marker. However, microsatellite markers are not as abundant as 
SNPs in the genome hence low marker density genome scans are generated yielding 
crude estimates of QTL location and magnitude (Slate et al., 2009).  
QTLs related to GI worm resistance have been identified at the genome- or 
chromosome-wide level. Regions of the ovine genome in Ch 3 was consistently 
associated with resistance to sheep strongyles (Beraldi et al., 2007; Davies et al.,  
2006; Dominik et al., 2010; Marshall et al., 2009).  Loci in Ch 4 (Matika et al.,  
                                                            
6 Recombination - the breaking and rejoining of DNA strands to form new molecules of DNA 
encoding a novel set of genetic information.  
7 Linkage disequilibrium - non-random association of alleles at two or more loci, that may or may not 
be on the same chromosome. 
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2011) and 6 (Beh et al., 2002; Beraldi et al., 2007) were also linked to worm 
resistance.  Probably the most relevant QTLs associated with worm resistance, which 
may also be related to T cell differentiation, are those found in Ch 1 and 11 
(Coppieters et al., 2009; Marshall et al., 2009).  RORC (RORγ) and STAT3, 
transcription factors of TH17 cells, are both on Ch 1 and 11.  Likewise, TBX21 and 
STAT5 transcription factors for TH1 and TH2 respectively are both located in Ch 11.  
In addition, Ch 20, which contains MHC Class II, has been suggested to influence 
resistance to strongyle worms (Coppieters et al., 2009; Davies et al., 2006).  QTLs 
controlling a particular trait may hypothetically be unique for one disease or shared 
among different diseases.  Since production of IgA may be stimulated by TH2 cells, 
and there is previous evidence that such cells promote resistance to T. circumcincta, 
it is possible that the phenotype of resistance/susceptibility is controlled by genes 
regulating TH differentiation.    
Recently, genetic maps of sheep have become available covering most genomic 
regions (van der Werf et al., 2007) and a large panel of SNP in sheep was made 
available to search for QTL by genome-wide association studies (Goddard & Hayes 
2009).  Ovine SNP chips that offers sufficient SNP density allows identification of 
over 50,000 SNPs in a single platform (Hayes et al., 2012; Johnston et al.,  2011; 
Kijas et al., 2009). This high-throughput genotyping technology gives hope to 
finding more QTLs for complex traits in a genome-wide association study.  However, 
the disadvantage of this approach is that a very large animal/population sample is 
required to gain meaningful data making this approach very expensive.  
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1.4.4.2.2 Candidate gene approach 
Candidate gene analysis evaluates a relationship between a trait and a mutation in 
specific functional genes selected for the differential expression in a particular 
phenotypic trait.   These candidate genes are selected based on their established or 
supposed function using causal association tests.  This method can be very powerful 
as it can detect trait loci even with very small effects.  However, it requires a true 
candidate gene, meaning that a valid correlation between its expression and 
phenotypic trait of interest has been established.  In this study, the immune-
physiological response is measured and correlated with expression of genes 
associated with the immune response, i.e. cytokines and markers.  Nucleotide 
polymorphisms are identified in differentially expressed genes, which will then be 
used as a basis in selecting candidate genes for genetic variation analysis.   
1.4.4.3  Genetic association of resistance/susceptibility to GI 
nematodes 
A number of genes have been linked with the ability of sheep to resist infection to GI 
parasites primarily based on FEC.  Three molecular markers that are linked to GI 
nematode resistance phenotype have been identified: MHC-DRB1 which lies on Ch 
20 (Buitkamp et al., 1996; Sayers et al., 2005a; Schwaiger et al., 1995) the first 
intron of IFNG on Ch 3 (Coltman et al., 2001b; Davies et al., 2006; Matika et al.,  
2011),  and IL-4 on Ch 5 (Benavides, 2009b).  A recent genome wide-scan of the 
African Red Maasai sheep has revealed novel QTLs associated with resistance to H. 
contortus and T. colubriformis located at Ch 6, 14 and 22  (Silva et al.,  2012).   
Association of MHC genes with resistance or susceptibility to nematode parasites 
may be attributed to a high degree of polymorphism and involvement in the 
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induction and regulation of the immune response (Cresswell,  1994b).  More 
specifically in T. circumcincta infections, protective response involves IgA activity 
(Halliday et al., 2007; Stear et al., 2004) and hypersensitive reaction (Greer et al.,  
2008; Jackson et al., 2004)  to reduce worm burdens.  Both mechanisms require a T 
cell response that entails antigen presentation through MHC Class II.    
In different sheep breeds, significant associations between FEC reductions were 
reported in GI nematode species under natural and induced infections with other 
MHC class II alleles including OLA-DRB 257 (Paterson et al., 1998), and Ovar-DY 
(Buitkamp et al., 1996).  Susceptibility was also associated with the MHC Class II 
locus wherein high FEC was observed in New Zealand sheep carrying OVAR 
DQA2*1201 allele (Hickford et al., 2011). 
One of the well-studied genetic markers associated with resistance to GI nematode is 
the allele DRB1*1101 (also known as G2 and Ovar-DRB1*0203) of the MHC-DRB1 
locus (Sayers et al., 2005a; Schwaiger et al., 1995).  Studies have focused on the 
relationship of this locus with the physiological and immunological processes 
involved in the development of resistance to GI nematodes of sheep.  Substitution of 
the most common allele by DRB1*1101 has resulted in 22- to 81-fold reduction in T. 
circumcincta FEC in lambs (Sayers et al., 2005a; Schwaiger et al., 1995).  Carrier 
lambs of DRB1*1101 allele had lower adult worm burden and higher mast cell and 
plasma lymphocyte count (Hassan et al., 2011).  However, no difference in FEC was 
observed between carriers and non-carriers in this study suggesting that the 
resistance conferred is not dependent on fecundity, a parameter which was 
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consistently shown to mediate resistance in T. circumcincta infections (Halliday et 
al., 2007; Smith, 2007).   
Aside from MHC genes, a number of studies have identified mutations in cytokine 
genes associated with resistance.  Low FEC and high T. circumcincta-specific IgA in 
free-living 4-month old lambs were associated with an allele at a microsatellite locus 
in the first intron of IFNG (Coltman et al., 2001a).  In addition, haplotype of the first 
intron of IFNG was found to be associated with low FEC in Texel and Suffolk breeds 
(Matika et al., 2011; Sayers et al., 2005b).  A combined pathway analysis of QTL 
and gene expression information has confirmed IFNG and MHC II to be associated 
with immune functions and cell responses on resistance to internal parasites (Sayre 
and Harris, 2012).   On the contrary, recent findings showed very little evidence 
linking IFNG with FEC (Dervishi et al., 2011; Silva et al., 2012), which is consistent 
with the work of (Beraldi et al., 2007).   
IL-4 has also been linked with reduced FEC when the most frequent allele was 
substituted by either IL-4*A or IL-4*C  (Benavides et al., 2009).  Another allele, 
CSRD2138 (Benavides et al., 2002) which lies close to IL-4 gene in Ch 5 has been 
associated with reductions in FEC after natural predominantly H. contortus challenge 
(Maddox et al.,  2001).   
The importance of the association of IFN and IL-4 alleles to resistance to GI 
nematodes rests on both genes significance to T helper (TH) cell differentiation. The 
expression of IL-4 and IFN is critical to TH2 and TH1 type of immune response 
respectively (Mosmann et al., 1986).  
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1.5 Immune response to GI nematode parasites 
Protective immunity to GI nematodes is acquired after gradual, continuous, low-level 
exposure with infective larvae over time (Balic et al., 2000b; MacDonald et al.,  
2002; Miller, 1984).  Protection is possible in primary infection but commences later 
compared to pre-infected lambs (Lacroux et al., 2006).  The greatest susceptibility to 
T. circumcincta infection occurs with weaned lambs during their first grazing season 
(Stear et al., 1999).  However, many sheep eventually control worm development 
and egg production. The cellular features of the immunological response in relation 
to the development of protection includes mucosal mastocytosis, increased numbers 
of globule leucocytes, and eosinophilia (Balic et al., 2000a; Gill et al.,  2000; 
Schallig, 2000; Stevenson et al., 1994; Urban et al., 1991).  How each of these 
response components contributes to protection is still unclear.   The effector 
mechanisms of protection is signalled to a large extent by cytokines that leads to 
reduction or clearance of worm load characterized by worm expulsion, diminished 
worm length, reduced worm fecundity, and failure or delayed larval development 
(Finkelman et al., 1991; Onah and Nawa, 2000).  
Development of protective immunity against GI nematode infections primarily 
involves antibody response which is largely T-cell dependent.  It is widely viewed 
that the response operates through the generation of parasite specific IgA and IgE 
antibody (Smith et al., 1986; Stear et al., 1999; Barger et al., 1985; Halliday et al., 
2010), which acts to exclude larval colonization and minimize tissue-damaging 
inflammation  (Macpherson et al., 2000).  Figure 1.3 summarizes the mechanisms of 
the existing paradigm on the immune response to infection with T. circumcincta and 
other GI worm parasites.  
Chapter 1  Introduction 
22 
 
1.5.1 Activation of immune response to GI nematode infection 
1.5.1.1 Signal induction of protective immune response 
Cells of the innate immune system have been shown to promote signalling of TH2 
response.  Two Dendritic cell (DC) subsets have been identified in sheep: DC2 
which was associated with TH2 cell type as it expresses high levels of IL-10 and 
DC1 which was linked to TH1 immune response owing to its up-regulation of IL-
12p40 (Matthews et al.,  2007).  Intestinal epithelial cells (IEC) are a major source of 
TH2 activating cytokines, notably thymic stromal lymphopoietin (TSLP), and IL-33 
(Allakhverdi et al., 2007; Owyang et al., 2006; Schmitz et al., 2005).  Mast cells and 
eosinophils are known to initiate and maintain TH2 responses through their 
production of elevated levels of TH2 type cytokines IL-4 and IL-13 (Gessner et al.,  
2005).   Eosinophils may also act as an antigen presenting cell for the induction of 













Figure 1.3  Immune response to Teladorsagia circumcincta infection.  Infective 
larvae (L3) are ingested by the host and then travel to the mucosal epithelium.  L3 
becomes L4 when they reach the gastric glands where they moult again to become 
L5 (immature adult) and re-enter the lumen of the abomasum to become egg-laying 
adults.  Primary infection characterized by high IgM is typically associated with 
worm establishment while secondary infection with repeated challenge leads to 
worm clearance/reduction over time.  Parasite antigens are processed and presented 
by dendritic cell to CD4+T cells via MHC Class II in abomasal lymph node.  A TH2 
type of response is initiated with effector functions mediated by the production of 
cytokines primarily IL-4, IL-5 and IL-13.  Antibody class switching to IgA and IgE 
is also facilitated by TH2 cells.  TH2 effector functions are carried out by 
eosinophils, mast cells, globule leucocytes, and goblet cells as well as worm-specific 
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1.5.1.2 Effector mechanisms of protection  
The gut has physiochemical properties that can avert the successful lodgement of 
larva and adult nematodes.  The GI mucus acts as a barrier through its surfactant 
activity (Belley et al., 1999; Lichtenberger, 1995). Evidence of worm removal with 
changes in smooth muscle contractility has been demonstrated in mice with 
Heligmosomoides polygyrus (Zhao et al., 2003) and with E/S of T. circumcincta 
(Scott and McKellar, 1998) in sheep in vitro.  These physiological mechanisms have 
been linked with IL-4 expression (Anthony et al., 2007).  However, none of them 
have been demonstrated in vivo in GI nematodes of sheep, hence it is uncertain if any 
of this mechanism operates in the expulsion of T. circumcincta. 
Mast cells are key effectors in TH2 and IgE-mediated protective immune response.  
Failure of larval establishment or expulsion of adult worm is thought to be 
hypersensitive reaction mediated by mast cell proliferation (Greer et al., 2008a; 
Miller, 1996; Stear et al., 1995) and consequent degranulation of mast cells is 
triggered by IgE, histamine, and cytokines (Kawakami and Galli, 2002; Pochanke et 
al., 2007).  T. circumcincta larvae failed to establish with influx of mast cells to the 
abomasum and draining lymph during the infection (Greer et al., 2008; Stear et al.,  
1995).  In addition, mucosal mast cells (MMC) were elevated in the abomasal 
mucosa of sheep that are immune to H. contortus   (Huntley et al., 1992).  Significant 
increase in mast cell proteinase was also seen in gastric lymph of sheep that are 
immune against T. circumcincta (Huntley et al., 1998; Stear et al., 1995).   
Accumulation of globule leukocytes, which are degranulated mucosal mast cells 
(Huntley et al., 1992),  have also been linked to rejection of T. circumcincta (Stear et 
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al., 1995) and H. contortus (Gamble and Zajac, 1992).  Taken together, mast cells 
are essential in mounting protective immunity to GI nematode infections.  However, 
mast cell-independent worm expulsion has been documented such as in O. ostertagi 
infection in cattle (Claerebout et al., 2005) and T. circumcincta in sheep (Lacroux et 
al., 2006).  
Eosinophils have been shown to have a significant role in protection to GI nematode 
infection.  Unsuccessful larval establishment was attributed to eosinophilia in 
Strongyloides ratti of mice (Galioto et al., 2006; Watanabe et al., 2000) and H. 
contortus of sheep (Balic et al., 2006; Robinson et al., 2010a).  Eosinophilic granules 
were shown to be capable of killing the larvae (Hamann et al.,  1987; McLaren et al.,  
1981) by adhering to the cuticle (Rainbird et al., 1998; Terefe et al.,  2009)  which is 
initiated by recognition of the antibody-bound antigen by the Fc receptors (Martin et 
al., 2001).  Eosinophils seem to act only on incoming larvae as they were found to be 
closely associated with larvae on tissues 1-2 days after infection but not so after 22 
weeks (Balic et al., 2006) and has no effect on adult worm numbers (Henderson and 
Stear, 2006).  However, their role in protective immunity is unclear as other studies 
show insignificant difference in circulating or tissue eosinophil population of sheep 
with low or high T. circumcincta burdens (Huntley et al., 1995; Schallig and Van 
Leeuwen, 1997).   
Neutrophils, basophils, and alternatively-activated macrophages have also been 
implicated in protective immune response to helminth infections.  Neutrophils may 
arbitrate nematode killing in gut nematode (Padigel et al., 2007) of mice and promote 
high level expression of TH2-associated cytokines (Anthony et al.,  2007; Morimoto 
Chapter 1  Introduction 
26 
 
et al., 2004).  Preliminary reports in mouse models have shown that basophils may 
be required to generate a TH2 response (Perrigoue et al., 2009; Yoshimoto et al., 
2009).  Current evidence also propose the participation of alternatively activated 
macrophages (AAMs) (Anderson and Mosser, 2002; Anthony et al., 2007; Wynn, 
2008) by immune-regulation (Taylor et al., 2006), tissue repair (Martin and 
Leibovich, 2005), and limiting parasite invasion (Anthony et al., 2006).   
It can be generalized based on the previous discussion that cellular response is 
crucial to the instigation, continuance, and conclusion of the immune response to GI 
nematode infections.  However, the resolution of infection requires the mobilization 
of the cells of the adaptive immune system.  It can also be concluded that multiple 
cell types may be involved in enhancing the protective TH2 type of response.   
1.5.2 Acquired immune response in helminth infections 
1.5.2.1 Antibody response 
The distribution of Ig isotypes in ruminants is different to many other species.   IgA 
is most abundant in mucosal secretions the most common isotype in both plasma and 
mucosal secretions is IgG1 (Conley and Delacroix, 1987; Gill et al., 1992; Simecka,  
1998).   
Several studies are in agreement that IgA, IgE and IgG may have a possible 
relationship with resistance to GI nematodes of sheep (Gill et al., 1994; Pernthaner et 
al., 2006; Schallig et al., 1994; Stear et al., 1995; Strain et al., 2002).  However, the 
majority of these studies looked at serum antibody levels that may not represent the 
local tissue immune response which is directly involved in the effector mechanism of 
protective immunity.  Furthermore, investigations were limited to establishment of 
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associations between parameters of resistance and antibody levels, and no reference 
to the direct IgA activity on the parasite.   
Subsequent studies have studied the local immune response by monitoring antibody 
levels in the efferent lymph by abomasal lymphatic cannulation (Pernthaner et al.,  
2006; Smith et al., 1983).  Measurements of serum and mucus antibody levels for 
IgG, IgE and IgA were also done following vaccination of lambs with fractionated 
E/S products of H. contortus (Bakker et al., 2004).  These studies have shown 
elevated levels of IgA in vaccinated/immune sheep confirming the important role of 
IgA in protective immunity to GI nematodes in sheep even in the local site of the 
immune response.  Furthermore, there was a strong relationship between peripheral 
eosinophils with serum and gastric mucus IgA activity (Martinez-Valladares et al.,  
2005). 
How IgA antibody works in mounting protective immunity against GI nematodes is 
not clear.  There are indications that IgA antibody can control worm development 
and egg production (Barger et al., 1985; Gill et al.,   1994; Halliday et al.,   2007).  
IgA antibody has been associated with the control of worm fecundity (Lacroux et al.,  
2006; Strain et al.,   2002; Strain and Stear, 2001) and worm length of H. contortus 
and T. circumcincta and is also implicated in rejection of incoming L3 and delay of 
larval development (Greer et al., 2008a; Jackson et al., 2004; Jackson et al., 1988).   
Likewise, there was significant linkage between IgA antibody levels, adult worm 
numbers, worm length and FEC in resistant and susceptible sheep (Beraldi et al.,  
2008). 
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The associations of IgA antibody with protection are thought to be mediated by 
hypersensitive reactions (Alizadeh et al., 1986; Greer et al., 2008; Jackson et al.,  
2009) or formation of antibody/immune cell complexes that prevents larval 
establishment and worm development.  An in vitro study suggested that larval 
establishment could be inhibited by eosinophil degranulation via secretory IgA (Abu-
Ghazaleh et al., 1989).  The experiment demonstrated eosinophil degranulation as 
indicated by signals from eosinophil-derived neurotoxin (EDN) co-incubated with Ig 
isotypes.  It seems physically unlikely for secretory IgA at the mucosal surface, and 
therefore outside the body, to bind to eosinophils in tissues. However, human 
eosinophils have receptors for the secretory component of IgA and binding of this 
component could trigger eosinophilic degranulation (Gounni et al., 1994).  Other 
mechanisms of protection have been identified including neutralization and 
inactivation of metabolic enzymes by IgA antibody (Gill et al., 1993a) and the feed-
suppressing activity that would result to reduced adult worm length in T. 
circumcincta with IgA (Beraldi et al., 2008; Craig et al., 2007; Smith et al., 1985; 
Stear et al., 2004). 
IgG levels have also been shown to be associated with resistance to nematode 
infections in a number of studies.  Egg production of H. polygyrus was reduced in the 
presence of polyclonal IgG antibodies (McCoy et al., 2008).  High IgG levels were 
associated with reduced worm infection in immunized (Harrison et al., 2008) and 
genetically resistant sheep (Gill, 1991; Pernthaner et al., 2006).  The protective 
activity of IgG was attributed to neutralizing metabolic enzymes (Smith et al., 1985) 
and suppressing the ability of the worms to feed (Bottjer et al., 1985). 
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The localization of mast cells and eosinophils in GI nematode primary infection is 
suggestive of an immediate hypersensitive reaction (Jackson et al., 2009).  Up-
regulated IgE activity was observed in sheep protected against H. contortus 
(Kooyman et al., 2000; Shakya et al., 2009; Shakya et al., 2011), T. circumcincta 
(Huntley et al., 1998) and T. colubriformis (Shaw et al., 1998) after secondary 
exposure. IgE up-regulation induced by the larval stage (Huntley et al., 1998) was 
associated with mast cell activity (Alizadeh et al., 1986) and eosinophil-mediated 
worm killing (Simecka, 1998).   
Indeed, there is compelling evidence that IgA mediates protective immunity to GI 
nematodes in sheep.  Notwithstanding the dearth of information on the direct effect 
of IgA on the worms, it is still convincing based on current literature that IgA 
promotes control of worm development.  The recent finding on trans-colostral 
transfer of immunity against H. contortus in goats is interesting (Guedes et al.,  
2010).  A negative FEC for up to four months was presented with low IgG and high 
IgA levels in the serum.  This opens another venue for exploring more on the 
potential of IgA antibody in conferring protection to GI nematodes. 
1.5.2.2 T cell response in helminth infections 
Cluster of differentiation (CD)4+ T cells are central to the role of protective 
immunity against nematode parasites (Finkelman et al., 1997).  In vivo and in vitro 
studies confirm that expulsion of GI nematodes is dependent on induction of T cells 
and challenge infection in athymic rodents resulted in the delay or non-expulsion of 
worms (Onah and Nawa, 2000).  CD4+ T cell depletion also abated nematode 
resistance of selected sheep lines (Pena et al., 2006).  That CD4+ T cells are 
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important in the control of immunity to GI nematode infection has been well studied 
in sheep (Gill, 1994; Gill et al., 1993a; Gill et al., 1993b; Miller and Horohov,  2006; 
Pena et al., 2006).  However, the underlying mechanisms that control infection, 
leading to susceptibility or resistance, have not been defined. 
The expanding range of CD4+ T cell subsets and their tendency towards plasticity 
(Panzer et al.,  2012) emphasizes the dynamics of helminth immunity for both worm 
and host species and strains.  Table 1.2 shows the characteristic features of the CD4+ 
T cell types associated with protective immunity to GI nematodes. 
Table 1.1  Main features of the different CD4+ T helper cell subsets 
 TH1 TH2 TH17 Treg 
     
Primary cytokines8 
 
IFN, IL-12 IL-4 IL-6, TGFβ TGFβ 
Secondary cytokines9 
 


















T-bet GATA3 RORt FOXP3 
STAT – signal transducer and activator of transcription; IL – interleukin; TGFβ- 
transforming growth factor beta; IFN – interferon gamma; (FOXP3)  Forkhead 
box P3; RORt – retinoic acid orphan nuclear receptor gamma t.  
 
                                                            
8 Primary cytokines – direct the differentiation of naïve Tcell to T helper subset 
9 Secondary cytokines – promote proliferation of TH cell subset 
10 Autocrine cytokines – produced selectively by TH cell subset 
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For GI nematode infection, it is unclear whether the generation of a TH1 response is 
associated with susceptibility and that resistance/susceptibility is simply a matter of 
TH1/ TH2 dichotomy  (Miller and Horohov, 2006; Maizels et al., 2009).  In mice, a 
highly polarized TH2 response controls H. polygyrus (Anthony et al., 2007). Host 
strain also affects the type of immune response. Trichuris muris is expelled from 
Balb/c mice by a polarized TH2 response but the AKR strain become chronically 
infected in the presence of a TH1 response (Maizels and Yazdanbakhsh, 2003).  In 
contrast, the immunology of T. circumcincta control in sheep seems to be distinct 
from these murine models  in that IFNγ expression was unaffected by infection of 
either  ‘immune’ or ‘naïve’ lambs (Craig et al., 2007).  The CD4+/CD25+/Foxp3+ 
regulatory T cell subset (Treg) has been shown to be critical for the clinical outcome 
of helminth infection.  Resistance to helminths in mice seems to be determined by a 
balanced TH1/ TH2/Treg response; unbalanced modified TH2 (high TH2/Treg) and 
uncontrolled TH1 (high TH1) results in persistent infection and clinical disease 
(Maizels and Yazdanbakhsh, 2003; Belkaid and Tarbell, 2009). 
More recently it has been found that the TH17 CD4+ T cell subset also plays an 
important role in human and mouse inflammatory bowel diseases as well as host 
responses to parasites (Weaver et al., 2007; Fouser et al., 2008; Bogaert et al., 2010). 
Indeed, there seems to be a reciprocal development of Treg and TH17 cells in 
autoimmune or bacteria-associated inflammatory diseases (Bettelli et al., 2006; Korn 
et al., 2009; Xu et al., 2011). 
The cytokine environment regulates the type of immune response; in mice, resistance 
to nematodes develops through the regulated differentiation and expansion of 
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effector cells like eosinophils, mast cells, and antibody-secreting cells (Patel et al.,  
2009).  These mechanisms are thought to be mediated by the cytokine environment 
as determined by the type of T helper cells that predominate in the immune response.   
In this study, I focused on cytokines and markers that are identified with the four 
major CD4+ TH cell subsets which included: IL-2, IL-4, IL-6, IL-7R, IL-10, IL-12, 
IL-17A, IL-21, IL-23A, EBI3, FOXP3, IFN, and TGFβ.  This set was selected on 
the basis that the differential expression of resistance and susceptibility in study 
lambs could be defined with the predominance of these transcripts corresponding 
with the type of immune response.  Cytokines may be produced by many different 
cells and are also known for their redundant functions.  Nevertheless, most of them 
have unique characteristics and may work synergistically or antagonistically with 
others.  Features of these cytokines are described in Table 1.3. 
Previous studies that described the immune response to common GI nematode 
infection in sheep involved acute challenge infection or infect-treat-challenge 
experiments.  In both cases, immune response was monitored at specific time points 
on cytokines and markers almost exclusive to TH1 and TH2 type of response.  In this 
study we simulated a natural, chronic infection with T. circumcincta by trickle 
infecting lambs for a period of three months with no anthelmintic treatments.  It is 
assumed that maturation of the immune response has developed after this period 
when the parameters of the immune response were measured. 
1.5.3 TH cell types in nematode infections 
The existing dogma on the type of immune response to helminth infection is the 
typical TH1 and TH2 response which corresponds to susceptibility and resistance 
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respectively (Mosmann and Sad,  1996).   In most murine models and human studies, 
GI nematodes generally trigger a TH2 type protective immune response with the 
production of signature cytokines IL-4, IL-5 and IL-13.  Experiments on mouse 
intestinal worm parasites  H. polygyrus and Nippostrongylus brasiliensis have linked 
high levels of interleukin 4 (IL4), IL10 and IL13 with resistance and high IL2 and 
interferon γ (IFNγ) with susceptibility (Maizels and Yazdanbakhsh, 2003; Anthony 
et al., 2007).  Other cytokines associated with the TH2 immune response include IL-
21 (Frohlich et al.,  2007) and IL-25 (Fallon et al.,  2006). 
Although discrimination between the two types of immune response based on 
cytokine profile is not very clear in ruminants, similar studies in sheep using acute 
challenge with T. circumcincta or H. contortus, of infected/reinfected (‘immune’) 
animals or selected resistant and susceptible lines has confirmed the murine data 
identifying the TH2 polarized immune response (Miller and Horohov, 2006; Craig et 
al., 2007; Ingham et al., 2008; Meeusen et al, 2005; Lacroux et al., 2006; Terefe et 
al., 2007; Craig et al., 2007; Shakya et al, 2009; Pernthaner et al, 2006; Robinsons et 
al., 2010).  
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Table 1.2  Basic features of cytokines and markers used in defining immune 
response to T. circumcincta (Delves and Roitt,  2011; Murphy et al.,  2008) 
Cytokine Producer cell Action 
   
IL-2  TH1 cells T and B cell proliferation 
 
IL-4 TH2 cells, natural killer  cells, 
mast cells 
B-cell activation, IgE switch,  
TH2 differentiation  
 
IL-6 TH2 cells, macrophages, 
endothelial cells, dendritic cells 
(DC) 
T- and B-cell growth and 
differentiation, TH17 induction, 
pro-inflammatory 
 
IL-7R Bone marrow and thymus Growth of pre-B and pre-T cells 
 
IL-10 Monocytes, macrophage, T and 
B cells,  DC 
Potent suppressor of macrophage 
and TH1 cell functions 
 
IL-12 Macrophage, DC, T and B cells Activates NK cells, differentiation 
to TH1 
 
IL-17A TH17 cells 
 
TH17  proliferation; stimulates 
production of  proinflammatory 
cytokines 
 





Expansion and maintenance of 
TH17 cells, promotes induction of 
pro-inflammatory cytokines 
 
IL-25 TH2 cells, macrophages, mast 
cells 
 
Promotes TH2 cytokine 
production 
 
EBI3 Treg cells Suppresses inflammatory 
response 
 
IFN TH1, NK cells Macrophage activation, Ig class 




Treg nuclear transcriptor Suppresses T cell proliferation 
TGFβ Chondrocytes, monocytes, T-
cells 
Inhibits cell growth, anti-
inflammatory, induces switch to 
IgA production 
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Protective immunity to GI nematode infection is correlated with mucosal 
mastocytosis, tissue or blood eosinophilia, and parasite-specific IgA, IgE, and IgG 
(Amarante et al., 2005; Balic et al., 2006; Bricarello et al., 2002; Gill et al., 2000).  
This is accompanied by the selective expansion of TH2 type CD4+ T helper cells 
with corresponding down-regulation of TH1 response (Balic et al., 2000b; Behnke et 
al., 2003; Craig et al., 2007; Gill et al., 2000; Terefe et al., 2007a; Urban et al.,  
1991; Watanabe et al., 2003).  The major characteristics of these cytokines are 
briefly accounted below. 
1.5.3.1 TH1-associated cytokines 
The direct role of IFN in GI nematode infections has not been established but since 
its function is to down-regulate IL-4 expression, TH2 proliferation is inhibited while 
the TH1 response predominates (Pulendran, 2004).  Some studies have shown 
constant or increased expression of IFN despite a predominant TH2 response 
(Meeusen et al., 2005; Pernthaner et al., 2006).  It is also interesting to note that 
IFN can work synergistically with IL-4 in the transcytosis of sIgA (Amin et al.,  
2007).  These observations may be attributed to polymorphisms in the IFN gene 
which may alter the immune response (Coltman et al., 2001a).   
IL-12 initiates the development of TH1 by driving naïve CD4+ T cells to TH1 cells 
and amplifies the expression of IFN.  IL-12 promotes a chronic intestinal nematode 
infection (Allison et al., 1997; Khan et al., 2001). 
IL-2 plays a central role in TH2 differentiation by stabilizing the accessibility of IL-4 
to STAT5 (Cote-Sierra et al., 2004).  It is also an important activator of Treg 
Chapter 1  Introduction 
36 
 
suppressive activity and increased IL-10 production (Brandenburg et al.,   2008; De 
La Rosa et al., 2004). 
Epstein-Barr virus-induced gene 3 (EBI3) is a widely expressed interleukin-12p40-
related protein that is essential in the regulation of effector T cells and inflammatory 
responses.  It is derived from the heterodimeric cytokine IL-27 that consists of EBI3, 
IL27 p28, a newly discovered IL-12p35-related polypeptide (Pflanz et al., 2002)  
EBI3 has been reported to be elevated in IBD secondary to influx or local 
proliferation of inflammatory cells (Gehlert et al., 2004). Initial studies suggested 
that it had an important role in promoting Th1 responses but subsequent studies have 
revealed that EBI3 receptor signalling influences a variety of immune cell types and 
can inhibit both Th1 and Th2 responses (Dokmeci et al., 2011; Nieuwenhuis et al.,  
2002; Zahn et al., 2005). It was also found to have inhibitory effects on Th17 T cells 
(Yang et al.,  2008a) and may contribute to the activity of Treg cells as a downstream 
target of FOXP3 (Collison et al.,  2007). 
1.5.3.2 TH2-associated cytokines 
IL-4 is critical to the signalling pathway that differentiates naïve CD4+ T cells into 
TH2 phenotype through STAT6 which involves up-regulation of GATA3 (Fallon et 
al., 2002; Zheng and Flavell, 1997).  IL-4 and IL-13 have been shown to mediate 
worm expulsion through increased mucosal permeability, and enhanced mucus 
production and muscle contractility (Madden et al., 2002; Meeusen et al., 2005; 
Anthony, 2007).  These cytokines also promote B cell responses, including isotype 
switching from IgM to IgA and IgE (Maizels and Yazdanbakhsh, 2003). 
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IL-5 and IL-13 are important in eliminating GI nematode parasites as IL-5 stimulates 
and activate eosinophils while IL-13 promotes antibody class switching to IgE.  Up-
regulation of these two cytokines after T. colubriformis challenge (Lacroux et al.,  
2006; Meeusen et al., 2005) coincided with increase IgE production (Kooyman et al., 
2000) and greater number of eosinophils (Henderson and Stear, 2006).  In addition, it 
has been shown both in vitro and in vivo that IL-5 influences the differentiation of 
IgA-producing plasma cells (Ramsay et al., 1994b).  However, other mechanisms 
can compensate for IgA synthesis in the absence of IL-5 (Simecka, 1998). 
IL-25 also known as IL-17E is produced by activated TH2 cells and mast cells.  
Owyang et al.(2006) have identified two major roles of IL-25 in immune regulation: 
promoting TH2 response by driving the expression of IL-4, IL-5 and IL-13 (Fallon et 
al., 2006; Fort et al., 2001) and limiting the production of pro-inflammatory 
cytokines and chronic pathologic inflammation at mucosal sites.  Indeed, IL-25 (-/-) 
developed severe intestinal inflammation with elevated levels of IFN and IL-17 in 
T. muris infection (Owyang et al., 2006). 
IL-10 was initially thought of as a TH2-type cytokine (Gause et al., 2003; Iwasaki 
and Kelsall, 1999) but recent findings show that it is not exclusive to this type of 
response; TH1 and Treg cells (Anderson et al., 2007; Beiting et al., 2007; Elliott et 
al., 2004) as can macrophage and DCs produce IL-10. 
1.5.3.3 Treg cells 
TH2 responses to GI nematodes are generally protective but uncontrolled effector 
mechanisms may result to pathology (D'Elia et al., 2009; Maizels and 
Yazdanbakhsh, 2003).  CD4+ Treg cells protect against this consequence (Tang and 
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Bluestone, 2008) by their ability to actively suppress the immune response (Belkaid 
and Rouse,  2005; Sakaguchi,  2000).  Treg cells strike a balance that reduces 
immune-mediated pathology to the host while still allowing sufficient immune 
response against the parasite (Belkaid and Tarbell, 2009).   
CD4+ Treg cells are usually identified as expressing CD25 (the α chain of the IL-2 
receptor) and the nuclear transcriptor FOXP3 (Fontenot et al., 2005; Hori et al.,  
2003).  FOXP3 is in control of Treg lineage (Zheng and Rudensky, 2007) 
particularly with chronic helminth infection.  In chronic H. polygyrus infection, a 
TH2-dominated cytokine profile was observed from 7-14 days of infection which 
shifted to a regulatory T cell response by day 28.  The regulatory profile was marked 
by expansion of FOXP3+ cells and elevated IL-10 and high frequency of TGFβ-
expressing CD4+ T cells (Finney et al., 2007) which are mediators of Treg cell 
differentiation.   
Much of the work on Treg cells had involved cancer, allergy and autoimmune 
diseases in mice and humans.  For helminth infection, Treg cell activity has been 
demonstrated in human infections with filarial worms Onchocerca volvulus (Korten 
et al., 2008) and Litosomoides sigmondontis (Taylor et al., 2005) and in the mouse 
strongyle H. polygyrus (Finney et al., 2007). Treg cell activity was also observed in 
paratuberculosis characterized by IL-10 up-regulation and consequent suppression of 
TH1 response in cattle (De Almeida et al., 2008) and sheep (Smeed et al., 2007).  
Treg cells were also implicated with increased IL-10 and TGFβ expression in the 
abomasal lymph node of T. circumcincta infection (Craig et al., 2007) and in the 
lymph of sheep resistant to H. contortus and T. colubriformis (Ingham et al., 2008) 
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1.5.3.4 TH17  
CD4+ TH17 cells have emerged as a distinct effector cell subset that produces IL-
17A and not IFN and IL-4, which define TH1 and TH2 lineage respectively.  A 
TH17 type of response is associated with inflammatory (Boniface et al., 2008) and 
autoimmune diseases (Weaver et al., 2006) like inflammatory bowel disease (IBD) 
and MS (Wilson et al., 2007).  In mice, TH17 cells express the transcription factor 
retinoic acid orphan receptor (ROR) t (Yang et al., 2008d) and STAT3 as the signal 
regulator.  IL-6 is critical to TH17 development as it drives the TGFβ-induced naive 
T cells to differentiate to TH17 instead of Treg lineage (Mangan et al.,  2006; 
Veldhoen et al., 2006). The other pathway involves TGFβ and IL-21 combination to 
signal differentiation of TH17 in the absence of IL-6 in mice (Korn et al., 2007) and 
in humans (Yang et al., 2008b).  IL-6 appears to be indispensable in the TH17 type 
of response as it not only activates STAT3 which is critical to TH17 differentiation, 
but also up-regulates IL-23R and works synergistically with IL-23 (Morishima et al.,  
2009; Yang et al.,  2007). 
TH17 were initially thought to be related to TH1 but are now considered a fixed 
CD4+ phenotype independent of the TH1 cell type (Annunziato and Romagnani,  
2011). IL-23 shares the common p40 subunit with IL-12; both are capable of 
inducing IFN production.  However, IL-23 is distinguished from IL-12 by its ability 
to amplify and stabilize the expansion of TH17 cells which produce IL-17A (Iwakura 
and Ishigame, 2006).  The relationship between TH1 and TH2 is further supported by 
TH17 committed cells being induced to differentiate into TH1; TH17 cells were re-
polarized to TH1 differentiation in the presence of IL-12 (Annunziato et al.,  2007).    
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IL-23 is a novel pro-inflammatory cytokine that has been linked to several 
autoimmune diseases and inflammatory pathology (Boniface et al.,  2008; Iwakura 
and Ishigame,  2006).  IL-23 activates STAT3 differentiation (Yang et al., 2007) and 
stimulates IL-17 production and expression (Iwakura and Ishigame, 2006).  Variants 
of IL23R gene have been associated with susceptibility to IBD (Duerr et al.,  2006; 
Lacher et al., 2010).  On account of this, IL-23 is targeted as a potential drug therapy 
for IBD, as it was shown to be enormously increased in affected patients (Tang et al.,  
2012).   
IL-21 is essential for amplification of TH17 cells (Korn et al.,  2007; Nurieva et al.,  
2007).  TH17 cells selectively produce IL-21 which activates STAT3, and induces 
expression of RORt, IL-17A and IL-17F thus; promoting further lineage 
commitment of TH17 cells (Wei et al., 2007).  IL-21 serves as a key modulator of 
TGFβ signalling, which leads to TH17 or Treg differentiation (Fantini et al., 2007).  
IL-21 has been known to regulate B cells particularly its transition to antibody-
producing plasma cells (Ettinger et al., 2005; Ozaki et al., 2002). 
IL-17 which is secreted chiefly by CD4+ T cells stimulates the production of IL-1β, 
IL-6, tumour necrosis factor-α (TNFα) and chemokines responsible for inflammation 
(Iwakura and Ishigame, 2006).  TH17 and IL-17A are also associated with immune-
pathologies in infectious diseases like tuberculosis, toxoplasmosis and 
schistosomiasis (Gaddi and Yap, 2007; Umemura et al., 2007; Wen et al., 2011). 
Whilst TGFβ has been identified to be involved in the induction of TH17 
differentiation (McGeachy et al., 2007; Veldhoen et al., 2006; Yang et al., 2008b), 
other studies have considered TGFβ to be not critical to human TH17 cell 
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development (Ghoreschi et al., 2010).  Deletion of TGFβ did not affect the 
proportion of gut TH17 cells (Gutcher et al., 2011) and cytokines IL-23 and IL-6 
were able to induce IL-17A production in the absence of TGFβ (Qin et al., 2009).  
As TGFβ is ubiquitous especially in mucosal tissues, it is difficult to establish its 
association to TH cell differentiation.  Whether TGFβ promotes TH17 differentiation 
or it suppresses the expression of other cytokines or transcription factors associated 
with other TH cell lineage is not clear.  The anti-inflammatory Treg cells are thought 
to interact with the pro-inflammatory TH17 cells as both have preferential 
localization at mucosal surface and require TGFβ to develop from antigen-naive T 
cells (Weaver and Hatton, 2009).  TGFβ-dependent expression of FOXP3 can be 
blocked by IL-21 (Fantini et al., 2007) and IL-6 resulting in TH17 instead of Treg 
cell differentiation FOXP3 which is the transcription factor of Tregs is inhibited by 
IL-6 (Bettelli et al., 2006; Fallon et al., 2006; Mangan et al., 2006). 
IL-7R plays a critical role in T lymphocyte development.  It is genetically associated 
with susceptibility to multiple sclerosis (MS) while IL-7 has been shown to directly 
expand effector TH17 cells in experimental autoimmune encephalitis (EAE) as well 
as MS (Liu et al., 2010).  Polymorphisms in IL-7R have been identified as risk factor 
for many autoimmune diseases like multiple sclerosis (MS) and inflammatory bowel 
disease (IBD) suggestive of the IL-7 pathway as a target for drug therapy 
(Mazzucchelli et al., 2012). 
1.6 Aims and importance of the study 
This project is a development of a previous study that showed a spectrum of response 
in naïve Blackface lambs with predicted genetic variability for resistance and 
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susceptibility to the GI nematode T. circumcincta (Beraldi et al., 2008).  The 
experiment focused on the phenotypic analysis of the cohort of lambs.  The lambs 
had been trickle-infected with L3 to simulate natural chronic infectio.  This has 
resulted in animals with a range of susceptibilities that reflected the nature and 
magnitude of the mature immune response. At one end of the spectrum were lambs 
with low faecal egg count and adult worm burden, and high IgA antibody and body 
weight.  At the other end of the spectrum were smaller lambs with high FEC and 
adult worm burden, and low IgA antibody.  Lambs with zero to low FEC were 
defined as resistant while those with high FEC were defined as susceptible. Adult 
worms were highly aggregated in a few susceptible lambs and absent in resistant 
lambs, while the early arrested larvae (EAL4) were uniformly distributed across the 
flock.   
I hypothesized that the spectrum of response in lambs has an immunological basis 
and that the expression of the immune response can be quantitatively correlated with 
phenotypic parameters of resistance.  Since orchestration of the different TH cell  
affects the consequent immune response, four subsets of CD4+ T cells (TH1, TH2, 
TH17, Treg) were investigated.  This was done by measurement of the transcripts of 
their characteristic markers and effector cytokines and quantitative expression 
correlated with individual traits of resistance and susceptibility.  The study tested this 
hypothesis with the following specific objectives: 
 
1. To quantify expression of genes associated with the different CD4+ T cell 
subsets in order to determine differential activation of  Treg and TH17 cells 
as well as the interaction between TH1 and TH2 subsets in resistant and 
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susceptible lambs.   
2. To develop an optimized real-time RT-qPCR assay for quantifying 
expression of a set of cytokines and markers in sheep. 
3. To correlate differentially-expressed genes in resistant/susceptible lambs with 
phenotypic traits. 
4. To describe the abomasal pathology associated with T. circumcincta infection 
in lambs in known resistant and susceptible lambs. 
5. To determine the presence of mutations in genes found to be differentially-
expressed in resistant/susceptible lambs. 
The study formed part of a big project with the ultimate aim to identify molecular 
markers for marker-assisted selection of sheep with resistance to T. circumcincta.  To 
attain this long-term goal, this study explored the dynamics of T cell immunity 
during T. circumcincta infection for possible identification of candidate gene marker. 




Chapter 2 Materials & Methods 
   




2.1 Animal experiment and tissue sample collection   
2.1.1 Source of tissue samples 
Tissue samples used in the study were sourced from a previous experiment (Beraldi 
et al., 2008) on 57 Blackface lambs bred at the Roslin Institute (Edinburgh, UK).. 
The parents of the study lambs belonged to a Blackface sheep population used 
previously for quantitative genetic and quantitative trait loci (QTL) analyses of FECs 
(Davies et al., 2006) and estimated breeding values for FECs of the parents were 
available. The dams available for mating were grouped into those above and below 
the mean of the sample. The mean breeding value for log-transformed FECs for the 
top-half dams was 0.193 (SD = 0.160, n = 23) while for the bottom-half the mean 
was 0.573 (SD = 0.138, n = 19). The three sires had breeding values of 0.468, 0.228 
and 0.063. In order to spread genetic variation in parasite resistance across the 
progeny, each sire was mated with an equal number of dams from the top-half and 
bottom-half of the breeding value distribution. The lambs had been kept as parasite-
free as possible by preventing them from grazing on pasture until the start of 
experimental infection.  Pregnant ewes were had been brought indoors and treated 
with three different parasiticides, moxidectin (Cydectin, 1 ml/5 kg body weight), 
levamisole (Levacide, 0.5 ml/2 kg), and fenbendazole (Panacur, 2.5–3 ml/sheep) 
After weaning at about three-month of age lambs had been infected with 
approximately 2,300 Teladorsagia circumcincta infective larvae (infected group) or 
sham-dosed (uninfected control) three times weekly until sacrifice (1214 weeks).  
The phenotypic data (FEC, AWC, IgA antibody levels, and body weight) used in the 
current study were generated from the experiment (Beraldi et al., 2008) described. 
Individual FEC was determined by modified McMaster technique (MAFF, 1968) two 




weeks before infection and on alternate weeks thereafter until sacrifice.  Adult worm 
counts were calculated from aliquots of the abomasal contents collected at post-
mortem.  Body weight was recorded at the start of the experiment (Day 02) which 
continued every two weeks until sacrifice (Figure 2.1).  Antibody capture ELISA in 
the serum has been performed to determine anti-T. circumcincta IgA measurements.  
Faeces for FEC were collected from each animal two weeks before infection and on 
alternate weeks thereafter until sacrifice while adult worm numbers were determined 
post-mortem.  Blood values and body weight were recorded at the start of the 
experiment (Day 02) which continued every two weeks until sacrifice (Figure 2.1). 
2.1.2 Tissue collection and preservation 
The lambs were sacrificed after approximately 3.5 months post-infection. Tissue 
blocks of abomasum and gastric lymph nodes measuring 5 mm thick were collected 
from each animal. The tissue samples were either preserved in RNAlater® (Ambion, 
UK) prior to storage in -80C for RNA extraction, or fixed in Zinc Salt fixative for 
histopathology (Gonzalez et al.,  2001). 
2.1.3 Histopathology 
Fixed tissue samples were sent to the Veterinary Pathology Unit, R(D)SVS, 
University of Edinburgh for processing into 5 µm thick sections stained with routine 
haematoxylin and eosin or toluidine blue for mast cell quantification. 
 
   








Figure 2.1  Experimental design and sampling schedule for phenotype analysis in 
lambs.  Resistant and susceptible lambs were infected with 2,300 L3 infective larvae 
three times a week until three days before sacrifice; non-infected controls were 
sham-dosed.  Phenotype data were collected and evaluated every two weeks (Beraldi 
et al.,  2008). Adult worm count was determined post-mortem.  Abomasal lymph 
node and abomasal mucosa were also collected for RNA extraction.  
   




2.2 RNA Methods 
2.2.1 RNA Extraction from abomasum and lymph node 
Total RNA was extracted using the protocol in the RiboPure™ kit (Ambion, UK) for 
abomasal lymph nodes, and RNeasy Mini Kit for abomasal mucosa tissue (Qiagen®).  
All samples were DNase I digested using Turbo DNAfree (Ambion, UK) as 
instructed in the kit (Section 2.2.1.2).  This was used as the starting material in the 
study (Table 1, Appendix 1). 
2.2.1.1 Quantification and assessment of RNA/DNA purity by UV 
absorbance  
The concentration of RNA/DNA was determined using the Nanodrop® ND-1000 
spectrophotometer (Nanodrop Technologies, Inc).  A 1.2 µl aliquot of nuclease-free 
water was selected as the zero absorbance reference.  Another 1.2 µl aliquot of 
sample was loaded onto the measurement pedestal and the absorbance was measured 
over a continuous spectrum producing a graph.  The A260/A280 and A260 /A230   ratios 
were calculated; an A260/A280 ratio in the range of 1.8 and 2.0 is generally acceptable 
as pure for DNA and RNA respectively.  The A260 /A230 ratio is used as a secondary 
measure of nucleic acid purity; values outside the 2.02.2 may suggest organic 
chemical contamination such as phenol and thiocyanates.  Data on quantification and 
assessment of extracted RNA from the lymph node and abomasal tissue samples are 
presented in Table 1, Appendix 1. 
2.2.1.2 DNase treatment of RNA 
The Turbo DNA-free™ kit (Ambion) was used for DNase re-treatment of RNA 
samples to remove contaminating genomic DNA.  This was done in samples that 




tested positive for DNA contamination in RT-minus reactions (Section 2.2.2).  A 0.1 
µl volume of 10x Turbo DNase buffer and 1 l Turbo DNAse I (2 U) were added to 
each tube containing eluted RNA.  The tubes were incubated for 30 min at 37C.  A 
0.1 µl volume of resuspended DNase inactivation reagent was added then incubated 
further for 5 min at room temperature with mixing. The tubes were then centrifuged 
at 10,000 x g for 1 min to pellet the inactivation reagent.  The supernatant was 
collected into microtubes and stored at -80C. 
2.2.1.3 Evaluation of RNA quality and integrity by Agilent bioanalyzer 
The quality and integrity of the RNA samples were analysed using the Agilent 
bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies).  This 
procedure assesses the RNA quality based on the concentration, ribosomal ratio and 
assessment of possible DNA contamination.  It also gives an RNA Integrity Number 
(RIN) for eukaryote total RNA as basis on evaluating the degradation of products.  
The RIN ranges from 1 (lowest integrity) to 10 (highest integrity); the cut-off value 
for the RIN in this experiment is 6.0 (Fleige and Pfaffl,  2006). 
All reagents for chip preparation were allowed to equilibrate to room temperature for 
30 min prior to use.  The chip was prepared by placing 550 l of RNA 6000 Nano 
gel into a spin filter tube then centrifuged at 1,500 x g for 10 min.  Gel-dye mix was 
prepared by mixing 65 l of filtered RNA 6000 Nano gel matrix with 1 l RNA 
6000 Nano dye concentrate.  The gel-dye mixture was centrifuged again at 10,000 x 
g for 10 min.   




A new RNA chip was placed on the Chip priming station.  A 9 l aliquot of Gel-Dye 
mix was pipetted in the well marked (G).  The chip was pressurized before loading 9 
l aliquot of gel-dye mix into the two wells marked (G).  A 5 l aliquot of RNA 
6000 Nano marker was added in all 12 sample wells and in well marked ().  An 
additional 1 l had to be loaded in unused wells.  The RNA samples and the RNA 
6000 Nano ladder aliquot were heated to 70C in water bath for 2 min to denature 
any secondary structure. A 1 l aliquot of ladder was added to the well marked (), 
then 1 l RNA was added to each of the sample wells.  The chip was vortexed at 
2,400 rpm for 1 min on an IKA chip vortex then positioned into the Agilent machine.  
The required RNA Nano assay was set on the Agilent 2100 Expert software (total 
RNA Nano) and the assay was performed.  
2.2.2 Reverse transcription  
Superscript III First Strand Synthesis system for RT-PCR Kit (Invitrogen™) kit was 
used to synthesize first strand cDNAs from the total RNA samples extracted 
previously.  A 1 l aliquot of oligonucleotide (dT) primers and 1 l of dNTP mix (10 
mM each) were added to 0.5-1 g of total RNA in 10 l final volume.  The tubes 
were heated to denature at 65C for 5 min and then cooled on ice for 1-5 min. A 
cDNA synthesis master mix containing 2 l of 10x RT Buffer, 4 l  25 mM MgCl2, 2 
l 0.1M DTT, 1 l  40 U/l RNaseOut and 1 l Superscript III RT (200 U/l) was 
prepared.  A 10 l aliquot of the master mix was added to each RNA/primer mixture.  
The reaction was incubated at 50C for 50 min followed by 5 min at 85C to 
inactivate the enzyme.  Reverse transcription without transcriptase (RT-minus), 
which was substituted with nuclease-free water was done as control experiments to 




detect products amplified from genomic DNA contamination which would interfere 
with qPCR applications.   
2.3 Polymerase chain reaction (PCR) 
2.3.1 Design of oligonucleotide primers 
Primers used for PCR and quantitative real-time RT-PCR (RT-qPCR) are presented 
in Table 3.1 and 3.2. RT-qPCR runs for IL-6, IL-10, IL-12B, IFN and TGFβ1 were 
performed using primers designed previously (Smeed et al., 2007; Gossner et al., 
2011).  The assay for these transcripts was re-optimized and the other transcripts 
worked out to suit an optimum quantification assay for the samples to be analysed in 
the current study.  Where available, ovine-specific sequences were used 
(http://www.ncbi.nlm.nih.gov/). Otherwise, sequences from the bovine species were 
utilized for the amplification of sheep sequences.  Sheep amplicons were cloned and 
sequenced; these sequences were then used to design ovine-specific primers.  
Primers for the genes of interest were designed either manually or by using Primer 3 
Plus (Untergasser et al.,  2007).  Since primers will be used for downstream RT-
qPCR applications stringent criteria were set which include: product size 100-200 bp, 
primer size 18-24 bp, primer Tm 55-60C with a maximum difference of 2C, and 
GC content of 40-60 %.  Other primer features that were considered were the 
maximum self and 3-complementarity, and Poly-X (i.e. repeats of any nucleotide in 
the primer sequence) that was set at 2.0-3.0.   
The designed primers were analyzed for secondary structure and dimerization in 
NetPrimer software (http://www.premierbiosoft.com/netprimer/index.html) with 
targeted score of 100 or nearest.  More emphasis was placed on the similarity in Tm, 




GC content, and G between the primers.  Primers forming hairpin loops, dimers, 
cross-dimers, palindromes and repeats were avoided as much as possible. 
Upon selection of suitable primers, specificity was checked using BLASTn (Altschul 
et al.,  1990).  Highly similar nucleotide sequence was searched to ensure that they 
were specific for the gene that they were designed for. 
2.3.2 PCR protocol 
PCR was performed using a PCR Sprint Thermocycler in a final volume of 50 l.  
Temperature gradient PCR was performed in PX2 Thermal cycler (Thermo 
Electron Corp.).  A typical reaction mix was set on ice which consisted of  5 l 10x 
Taq DNA Polymerase buffer (Promega) with or without MgCl2 (final concentration 
of MgCl2 varied from 2.0-4.0 mM), 1 l dNTP mix (to a final concentration of 200 
M each of dATP, dCTP, dGTP, and dTTP), 1 l of forward and reverse primer at 
500 M, 0.4 l Taq DNA polymerase (5 U/l), and 0.5-2.0 l diluted template DNA 
synthesized from 0.5-1.0 g of RNA.  The reaction was made to 50 l total volume 
with nuclease-free water.   
The programme was set to heat the samples to 94-95C for 2 min for the initial 
denaturation.  The second stage was the thermo-cycling phase, which consisted of a 
further denaturation of 30-60 sec at 94C, annealing at an appropriate temperature 
determined for each gene for 30-60 sec and an extension at 72C for 2 min.  This was 
usually repeated for 30-35 cycles before the final extension of 5-7 min at 72C.   
 




2.3.3 Agarose gel electrophoresis and examination in transillluminator 
PCR products were visualized by agarose gel electrophoresis.  The gels (1.0-1.2%) 
were prepared by dissolving LE Seakem, agarose powder (Cambrex Bio Science) 
into 1 % Bionic buffer (Sigma, Aldrich) and heated until the agarose was dissolved 
completely. The solution was cooled to 50C then 0.04 l /ml of GelRedTM Nucleic 
Acid Gel Stain (Biotium) was added before pouring the gel into the tray to allow it to 
set. 
The gel tray was fitted into the electrophoresis chamber and submerged in 1x 
Bionic™ buffer.  Samples were mixed with 6x loading dye (Promega) before loading 
into wells alongside DNA ladders at 100 bp size.  Electrophoresis was carried out at 
150V for ~30 min or until DNA separation was achieved.  The product size was 
determined through visualization of bands under UV light using UV- 
transillumination advanced imaging system (Alpha Innotech Fluorchem HD2). 
2.3.4 PCR product column purification  
The MinElute PCR Purification Kit (Qiagen®) was used to clean up the amplified 
DNA fragment in the PCR product.  5x volume of buffer PBI was added and mixed 
to each volume of PCR product.  The solution was applied onto the silica membrane 
of the spin column, and then centrifuged at 16,000 x g for 1 min (Biofuge Pico, 
Heraeus).  The flow through was discarded and the columns were washed with 750 
l buffer PE by centrifuging for another minute.  The flow through was discarded 
again and the columns centrifuged for a further 1 min before being transferred into 
new microtubes.  Elution buffer (10 mM Tris-HCl, pH 8.5) was applied onto the 




silica membrane, and then centrifuged at 16,000 x g for 1 min to elute the product.  
The eluted PCR product was quantified as described in Section 2.2.1.1. 
2.3.5 PCR product gel extraction 
For some genes, more than one DNA product was generated in the PCR reaction, 
which was revealed by gel electrophoresis (Section 2.3.3).  In these cases, products 
were purified by gel extraction using QIAquick Gel Extraction microcentrifuge 
protocol (Qiagen®).  The target DNA fragment was excised from the agarose gel 
with a scalpel.  The gel slice, which weighed ≤ 400 mg was placed in a microtube, 
where 3 volumes of buffer QG to 1 volume of gel were added.  The gel was 
incubated at 50C for 10 min to allow it to dissolve completely.  A gel volume of 
isopropanol was added and mixed with the sample before loading on a column then 
centrifuged for 1 min at 16,000 x g.  The flow through was discarded and the column 
was placed back in the same tube.  The sample was washed with 0.75 ml Buffer PE 
then centrifuged for 1 min at 16,000 x g.  The flow through was discarded and the 
tube was returned to the same tube and spun again as in previous step to remove any 
ethanol residue.  The column was then transferred to a clean microcentrifuge tube.  
To elute DNA, 50 l of Buffer EB was added and allowed to stand for a minute, and 
then centrifuged for another minute. 
2.4 Cloning and sequencing of ovine transcripts 
2.4.1 Ligation 
Purified PCR products were ligated and transformed using the pGEM-T Easy 
vector kit (Promega).  The ligation reaction was set up in 0.5 ml microcentrifuge 




tubes (Axygen) which consisted of 5 l of 2x ligation buffer, 1 l pGEM-T Easy 
vector (50 ng), 0.1-0.3 l of PCR product (at insert:vector ratio of 1:1 and 3:1), 1 l 
T4 DNA Ligase, and deionized water to a final volume of 10 l.  The reaction was 
mixed by pipetting, and then incubated at room temperature for 1 hr.  Alternatively, 
incubation was done overnight at 4C to increase the yield of transformants.   
2.4.2 Transformation in competent cells  
The recombinant DNA was allowed to replicate in E. coli JM 109 competent cells by 
mixing with the ligation reactions.  A 4 l aliquot of the ligation reaction was 
transferred to 15 ml Falcon tubes (Becton Dickinson Labware) on ice.  E. coli JM 
109 High Efficiency Competent Cells (Promega) were removed from -80C storage 
and allowed to thaw in an ice bath for about 5 min.  A 20 l aliquot of competent 
cells were transferred into each tube and placed back on ice for 20 min.  Heat shock 
was applied to the cells by immersing the tubes in water bath for 45 sec at 42C 
before cooling back in ice for 2 min.  A 980 l of LB broth (Appendix 2) was added 
in each tube with the competent cells-ligation reaction mixture.  The cells were 
incubated for 1.5 hrs at 37C in orbital shaker at 200 rpm.  Each transformation 
culture was plated on LB/ampicillin/IPTG/X-Gal agar plate (Appendix 2) then 
incubated overnight at 37C. 
2.4.3 Plasmid DNA extraction 
Plasmid DNA was isolated using the QIAprep Spin Miniprep kit (Qiagen).  
Colonies were picked from the agar plate then inoculated in 5 ml LB broth with 10 l 
ampicillin (Appendix 2).  The inoculants were put in a shaker incubator overnight at 




37C.  The bacterial cultures were pelletized by spinning at 4,000 rpm (2500 x g) for 
5 min then the supernatant was poured off.  The pelleted bacterial cells were re-
suspended in 250 l buffer P1 with added RNAse A then transferred to a new tube.  
The cells were lysed with 250 l buffer P2 (containing NaOH/SDS), and then 
neutralized by adding 350 l buffer N3 (containing guanidine hydrochloride and 
acetic acid).  In between these steps, the tubes were inverted six times to mix.  The 
tubes were then centrifuged at 16,000 x g for 10 min and the supernatants were 
transferred onto QIAprep spin columns.  To bind the plasmid DNA, the tube was 
centrifuged for 1 min at 16,000 x g, and the flow through was discarded.  This was 
followed by washing with 500 l buffer PB (containing guanidine hydrochloride and 
isopropanol) and centrifuged for 1 min at 16,000 x g.  The flow through was 
discarded before adding 750 l buffer PE to each column.  A further 1 min 
centrifugation was done to remove any residual buffer.  To elute the DNA, the 
column was transferred in a 1.5 ml collection tube, to which 50 l of buffer EB was 
applied before setting in the centrifuge at 16,000 x g for 1 min.  The eluted DNA was 
evaluated for purity and concentration by UV absorbance (Section 2.2.1.1). 
2.4.4 Digestion of plasmid with restriction enzyme  
The restriction enzyme used for each plasmid DNA was based on the detailed 
restriction map generated by the Sequence Manipulation Suite (SMI) software 
(http://www.bioinformatics.org/sms2/).  Restriction enzyme digestion was set up in 
total volume reaction of 20 l.  All reagents used were from New England Biolabs.  
The reaction was composed of 2 l 10x restriction enzyme buffer, 0.1 l BSA (if 
required), 0.5 g DNA, 0.5 l  restriction enzyme (2-10 U), and nuclease-free water.  




The components were mixed by pipetting and then the tubes were pulse-spun before 
loading in water bath for incubation.  The tubes were left in the bath for 1.5 hrs at 
37C.  Aliquots of the restriction digest were size-fractionated in routine agarose gel 
(Section 2.3.3) and visualized under UV trans-illumination. 
2.4.5 DNA Sequencing  
The BigDye Terminator v 3.1 Cycle sequencing kit (Applied Biosystems, 
Warrington, UK) was used to sequence pGEM T-easy plasmids in three independent 
reactions from each clone in forward and reverse directions.  The sequencing 
reaction was set up at 10 l total volume mix using the following components: 0.5 l 
Big Dye, 1.75 l 5x sequencing buffer, 3.2 l sequencing primer (SP6 or T7) , 
equivalent amount of 200-500 ng for cloned plasmids and 2-5 ng for purified PCR 
product of DNA template, and nuclease-free water.  The reaction was incubated in 
the PCR machine as follows: 96C for 10 sec, 50C for 5 sec, and 60C for 2 min, 
for 30 cycles. ABI 3730 capillary sequencing of samples was performed at the 
GenePool (http://genepool.bio.ed.ac.uk/). 
2.4.6 Analysis of sequences  
Three independent sequences were obtained for each clone and primers.  All 
sequences were checked with Basic Local Alignment Search Tool (BLAST) 
(Altschul et al.,  1990) to ensure that they contained the proper insert.  In case of 
mismatches, sequences were generated either from other clones in the same culture 
plate or from new set of clones. Consensus alignment with bovine or ovine 
sequences, where available, was performed using ClustalW2 (Larkin et al.,  2007).  




All nucleotide sequences generated and used in the study are presented in Table 2 
and 3, Appendix 1.   
2.4.7 Linearization and purification of plasmid DNA 
NdeI or NcoI enzymes (New England Biolabs) were used to linearize purified 
plasmid DNA of target genes.  The reaction was set up with 2 l of restriction 
enzyme buffer, 1-2 l of restriction enzyme, 500 ng of pDNA and nuclease free 
water to make up 10 l total volume.  The mixture was incubated overnight at 37C.  
A 2 µl aliquot of the plasmid was run on 0.8 % agarose gel to check if linearization 
was complete. 
Linearized plasmids were cleaned-up using MinElute Reaction Cleanup kit 
(Qiagen®).  A 300 l of buffer ERC was mixed with the pooled reaction then 
transferred into MinElute columns.  This was centrifuged at 16,000 x g for 1 min 
before adding 750 l of buffer PE, and then spun again for 1 min.  The flow through 
was discarded then centrifuged again for 1 min.  The column was then placed in a 
new collection tube where 10 l of buffer EB was added to elute the DNA.  Another 
1 min centrifugation step was done before collecting the eluted DNA.  A 2 l aliquot 
of the cleaned-up linearized plasmid was run on 0.8 % agarose gel to confirm that the 
linearization was complete. 
2.5 Optimization of RT-qPCR for sheep tissues 
2.5.1 Generation of standard curves from plasmids of DNA clones 
All reactions were prepared using CAS-1200 Precision Liquid Handling System and 
perfomed on the Rotor-Gene RG-3000 and The Rotor-Gene -Q in combination 




with Rotorgene software version 2.02 (Corbett Life Science), and SYBR Green I 
(Biogene) detection system.   
DNA from linearized plasmids (pDNA) from clones of target gene sequences were 
used to generate standard curves.  A total reaction volume of 10 l was set up 
containing: 1 l of 10x Taq DNA Polymerase buffer (Promega) with final 
concentration of MgCl2 optimized to a range of 2.0-3.5, 0.2 l dNTP mix (to a final 
concentration of 800 M), forward and reverse primer optimized at 0.25-1.0 M, 
0.35 l Sybr Green 0.1 %, 0.075 l Taq DNA polymerase (5 U/l), and 5 l template 
DNA synthesized from 0.5-1.0 g RNA.  Six serial dilutions of plasmid DNA diluted 
1 in 7 were assembled in duplicates in 72-well reaction plates.  5 ng of linearized 
plasmid DNA was used in the first standard to calculate for expected number of 
copies.  A no-template control (NTC) was included in the run to test for DNA 
contamination.   
The cycling conditions were optimized for each transcript but default setting was 
initially used which were as follows: 94ºC initial hold step, followed by 20 seconds 
each at 94ºC, 60ºC, and 72ºC for 40 cycles.  Fluorescence was acquired at the end of 
each cycle after the extension step to the FAM/SYBR green channel.  A hold step at 
94ºC for 20 sec was set to denature all annealing pairs before the melt curve analysis 
was performed at 65ºC rising to 94ºC at 1ºC per second increments. 
2.5.2 Optimization of primer concentration   
Primer concentration matrix which ranged between 0.11.0 µm, were set up using 
standard curve generated from pDNA (Section 2.3.3.1).  A no template control with 




the lowest and highest concentration was run alongside to detect contamination and 
amplification of primer dimers and   non-specific products.  Each primer 
combination was set up in duplicates.  Six serial dilutions of linearized pDNA with 
the insert of the gene of interest were included in the run.  Combinations of reverse 
and forward primers that yielded the lowest Cq without primer dimers were selected 
for each gene.   
2.5.3 Magnesium optimization 
After the suitable primer concentration for each gene of interest was identified, the 
amount of MgCl2 required to run an optimized RT-qPCR assay was determined.   
MgCl2 titration from 1.55.0 mM in 0.5 mM increments was set up.  Similar 
standard curves used in primer optimization were set up alongside different 
concentrations of MgCl2.  The assay was run in triplicates and the magnesium 
concentration that showed the lowest Cq and single melt peak curve with the least 
background was selected.  
2.5.4 Annealing temperature optimization 
The optimal annealing temperature for amplification was also determined for each 
gene after optimising magnesium and primer concentration.  The optimized standard 
curves taken from real time qPCR runs using pDNA samples were used to determine 
the efficiency of the PCR assays.  
2.5.5 Determination of optimum cDNA template concentration 
The best concentration of cDNA for RT-qPCR was determined for lymph node and 
abomasal tissues.  This step checks for inhibitory factors in the RT-qPCR assays that 




are associated with highly concentrated template.  Also, too dilute templates may 
give rise to low detectability and non-specific amplifications.   
A pool of neat cDNA from each of the samples was diluted 1/10 to 1/80 in nuclease-
free water to generate standard curves using the optimized primer and magnesium 
concentration and annealing conditions.  Standard curves from serial dilutions of 
pooled cDNA were used to confirm the efficiency and to determine the working 
concentration for the assays. The lowest cDNA concentration that gave the lowest Cq 
value and single peak melt curve was selected. 
2.5.6 Selection of reference genes 
Real time-qPCR runs on all cDNA samples were performed on four reference genes 
namely: GAPDH, HPRT, YWHAZ, and SDHA, which had been optimized for use in 
sheep tissues (Smeed et al.,  2007).  The stability of each reference gene was 
evaluated for each RT batch in both lymph node and abomasal tissues (Table 1, 
Appendix 1).  Each sample from one RT reaction was assayed in triplicate.  The 
plasmid dilution series (Section 2.5.1) was used as a standard curve.  Two reference 
genes were selected using GeNorm v3.4 (Vandesompele et al.,  2002) and the 
NormFinder Microsoft Excel applet  (Andersen et al., 2004).  The algorithms of 
these applications determined the most suitable gene in the given samples taking into 
account the average pairwise variation with all other tested reference genes.  Optimal 
normalization gene was identified among other candidate genes that allowed efficient 
estimation of overall expression and variation between sample subgroups.  YWHAZ 
and SDHA were chosen to normalize the RT-qPCR assays for both lymph node and 
abomasal tissues. 




2.6 Relative and absolute quantification assay 
2.6.1 Experimental set-up 
For the relative quantification assay, 15 samples were used from a total of 57 animals 
sourced from the phenotype experiment (Beraldi et al., 2008).  This was represented 
by the five most resistant and five most susceptible animals and the five uninfected 
controls for all 14 genes.  The groupings were defined according to the infection 
ranks of the lambs based on their FEC and adult worm count (Table 1, Appendix 1).   
Absolute quantification assay for five genes, which were found to have significant 
differential expression based on the relative quantification assay, was used in 55 
animals analysed individually and also in four groups.  Four groups consisted of 10 
uninfected controls and 15 each of the resistant, intermediate, and susceptible 
animals based on their infection ranks (Table 5.1). Two of the original 57 samples 
were excluded from the assay due to RNA degradation.  Both relative and absolute 
copy number expression levels were quantified in three replicates in three separate 
RT-qPCR runs, each time using cDNA from a different RT reaction. 
2.6.2 Data processing and analysis  
Gene expression levels were calculated in GenEx version 5.3.4.157 (www.multid.se) 
using the comparative 2-(ΔΔ Cq) method and normalized to the geometric mean of 
the stably-expressed reference genes (SDHA and YWHAZ).  Fold changes were 
calculated from delta Cq values using GenEx.  
Normalized copy numbers were obtained using the normalization factor determined 
by GeNorm. The expression levels were normalized by dividing the copy number 




derived from the standard curve by the calculated normalization factor for each 
individual sample.  Plasmid serial dilutions were run alongside cDNA samples for 
each gene to determine the copy numbers for each sample.   
The known copy numbers of plasmid DNA were used to estimate copy number of 
samples based on the formula: 
Number of molecules per ng = 1x10-9/(M g/mol) x 6.023x1023 molecules/mol 
Where (M) = size of plasmid and insert size in bp x 660 g/mol per bp 
 
 
2.6.3 Normalization of real time data 
Copy numbers of each gene of interest was normalized to allow for experimental 
variation in starting material both in the RT step and the cDNA template used in the 
RT-qPCR assay.  This also checks for technical errors within the run.  The 
normalization coefficient of each sample was determined based on the expression of 
the selected reference genes YWHAZ and SDHA.  Cq values of both genes were 
exported in Excel format, and then the GeNorm software (Vandesompele et al.,  
2002) was ran to calculate for individual sample normalization coefficient.  
2.6.4 Statistical analysis 
The mixed effect model of general linear analysis (using Minitab 15.1.0.0) was used 
to establish common variance among groups. This evaluated normal data distribution 
and calculated the variance associated with fixed effects of RT-qPCR replicate runs, 
reverse transcription steps and the effect of individual sheep differences within each 
group. Statistical differences between groups were determined by one-way ANOVA 




with Tukey-Kramer's post-hoc test for multiple pairwise comparison analysis, in 
GenEx. The correlations were analyzed with Spearman’s correlation coefficient 
using Graphpad Prism v 5.0. P-values less than 0.05 were considered significant.  
2.7 Identification of Ovar DRB1*0203 allele 
Identification of allele Ovar DRB1*0203 was conducted on the same group of 15 
animals used in relative quantification assay (Table 5.1).  Primers that had been used 
previously (Schwaiger et al.,  1995) were utilized to run a standard PCR as described 
in Section 2.3.2. 50 ng of genomic DNA extracted from the 15 lambs were used as 
template (Section 2.8.1.5). 
PCR products were purified (Section 2.4.3) and sequenced as described in Section 
2.4.5.  At least three independent sequences were generated from each sample, which 
were aligned with Ovar DRB*0203 allele using ClustalW2 (Larkin et al.,  2007) to 
generate a consensus.  Nucleotide consensus sequences were aligned with Ovar 
DRB*0203 allele and the archetypal Ovar DRB1.  Subsequently, the nucleotide 
sequences were translated to predicted amino acids and compared with the protein of 
DRB*1101.  
2.8 Single nucleotide polymorphism analysis of IL21 and IL21R 
2.8.1 Generation of full length sequence of IL21 and IL21R 
2.8.1.1 Cloning and sequencing of gene fragments  
Sets of primers were designed based on the bovine mRNA sequences (Table 6.2), to 
generate amplicons that span the coding regions of IL-21 and IL-21R.  Standard PCR 
(Section 2.3.2) was performed and the product purified (Section 2.3.4) for 




subsequent cloning and sequence analysis as described in Section 2.4.  At least three 
independent sequences were generated from each clone. 
2.8.1.2 Rapid amplification of cDNA ends (RACE) 
The sequences of the 5’UTR and 3’UTR of bovine IL-21 mRNA were not available 
in the genetic sequence database (Genbank®).  In order to generate a full length 
sequence spanning the coding region of IL-21, RNA ligase-mediated rapid 
amplification of 5’ and 3’ cDNA ends (RLM-RACE) was performed using the 
Invitrogen GeneRacer™ kit. 
2.8.1.2.1 Primer design for RACE 
At least two gene-specific primers (GSPs) were designed initially for 5’ end of IL-
21.  The primer sets were designed on the basis of the following criteria:  50-70 % 
GC content, 23-28 nucleotides long, and an annealing temperature greater than 72ºC 
to improve the specificity of the PCR. 
Four representative RNA samples extracted from the gastric lymph nodes selected 
for high concentration and purity were used for RLM-RACE.  The integrity and 
quality of RNA has been evaluated previously (Section 2.2.1.3).   
2.8.1.2.2 Dephosphorylating RNA 
To eliminate truncated mRNA and non-mRNA from subsequent ligation with the 
GeneRacer™ RNA Oligo, 5’ phosphates was removed.  Dephosphorylation was set 
up on ice in a 10 µl volume reaction containing 1 µg of total RNA, 1 µl 10x CIP 
buffer, 1 µl RNaseOut™ (40 U/ µl), CIP (10 U/ µl), and DEPC water.  The reaction 
was incubated at 50ºC for 1 hr, and then spun briefly before placing on ice. 




2.8.1.2.3 Precipitation of RNA 
After dephosphorylation, RNA was precipitated by adding 90 µl DEPC and 100 µl 
phenol:chloroform:isoamyl alcohol, (25:24:1) included in the kit.  The mix was 
vortexed vigorously for 30 sec before centrifuging at 12,060 x g for 5 min.  The 
aqueous top phase was aspirated and transferred to a microcentrifuge tube (100 µl).  
A 2 µl volume of 10 mg/ml mussel glycogen and 10 µl 3 M sodium acetate was 
added into the tube and mixed before freeze drying for 10 min.  To pellet RNA, the 
microtube was centrifuged at 12,000 x g for 20 minutes at 4°C.  The supernatant was 
removed by pipette and to the pellet was added 500 µl 70% ethanol.  The mixture 
was inverted several times, vortexed briefly, and then centrifuged for 2 min at 4°C.  
Ethanol was removed by pipette and then the remaining pellet was air-dried for 1-2 
min at room temperature.  The pellet was resuspended in 7 µl nuclease-free water. 
2.8.1.2.4 Removing the mRNA cap structure 
To remove the 5’ cap structure from full-length mRNA, a 10 µl decapping reaction 
was set up on ice.  The 7 µl dephosphorylated RNA was mixed with 1 µl 10x TAP 
buffer, 1 µl RNaseOut™ (40 U/µl), and 1 µl of TAP (0.5 U/µl).  The reaction was 
incubated at 37ºC for 1 hr, which was followed by a brief centrifugation before 
placing on ice.  RNA was precipitated and pelleted as described in section 2.8.1.2.3 
and then re-suspended in 7 µl DEPC water. 
2.8.1.2.5 Ligation of the RNA Oligo to Decapped mRNA 
After decapping the mRNA, the GeneRacer™ RNA Oligo was ligated into the 5’ end 
of the mRNA.  The 7 µl dephosphorylated, decapped RNA was added into the pre-
aliquoted, lyophilized GeneRacer™ RNA Oligo (0.25 µg), pipetted several times to 




ensure even mixing and resuspension of the RNA Oligo, then centrifuged briefly to 
collect fluid.  The reaction was incubated for 5 min to relax the RNA secondary 
structure, and then placed on ice for 2 min. The following reagents were then added 
to the tube: 1 µl each of 10X ligase buffer, 10 mM ATP, RNaseOut™ (40 U/µl), and 
T4 RNA ligase (5 U/µl).  The reaction was incubated at 37ºC for 1 hr followed by 
brief centrifugation before placing on ice.   
2.8.1.2.6 Reverse transcription 
RNA was precipitated as described previously (Section 2.8.1.2.3).  The RNA pellet 
was resuspended in 10 µl nuclease-free water then proceeded to reverse transcribing 
mRNA using SuperScipt III RT kit (Invitrogen).  To 10 µl ligated RNA was added 1 
µl each of primers in the kit, DNTP mix, and sterile water.  The reaction was 
incubated at 65ºC for 5 min to remove any secondary RNA structure. Subsequent 
steps were based on the protocol as described in Section 2.2.  The reverse transcribed 
RNA was stored at -20ºC. 
2.8.1.3 Amplifying cDNA ends 
In order to amplify the cDNA with known priming site at the 5’ end, PCR Setup was 
set up.  The reaction consisted of: 4.5 µl GeneRacer™ 5’ Primer (10 µM), 1.5 µl 
reverse GSP  (10 µM), RT template, 5 µl 10x Pfx amplification buffer, 1.5 µl dNTP, 
0.5 µl Platinum® Pfx DNA Polymerase (2.5 U/µl), 1 µl MgSO4 (50 mM), and 
nuclease-free water to a final volume of 50 µl.  The annealing conditions consisted 
of: an initial denaturation step at  94ºC for 2 min, followed by further denaturation at 
94ºC for 30 sec,  annealing at 67ºC for 30 sec and extension at 68ºC for 1 min in 25 
cycles.  After PCR, the product was analysed by gel electrophoresis (Section 2.3.3).  




If no distinct band but a smear was visualized, primers were designed to perform 
Nested PCR.  Nested PCR would increase the specificity and sensitivity of RACE 
products for the 5’ ends of the gene. 
2.8.1.3.1 Nested PCR 
To perform nested PCR, 1 µl of the original PCR product was used as a template.  
This was mixed with 1 µl GeneRacer™ 5’ Nested (10 µM), Reverse Nested GSP (10 
µM), 5 µl 10x PCR buffer, 1 µl dNTP Mix (10 mM each), 1 µl Platinum® Pfx DNA 
Polymerase (2.5 U/µl), 1 µl MgSO4 (50mM), and sterile water to a final volume of 
50 µl.  The cycling parameters used to amplify the product were: 94ºC for 2 min, 
94ºC for 30 sec, 65ºC for 30 sec, 68ºC for 2 min for 15-25 cycles and a final 
extension  stage at 68ºC for a cycle of 10 min.  The nested PCR product was 
analysed on an agarose gel (Section 2.3.3), then gel-purified (Section 2.3.5) to set up 
the TOPO® cloning reaction. 
2.8.1.4 Cloning and sequencing of RACE products 
The TOPO® cloning reaction protocol was applied to the nested PCR product for 
eventual transformation into competent E. coli cells.  The reaction consisted of the 
following: 100 ng of PCR product, 1 µl of salt solution, and sterile water to a total 
volume of 5 µl before adding 1 µl of TOPO® vector (One Shot® TOP10).  The 
reaction was incubated at 23ºC for 5 min, and then placed on ice. 
2.8.1.4.1 Transforming One Shot® TOP10 Competent cells 
An aliquot of 2 µl TOPO® cloning reaction was added into a vial of One Shot® 
chemically-competent E. coli.  The cells were incubated for 5 min then heat-shocked 




for 30 sec at 42ºC.  The tubes were transferred on ice before adding 350 µl of SOC 
medium.  The tube was then placed horizontally in a shaker incubator (200 rpm) at 
37ºC for one hour.  A 10-50 µl volume of each transformant was spread on a pre-
warmed selective plate and then incubated overnight at 37ºC.  Ten colonies were 
picked from the plate, followed by overnight incubation in orbital shaker at 37ºC in 
LB agar containing 50 µg/ml kanamycin.  Plasmids were isolated (Section 2.4.3) and 
then evaluated for concentration and purity (Section 2.2.1.1).  Plasmid inserts were 
analysed by restriction analysis (Section 2.4.4). 
2.8.1.5 Genomic DNA extraction from tissues 
Genomic DNA of 55 lambs which served as template for SNP analysis was extracted 
using the DNeasy Blood kit (Qiagen®).  Frozen whole blood cells in EDTA (0.5 M, 
pH 8.0) were thawed completely.  To 25 µl of blood cells were added 20 µl of 
proteinase K (20 mg/ml) and 175 µl PBS.  The tube was vortexed to mix thoroughly 
before adding 200 µl of buffer AL, and then incubated at 56ºC for 10 min.  A 200 µl 
volume of ethanol was added and mixed before loading into DNEasy columns.  The 
tubes were centrifuged at 6,000 x g for 1 min.  The flow through was discarded and 
the spin column was placed into a 1.2 µl collection tube.  500 µl buffer AWI was 
added and then centrifuged for 1 min at 6,000 x g.  The flow through was discarded 
and the tube placed in a new collection tube.  500 µl of AW2 buffer was added and 
then centrifuged for 3 min at 20,000 x g.  The flow through and collection tube was 
discarded.  Finally, the spin column was placed in a clean microcentrifuge tube.  500 
µl of buffer AE was pipetted onto the DNEasy membrane, incubated for 1 min and 
then centrifuged at 6,000 x g to elute the gDNA. 




2.8.2 High-resolution Melt Analysis (HRM) 
High resolution melt analysis is a technique that detects variation in nucleic acid 
sequences after amplification of the gene by PCR (Nguyen-Dumont et al.,  
2009;Vossen et al.,  2009).  A specialized dye is used which is highly fluorescent 
when bound to double stranded DNA and poorly fluorescent when unbound.  Post-
amplification, the PCR product is gradually denatured by increasing the temperature 
in small increments.  This results in release of the dye and drop in fluorescence 
producing the characteristic melting profile.  HRM characterizes DNA samples 
according to their dissociation behaviour as they transition from double-stranded to 
single-stranded DNA (ssDNA) with increasing temperature. 
2.8.2.1 Primer design 
Specific considerations were made in designing primers for HRM PCR in addition to 
those mentioned in Section 2.2.3.1.  Primers were 18-30 nucleotides long, have 
melting temperature of ≥ 56ºC, and GC content of 40-60 %. 
2.8.2.2 High resolution melt PCR 
HRM PCR assays were performed with the Rotor-Gene Q using the Type-it® 
HRM™ PCR protocol with reactions set up using CAS-1200 Precision Liquid 
Handling system (all Qiagen).  The top ten each of the most resistant and most 
susceptible lambs based on their infection ranks were used for HRM analysis.  The 
reaction mix was composed of 5.0 µl 2x HRM PCR Master Mix, 0.7-1.0 µl of 
forward and reverse primer (10 µM), 1-3 ng of gDNA template and sterile water to 
make a final volume of 10 µl.  The recommended cycling protocol for HRM analysis 
on the RotorGene-Q machine was initially used, and then optimized for each specific 




gene fragment of the full-length sequence.  Cycling conditions included an initial 
PCR activation step of 5 min at 95ºC followed by 3-step cycling which consisted a 
denaturation step of 10 sec at 95ºC and a combined annealing/elongation step of 30 
sec at 55ºC for 45 cycles.  The amplification step was followed by continuous 
fluorescence data acquisition of the melting points which ran for 2 sec ramping 
between 65- 95ºC at 0.1ºC increments.  
2.8.2.3  HRM-PCR data analysis 
2.8.2.3.1 Product amplification analysis 
All HRM-PCR data analyses were done using the Rotorgene-Q software version 2.02 
(Corbett Life Science). Prior to HRM data analysis, quantitative real-time 
amplification of the PCR product for each sample was analysed.  A filtering system 
was instituted to improve the efficiency of the subsequent HRM analysis which 
included: Cq values of the amplification step at < 30, individual reaction efficiency 
of > 1.4, and a single melt peak generated by melt curve analysis which is indicative 
of a single amplified product.  Gene fragments that did not meet these criteria were 
repeated or optimized. 




2.8.2.3.2 Normalization of HRM data 
HRM analysis was viewed as a normalized or a difference plot.  Normalized curves 
provided differences in genotypes based on curve shifting and curve shape change.  
Difference plots draw a visual interpretation of melt curve transitions as 
distinguished change in fluorescence of a sample to a selected control at each 
temperature transition. 
The regions at least 5ºC below and above the Tm of the samples were manually 
selected for each HRM assay, encompassing representative baseline data for the pre-
melt and post-melt phases.  Data points within these regions were included in the 
analysis.  
In the difference graph plot, the genotype bar was selected to identify the sample that 
will be compared to all other samples against.  Since no reference sample was 
included in the assay, samples with replicates that stick together and lie close to the 
middle of the spectrum were selected.  A confidence value which provided an 
integrity check of auto-called results was set at 90 %.  Samples that fell below this 
threshold were flagged as variation.  PCR products from these samples were purified, 
cloned and sequenced for SNP analysis.  
2.8.3 SNP analysis of sequences 
Three clones of each gene fragment that showed differential expression in HRM 
analysis were sequenced on both strands (Section 2.4.5).  All sequences were aligned 
against the generated ovine full length sequence (Section 2.8.1) using ClustalW2 
(Larkin et al.,  2007) to generate a consensus.  Differences between the genomic 




sequences were considered to be SNPs when the similar change was established in 
two or more of the aligned sequences. 
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3.1   Introduction 
A major hindrance in understanding the immune-pathological basis of ovine diseases 
is the lack of adequate assays suitable for quantifying gene expression.  The advent 
of functional and capture protein arrays have found their way to the mainstream of 
protein expression studies but its application is almost exclusive to mouse models 
and humans.  Whilst it is ideal that protein levels are measured to represent gene 
expression, there is limited availability of antibodies in sheep (Amsen et al., 2009).  
Moreover, the low expression of certain genes (e.g. many cytokines in tissues) 
renders the measurement of protein levels impractical.   
Quantifying gene expression by transcript measurements is however limited by its 
possible misrepresentation of the actual protein levels in tissues.  Inconsistent protein 
expression with mRNA transcript levels has been linked to post-transcription and 
post-translation modifications.  For example, IL-4 and IL-10 can be partially 
degraded at the translation stage (Amsen et al., 2009; Le et al., 1997), or post-
transcriptionally with IL-1 and IL-18 (Harness et al., 2001).  However, several 
studies have established correlation between cytokines measured by RT-qPCR and 
protein levels quantified by enzyme-linked immunosorbent assay (Heid et al., 1996; 
Overbergh et al., 2003; Overbergh et al., 1994; Whelan et al., 2003). 
In order to quantify the expression of gene transcripts that are associated with 
resistance and susceptibility to T. circumcincta, which is the primary aim of this 
project, I developed an optimized RT-qPCR assay for sheep.  RT qPCR is a tool in 
quantifying gene expression particularly in lowly-expressed transcripts like cytokines 
(Giulietti et al., 2001).  RT-qPCR allows for the quick and direct measurement of 
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PCR product during the exponential phase of amplification of genes (Overbergh et 
al., 2003).  The dynamic range of quantification, high accuracy, sensitivity and 
reproducibility offered by RT-qPCR (Gibson et al., 1996; Heid et al., 1996) makes it 
a reliable choice in gene expression analysis.  Cytokine expression can also be 
evaluated using techniques such as Northern blot and in situ hybridization but these 
are, at best semi-quantitative and require high amounts of RNA which are not often 
available (Vandenbroucke et al., 2001).  This is overcome by RT-qPCR because it 
can generate accurate and reliable data even with small amounts of template. 
The starting material in this project is the extracted RNA from abomasal mucosa and 
lymph nodes.  It is desired whenever possible that samples to be assayed should have 
undergone similar RNA extraction process prior to all downstream applications.  It 
was therefore necessary that the assay be optimized before utilizing the RNA 
samples to ensure that the same material is used for all the assays. 
This study aimed to develop a workable RT-qPCR assay that would provide an 
efficient and accurate quantification of ovine transcripts.  The approach involved 
cloning and sequencing of ovine mRNA transcripts for a panel of cytokines and 
markers that characterize the immune response of sheep to T. circumcincta infection.  
All factors that influence the quantification of gene transcripts with RT-qPCR were 
optimized like primer and magnesium concentration, and the annealing conditions.   
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3.2   Primer design and amplification of RT-qPCR product 
Primers were designed as described in Section 2.3.1.  It was also considered that 
primers hybridize to about half the 3’end of one exon and to the 5’end of the next 
exon to avoid co-amplification of genomic DNA.  RT-qPCR was performed using 
the basic thermo-cycling reactions detailed in Section 2.3.2.  Temperature gradients 
and increasing concentrations of MgCl2 were employed to increase detection 
sensitivity of the RT-qPCR (Bustin,  2004,  2009). 
The RT-qPCR protocol was developed for a panel of cytokines and markers that 
included IL-2, IL-4, IL-7R, IL-17A, IL-21, IL-23A, IL-25, EBI3, and FOXP3.  Other 
transcripts in the panel (IL-6, IL-10, IL-12p40, IFN, and TGFβ) including the 
reference genes SDHA and YWHAZ primers had been designed previously (Gossner 
et al., 2011b; Smeed et al.,  2007)  and re-optimized for the current study.  Bovine 
sequences were utilized initially to design primers for ovine transcripts that were not 
available from published sequence database; these included IL-7R, IL-17A, IL-21, 
IL-23A, and IL-25 (Table 3.1).  Table 3.2 shows the primers used to sequence the 
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Table 3.1  Primer sets based on Bos taurus sequence for amplification of ovine 
cytokine transcripts by endpoint PCR.   
Gene Accessi
on No. 








































































52⁰C 500 4.0 928 
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Table 3.2.  Primers used in RT- qPCR assay. 
Gene Accession number Primer sequence (5’ to 3’) Product size 
    








IL-6 X68723.1 F: TCCAGAACGAGTTTGAGG 
R: CATCCGAATAGCTCTCAG 
236 










IL-12p40  AF004024 F: TCAGACCAGAGCAGTGAGGT 
R: GCAGGTGAAGTGTCCAGAAT 
243 
IL-17A NM_001008412.1 F: GAAGGCCCACCGATTATC 
R: GCATTGATACAGCCTGAGTG 
124 
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Table 3.2 cont’n 
Gene Accession number Primer sequence (5’ to 3’) Product size 
IL-23A XM_588269.4 F: ACCTGTGAGCCAATGAGTTC 
R: GGTCAACATCGTCAGTCAGTC 
93



















TGFβ X76916 F: GAACTGCTGTGTTCGTCAGC 
R: GGTTGTGCTGGTTGTACAGG 
170 
SDHA* NM_174178.2 F: ACCTGATGCTTTGTGCTCTGC 
R: CCTGGATGGGCTTGGAGTAA 
126 
YWHAZ* AY970970.1 F:TGTAGGAGCCCGTAGGTCATC 
R: TCTCTCTGTATTCTCGAGCCATC 
101 
* reference genes 
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OVINE      -------------------------------------------CTAAGGTGGATGGCATT 17 
BOVINE     AATGTGAGTTTCAATCCTGAAAGTTTCCTGGACTGCCAGATTCATAAGGTGGATGGCATT 948 
HUMAN      AATGTGAGTTTCAATCCTGAAAGTTTCCTGGACTGCCAGATTCATAGGGTGGATGACATT 1031 
MURINE     AATGTGAGTTTCAATCCCGAAAGTTTCCTGGACTGCCAGATTCATGAGGTGAAAGGCGTT 1076 
                                                      .*..****.*:*.*.** 
 
OVINE      CAAGCTAGAGATGAAGCAGAAGGCTTCCTGCAAGACCCTCTTTCTCTGCAGCTAGAGGAG 77 
BOVINE     CAAGCTAAAGATGAAGCAGAAGGCTTCCTGCAAGACCCTCTTCCTCCACAGCCAGAAGAG 1008 
HUMAN      CAAGCTAGAGATGAAGTGGAAGGTTTTCTGCAAGATACGTTTCCTCAGCAACTAGAAGAA 1091 
MURINE     GAAGCCAGGGACGAGGTGGAAAGTTTTCTGCCCAATGATCTTCCTGCACAGCCAGAGGAG 1136 
            **** *..** **.* .***.* ** ****...*  .  ** **  .**.* ***.**. 
 
OVINE      AGTGAGAAGCAGAGGTTCAGAGGCGGGATGCAGGGTCCCAGCTGGCCCTCCGAGCAAGCA 137 
BOVINE     AGTGACAAGCAGAGGTTCAGAGCCGGGATGCAGGGTCCCAGCTGGCCCTCCGAGCAAGCA 1068 
HUMAN      TCTGAGAAGCAGAGGCTTGGAGGGGATGTGCAGAGCCCCAACTGCCCATCTGAGGATGTA 1151 
MURINE     TTGGAGACACAGGGACACAGAGCCGCTGTACACAGTGCAAACCGCTCGCCTGAGACTTCA 1196 
           :  ** *..***.*. : .***  *  .*.** .*  *.*.* *  *  * *** .:  * 
 
OVINE      GGCATTACGCCTAAAATTTTCAGAGGAGAGTCACCATTCAGATGCTTGGCTGGGAATGCC 197 
BOVINE     GGCATTACCCCTAAAATTTTCAGAGGAGAGTCACCATTCAGATGCCTGGCTGGGAATGCC 1128 
HUMAN      GTCATCACTCCAGAAAGCTTTGGAAGAGATTCATCCCTCACATGCCTGGCTGGGAATGTC 1211 
MURINE     GTCAGCCCACCAGAAACAGTTAGAAGAGAGTCACCCTTAAGATGCCTGGCTAGAAATCTG 1256 
           * **  .* **:.***   * .**.**** *** *. *.* **** *****.*.***    
 
OVINE      AGTGTGTGTGATGCCCCTGGGCTTCCCTCCTCCAGGTCTCCTAATGGCAGGGATGGTGGC 257 
BOVINE     AGTGTGTGTGATGCCCCTGGGCTCCTCTCCTCCAGGTCTCCTAATGGCAGGGAAGGTGGC 1188 
HUMAN      AGTGCATGTGACGCCCCTATTCTCTCCTCTTCCAGGTCCCTAGACTGCAGGGAGAGTGGC 1271 
MURINE     AGTACCTGCAATGCCCCTCCACTCCTTTCCTCTAGGTCCCCTGACTACAGAGATGGTGAC 1316 
           ***.  ** .* ******   **    ** ** ***** * :.*  .***.** .***.* 
 
OVINE      AAGAGCAGACCTCTAGTGTACCAGGACCTGCTCCTCAGACCTGGAACTACAAA----CAG 313 
BOVINE     AAGAGCAGACCTCTAGTGTACCAGGACCTGCTCCTCGGACCTGGAACTACAAA----CAG 1244 
HUMAN      AAGAATGGGCCTCATGTGTACCAGGACCTCCTGCTTAGCCTTGGGACTACAAA----CAG 1327 
MURINE     AGAAATAGGCCTCCTGTGTATCAAGACTTGCTGCCAAACTCTGGAAACACAAATGTCCCT 1376 
           *..*. .*.**** :***** **.*** * ** *  ...  ***.*. *****    *.  
 
OVINE      CTCCCTG--TCCCCTTCGTTTCCATTCCAACCCGGAATCCTGACATTAAACCCTGTTGCC 371 
BOVINE     CTCCCTG--CCCCCTCCGTTTCCATTCCAACCCGGAATCCTGACATTGAACCCTGTTGCC 1302 
HUMAN      CACGCTG--CCCCCTCCATTTTCTCTCCAATCTGGAATCCTGACATTGAACCCAGTTGCT 1385 
MURINE     GTCCCTGTCCCTCAACCATTGCCTTTCCAGTCGGGAATCCT------GATACCAGTTTCT 1430 
            :* ***   * *.: *.**  *: ****. * ********      .*:.**:*** *  
 
OVINE      CAGGGGCAGCCCATCCTCACTTCCTTGGGATCAAGTCAAGAAGAAGCCTATGTCACCATG 431 
BOVINE     CAGGGGCAGCCCATCCTCACTTCCTTGGGATCAAGTCAAGAAGAAGCCTATGTCACCATG 1362 
HUMAN      CAGGGTCAGCCCATTCTTACTTCCCTGGGATCAAATCAAGAAGAAGCATATGTCACCATG 1445 
MURINE     CAGAGACAGCCCATCTCCACTTCCTCAGTACTGAATCAAGAAGAAGCGTATGTCACCATG 1490 
           ***.* ********    ******  .* *  .*.************ ************ 
 
OVINE      TCCAGCTTCTACCAAAACCAGTGAGTTGTAAGAAACCCAAGAT---------CAGAACCA 482 
BOVINE     TCCAGCTTCTACCAAAACCAATGAGTTGTAAGAAACCCAAGAT---------CAGAACCA 1413 
HUMAN      TCCAGCTTCTACCAAAACCAGTGAAGTGTAAGAAACCCAGACTGAACTTACCGTGAGCGA 1505 
MURINE     TCTAGTTTTTACCAAAACAAATGAATTATAAGAAAACCCTTCCAT-------CGACAACC 1543 
           ** ** ** *********.*.***. *.*******.**.  .            .... . 
 
OVINE      TCATGATGACCGAA---------------------------------------------- 496 
BOVINE     TCATGATGAACGAAGATG------ACTGAGTCCCACTCTCTCCCACAGCACAAACAAACA 1467 
HUMAN      CAAAGATGATTTAAAAGGGAAGTCTAGAGTTCCTAGTCTCCCTCACAGCACAGAGAAGAC 1565 
MURINE     AAATGATCACTGAGATGGAAAGTCTGGAATGCTTGCTCTCCCCCGTAGCTCACAGAAGAG 1603 
                 .*:*** *   *.                                               
 
Figure 3.1  Alignment of sheep IL-7R nucleotide sequence with cattle (XM_599818.4), 
human (NM_002185.2), and mouse (NM_008372.4) sequences; with alignment scores 
against ovine transcripts of 95 %, 77 %, and 67 % respectively. (*) indicates identical 
nucleotide bases in all sequences. 
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OVINE      --------------------------------------TGAATTTCTGCCAGCTCCAGAA 22 
BOVINE     GTTGATCAGCTGAAAAACTATGTGAATGACTTGGATCCTGAATTTCTGCCAGCTCCAGAA 192 
HUMAN      GTTGATCAGCTGAAAAATTATGTGAATGACTTGGTCCCTGAATTTCTGCCAGCTCCAGAA 240 
PORCINE    GTTGATCAGCTGAAAAATTATGTTCATGACTTGGACCCTGAATTGCTGCCAGCTCCAGAA 122 
MURINE     GTTGAACAGCTGAAAATCTATGAAAATGACTTGGATCCTGAACTTCTATCAGCTCCACAA 227 
                                                 **** * **. ******** ** 
 
OVINE      GATGTAAAGAGACACTGTGAGCGGTCAGCTTTTTCATGTTTTCAGAAGGTTCAACTAAAG 82 
BOVINE     GATGTAAAGAGACACTGTGAGCGGTCAGCTTTTTCATGTTTTCAGAAGGTTCAACTAAAG 252 
HUMAN      GATGTAGAGACAAACTGTGAGTGGTCAGCTTTTTCCTGCTTTCAGAAGGCCCAACTAAAG 300 
PORCINE    GATGTACAGAGACACTGTGAGCAGTCAGCTTTTTCATGTTTTCAGAAGGTCGAACTAAAG 182 
MURINE     GATGTAAAGGGGCACTGTGAGCATGCAGCTTTTGCCTGTTTTCAGAAGGCCAAACTCAAG 287 
           ****** **. ..******** .  ******** *.** **********   ****.*** 
 
OVINE      TCAGCAAATAATGGAGACAACGAAAAGATAATCAACATACTAACTAAACAGCTGAAGAGG 142 
BOVINE     TCAGCAAATAATGGAGACAACGAAAAGATAATCAACATATTAACTAAACAGCTGAAGAGG 312 
HUMAN      TCAGCAAATACAGGAAACAATGAAAGGATAATCAATGTATCAATTAAAAAGCTGAAGAGG 360 
PORCINE    TCAGCAAATACGGGAGACAATGAAAAGATAATCAATGTATTAATAAAACAGCTGAAGAGG 242 
MURINE     CCATCAAACCCTGGAAACAATAAGACATTCATCATTGACCTCGTGGCCCAGCTCAGGAGG 347 
            ** **** .. ***.**** .*.* .:*.****: .:.  ..  ....**** *.**** 
 
OVINE      AAACTGCCTCCCACAAATGCAGGGAGAAGACAGAAACATGAACTAACATGTCCTTCTTGT 202 
BOVINE     AAACTACCTGCCACAAATACAGGGAGAAGACAGAAACATGAAGTAACATGTCCTTCTTGT 372 
HUMAN      AAACCACCTTCCACAAATGCAGGGAGAAGACAGAAACACAGACTAACATGCCCTTCATGT 420 
PORCINE    AAACTACCTCCCACAAATGCAGGGAGAAGACAGAAACATGGGCTAACATGTCCTACATGT 302 
MURINE     AGGCTGCCTGCCAGGAGGGGAGGAAAGAAACAGAAGCACATAGCTAAATGCCCTTCCTGT 407 
           *..* .*** *** .*. . ***.*..*.******.** . .  :*.*** ***:* *** 
 
OVINE      GATTCTTATGAGAAAAAGCCACCCAAGGAATACCTAGAAAGACTGAAATCGCTCATCCAA 262 
BOVINE     GATTCTTATGAGAAAAAACCACCCAAGGAATACCTAGAAAGACTGAAATCACTCATCCAA 432 
HUMAN      GATTCTTATGAGAAAAAACCACCCAAAGAATTCCTAGAAAGATTCAAATCACTTCTCCAA 480 
PORCINE    GATTCGTATGAGAAAAAACCAATCAAAGAATTCCTAGAAAGACTGAAATCGCTCATCCAA 362 
MURINE     GATTCGTATGAGAAAAGGACACCCAAAGAATTCCTAGAAAGACTAAAATGGCTCCTTCAA 467 
           ***** **********...**. ***.****:********** * **** .** .* *** 
 
OVINE      AAG--------------------------------------------------------- 265 
BOVINE     AAG--------------------------------------------------------- 435 
HUMAN      AAGGTATCTACCTTAAGTTTCATTTGATTTTCTGCTTTATCTTTACCTATCCAGATTTGC 540 
PORCINE    AAG--------------------------------------------------------- 365 
MURINE     AAG--------------------------------------------------------- 470 
           ***                                                          
 
OVINE      ---------------------------------AT------------------------- 267 
BOVINE     ---------------------------------ATGATTCATCAGCATCTGTCCTAG--- 459 
HUMAN      TTCTTAGTTACTCACGGTATACTATTTCCACAGATGATTCATCAGCATCTGTCCTCTAGA 600 
PORCINE    ---------------------------------ATGATTCATCAGCATCTGTCCTAG--- 389 
MURINE     ---------------------------------ATGATTCATCAGCATCTCTCCTAGAAC 497 
                                                 **                          
Figure 3.2  Alignment of sheep IL-21 nucleotide sequence with cattle (NM_198832.1), 
human (NM_001207006.1), pig (NM_214415.1), and mouse (NM_021782.2) 
sequences; with alignment scores against ovine transcripts of 97 %, 86 %, 91 %, and 72 
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OVINE      ----------------------------------------------------------AT 2 
BOVINE     GTCAGAGGACAGCAGCCCTGCTTGGACTCGGGGCCAACAGCTCTCACAGCAACTCTGCAT 131 
HUMAN      GCCTGGGGGCAGCAGCCCTGCCTGGACTCAGTGCCAGCAGCTTTCACAGAAGCTCTGCAC 291 
PORCINE    GCCTGAGGGCAGCAGCCCTGCTTGGGCTCAAGGCCAGCAGCTCTCACAGCAGCTCTGCAC 277 
MURINE     GCCTAGGAGTAGCAGTCCTGACTGGGCTCAGTGCCAGCAGCTCTCTCGGAATCTCTGCAT 237 
                                                                     *  
 
OVINE      GCTAGCCTGGAGTGCACACCTACCAATGGGACATGTGGATCTACCAAGAGAAGAAGGAGG 62 
BOVINE     GCTGGCCTGGAGTGCACACCTACCAATGGGACATGTGGATCTACCAAGAGAAGAAGGAGG 191 
HUMAN      ACTGGCCTGGAGTGCACATCCACTAGTGGGACACATGGATCT---AAGAGAAGAGGGAGA 348 
PORCINE    GCTGGCCTGGACTGCACATCTACCAATGGGACATGTGGATCTACCAAGAGAAGAGGGAGA 337 
MURINE     GCTAGCCTGGAACGCACATGCACCAGCGGGACATATGAATCTACTAAGAGAAGAAGAGGA 297 
           .**.*******  *****   ** *. ****** .**.****   *********.*..*. 
 
OVINE      TGATGAGACTACAGATGATGTCCCCCGTATCCAGTGTGAGGATGGCTGTGATCCACAAGG 122 
BOVINE     TGATAAGACTACAGATGATGTCCCCCGTATCCAGTGTGAGGATGGCTGTGATCCACAAGG 251 
HUMAN      TGAAGAGACTACAAATGATGTTCCCCATATCCAGTGTGGAGATGGCTGTGACCCCCAAGG 408 
PORCINE    TGATGAGACTACAAGTGAAGTCCCCCATATCCAGTGCGGGGATGGCTGTGATCCTCAGGG 397 
MURINE     TGAAGAGACTAAAAATAATGTGCCCCGTATCCAGTGTGAAGATGGTTGTGACCCACAAGG 357 
           ***:.******.*..*.*:** ****.********* *..***** ***** ** **.** 
 
OVINE      ACTCAGGGACAACAGTCAGTCCTGCTTGCGAAGGATTCATCGAGGCCTGGTTTTTTACGA 182 
BOVINE     ACTCAGGGACAACAGTCAGTCCTGCTTGCAAAGAATTCATCGAGGCCTGGTTTTTTACGA 311 
HUMAN      ACTCAGGGACAACAGTCAGTTCTGCTTGCAAAGGATCCACCAGGGTCTGATTTTTTATGA 468 
PORCINE    ACTCAGGGACAACAGTCAGTCCTGCTTGCAAAGGATCCACCAAGGCCTGGTTTTTTATGA 457 
MURINE     ACTCAAGGACAACAGCCAGTTCTGCTTGCAAAGGATCCGCCAAGGTCTGGCTTTTTATAA 417 
           *****.********* **** ********.***.** *. *..** ***. ****** .* 
 
OVINE      GAAGCTTCTGGGCTCAGATAGTTTCACAGGGGAGCCTTCTCTATTCCCAGATGGCCCTGT 242 
BOVINE     GAAGCTGCTGGGCTCAGATATTTTCACAGGGGAGCCTTCTCTACTCCCAAATGGCCCTGT 371 
HUMAN      GAAGCTGCTAGGATCGGATATTTTCACAGGGGAGCCTTCTCTGCTCCCTGATAGCCCTGT 528 
PORCINE    GAAGCTGCTGGGCTCAGACATTTTCACAGGGGAGCCTTCTCTACACCCTGATGGCTCTGT 517 
MURINE     GCACCTGCTTGACTCTGACATCTTCAAAGGGGAGCCTGCTCTACTCCCTGATAGCCCCAT 477 
           *.* ** ** *..** ** *  ****.********** ****. :***:.**.** * .* 
 
OVINE      GGACCAGCTTCACGCCTCCATACTGGGCCTCAGGGAACTCTTGCAGCCCAAGGGTCACCA 302 
BOVINE     GGACCAGCTTCACGCCTCCATACTGGGCCTCAGGGAACTCTTGCAGCCCAAGGGTCACCA 431 
HUMAN      GGGCCAGCTTCATGCCTCCCTACTGGGCCTCAGCCAACTCCTGCAGCCTGAGGGTCACCA 588 
PORCINE    GGGCCAGCTTCACGCCTCCCTACTGGGCCTCAGGCAACTCTTGCAGCCCGAGGGTCACCA 577 
MURINE     GGAGCAACTTCACACCTCCCTACTAGGACTCAGCCAACTCCTCCAGCCAGAGGATCACCC 537 
           **. **.***** .*****.****.**.*****  ***** * ***** .***.*****. 
 
OVINE      CTGGGAAGCTGAGCAGACTCCAAGCCCTATTCCCAGCCAGCCATGGCAGCGCCTCCTTCT 362 
BOVINE     CTGGGAAACTGAGCAGACTCCAAGCCCTATTCCCAGCCAGCCATGGCAGCGCCTCCTTCT 491 
HUMAN      CTGGGAGACTCAGCAGATTCCAAGCCTCAGTCCCAGCCAGCCATGGCAGCGTCTCCTTCT 648 
PORCINE    CTGGGAGACTGAGCAGACGCCAAGCCCCAGTCCCAGCCAGCCCTGGCAACGCCTCCTTCT 637 
MURINE     CCGGGAGACCCAACAGATGCCCAGCCTGAGTTCTAGTCAGCAGTGGCAGCGCCCCCTTCT 597 
           * ****..*  *.****  **.****  * * * ** ****. *****.** * ****** 
 
OVINE      CCGTCTCAAGATCCTTCGAAGCCTCCAGGCCTTTGTGGCTGTAGCTGCCCGGGTCTTTGC 422 
BOVINE     CCGTCTCAAGATCCTTCGAAGCCTCCAGGCCTTTGTGGCTGTAGCTGCCCGGGTCTTTGC 551 
HUMAN      CCGCTTCAAAATCCTTCGCAGCCTCCAGGCCTTTGTGGCTGTAGCCGCCCGGGTCTTTGC 708 
PORCINE    CCGCCTCAAGATCCTTCGCAGCCTCCAGGCCTTTGTGGCTGTAGCTGCCCGGGTCTTCGC 697 
MURINE     CCGTTCCAAGATCCTTCGAAGCCTCCAGGCCTTTTTGGCCATAGCTGCCCGGGTCTTTGC 657 
           ***   ***.********.*************** **** .**** *********** ** 
 
Figure 3.3  Alignment of sheep IL-23A nucleotide sequence with cattle (XM_588269.4), 
human (NM_016584.2), pig (AB521204.1), and mouse (NM_031252.2) sequences; with 
alignment scores against ovine transcripts of 97 %, 83 %, 87 %, and 75 % respectively.  (*) 
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OVINE      CCACGGAGCAGCAACTCT----GAGCCCCTAAAGCCAGCAGCTTAAGGATGACAC----- 473 
BOVINE     CCACGGAGCAGCAACTCT----GAGCCCCTAAAGCCAGTAGCTTAAGGATGACAC----- 602 
HUMAN      CCATGGAGCAGCAACCCT----GAGTCCCTAAAGGCAGCAGCTCAAGGATGGCAC----- 759 
PORCINE    CCATGGAGCAGCAACTCT----GAGCCAGTAAAGCCAGCAGCTTAAGGATGACAC----- 748 
MURINE     CCACGGAGCAGCAACTCTGACTGAGCCCTTAGTGCCAACAGCTTAAGGATGCCCAGGTTC 717 
           *** *********** **    *** *. **.:* **. **** ******* *..      
 
OVINE      ------------------------------------------------------------ 
BOVINE     ------------------------------------------------------------ 
HUMAN      ------------------------------------------------------------ 
PORCINE    ------------------------------------------------------------ 
MURINE     CCATGGCTACCATGATAAGACTAATCTATCAGCCCAGACATCTACCAGTTAATTAACCCA 777 
                                                                        
 
OVINE      --------------------------------------------CCAGACCTCCATGG-- 487 
BOVINE     --------------------------------------------CCAGACCTCCGTGG-- 616 
HUMAN      --------------------------------------------TCAGATCTCCATGG-- 773 
PORCINE    --------------------------------------------CAAGACCTCCATTG-- 762 
MURINE     TTAGGACTTGTGCTGTTCTTGTTTTGTTTGTTTTGCGTGAAGGGCAAGGACACCATTATT 837 
                                                        .**. *:**.* .   
 
OVINE      -------------------CTCAGTAATG------------------------------- 497 
BOVINE     -------------------CTCAGTAATG------------------------------- 626 
HUMAN      -------------------CCCAGCAAGG------------------------------- 783 
PORCINE    -------------------CTCAGCAATG------------------------------- 772 
MURINE     AAAGAGAAAAGAAACAAACCCCAGAGCAGGCAGCTGGCTAGAGAAAGGAGCTGGAGAAGA 897 
                              * *** .. *                                
 
OVINE      ------------------------------------------------------------ 
BOVINE     ------------------------------------------------------------ 
HUMAN      ------------------------------------------------------------ 
PORCINE    ------------------------------------------------------------ 
MURINE     AGAATAAAGTCTCGAGCCCTTGGCCTTGGAAGCGGGCAAGCAGCTGCGTGGCCTGAGGGG 957 
                                                                        
 
OVINE      -----------------------TTAAGATCAATCTATCAACCTAGACACCTGTGAGCCA 534 
BOVINE     -----------------------CTAAGATCAATCTATCAAC-TAGACACCTGTGAGCCA 662 
HUMAN      -----------------------CCAAGATAAATCTACCACCCCAGGCACCTGTGAGCCA 820 
PORCINE    -----------------------CTAAAATGAAG----------------CTATGAGCCA 793 
MURINE     AAGGGGGCGGTGGCATCGAGAAACTGTGAGAAAACCCAGAGCATCAGAAAAAGTGAGCCC 1017 
                                    .:.*  **                 .:.******. 
 
OVINE      A---------------------------TGAGTTCATCGGTCCATTA-ATTTTAATGAG- 565 
BOVINE     A---------------------------CAAGTTCATTGGTCCATTA-ATTTTAATGAG- 693 
HUMAN      A---------------------------CAGGTTAATTAGTCCATTA-ATTTTAGTGGG- 851 
PORCINE    A---------------------------CAAGTTCATCAATCCATTA-ATTTTAATGGG- 824 
MURINE     AGGCTTTGGCCATTATCTGTAAGAAAAACAAGAAAAGGGGAACATTATACTTTCCTGGGT 1077 
           *                            ..*::.*  ..:.***** * ***. **.*  
 
OVINE      ----------------------------------------------------ACTTATTC 573 
BOVINE     ----------------------------------------------------ACTTATTC 701 
HUMAN      ----------------------------------------------------ACCTGCAT 859 
PORCINE    ----------------------------------------------------ACTTGCTC 832 
MURINE     GGCTCAGGGAAATGTGCAGATGCACAGTACTCCAGACAGCAGCTCTGTACCTGCCTGCTC 1137 
                                                                    .* *. :  
 
OVINE      TG-----------------------------------TTGAAAAATTACCAAAA------ 592 
BOVINE     TG-----------------------------------TTGAAAAATTACCAAAACTGACT 726 
HUMAN      AT-----------------------------------GTTGAAAATTACCAATACTGACT 884 
PORCINE    TG-----------------------------------TTGAAAACTTACCTACACTGACT 857 
MURINE     TGTCCCTCAGTTCTAACAGAATCTAGTCACTAAGAACTAACAGGACTACCAATACGAACT 1197 
          :                                     :  *... ****:* *       
Figure 3.3 cont’n.  Alignment of sheep IL-23A nucleotide sequence with related 
species.   




OVINE      --------------------------------------------AGTGTGCTCATGCCTC 16 
BOVINE     CCAGCAAAGGACAGAATTCCACTGAGGAGTGGCTGAAGTGGAACAGTGTGCTCATGCCTC 232 
HUMAN      CCAGCAAAGGGCAGGACACCTCTGAGGAGCTGCTGAGGTGGAGCACTGTGCCTGTGCCTC 133 
PORCINE    CCAGCAAAGGACAGAACCCCATAGAAGAGTGGCTGAAGCAGAATGCTGTGCTCATGCCTC 148 
MURINE     CCAGCAAAGAGCAAGAACCCCCGGAGGAGTGGCTGAAGTGGAGCTCTGCATCTGTGTCCC 233 
                                                         ** .   .** * * 
 
OVINE      CCCCAGAGACCACCAGCCTCGCCCACCACTCAGAATCCTGCAGTTCCAGCAAGGATGGAC 76 
BOVINE     CCCCAGAGACCACCAGCCTCGCCCACCACCCAGAACCCTGCAGTTCCAGCAGGGATGGAC 292 
HUMAN      CCCTAGAGCCTGCTAGGCCCAACCGCCACCCAGAGTCCTGTAGGGCCAGTGAAGATGGAC 193 
PORCINE    CTCTGGAGATGGCCAGCCCCACTCCCCACCCAGAATCCTGCAAGGCGAGTGAAGACGGAC 208 
MURINE     CCCCAGAGCCTCTGAGCCACACCCACCACGCAGAATCCTGCAGGGCCAGCAAGGATGGCC 293 
           * * .***.     ** * *.. * **** ****. **** *.  * ** ...** **.* 
 
OVINE      CCCTCAACAGCCGTTCCATCGCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCGGC 136 
BOVINE     CCCTCAACAGCCGCTCCATCGCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCGGC 352 
HUMAN      CCCTCAACAGCAGGGCCATCTCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCGGC 253 
PORCINE    CCCTCAACAGCAGATCCATTGCCCCTTGGAGATACGAGTTGGACAGAGACTTGAACCGGC 268 
MURINE     CCCTCAACAGCAGGGCCATCTCTCCTTGGAGCTATGAGTTGGACAGGGACTTGAATCGGG 353 
           ***********.*  ****  * ** *****.** ***********.******** ***  
 
OVINE      TCCCGCAGGATCTGTACCACGCACGCTGCCTGTGTCCACACTGTGTCAGCCTCCAGACGG 196 
BOVINE     TCCCGCAGGATCTGTACCACGCACGTTGCCTGTGTCCACACTGTGTCAGCCTGCAGACGG 412 
HUMAN      TCCCCCAGGACCTGTACCACGCCCGTTGCCTGTGCCCGCACTGCGTCAGCCTACAGACAG 313 
PORCINE    TGCCCCAGGACTTGTACCACGCTCGTTGCCTGTGTCCACACTGTGTCAGCCTCCGGACGG 328 
MURINE     TCCCCCAGGACCTGTACCACGCTCGATGCCTGTGCCCACACTGCGTCAGCCTACAGACAG 413 
                * ** *****  ********** ** ******** **.***** ******** *.***.* 
 
OVINE      GCTCCCACATGGACCCCCTGGGAAACTCAGAGCTGCTCTACCA----------------- 239 
BOVINE     GCTCCCACATGGACCCCCTGGGAAACTCAGAGCTGCTCTACCACAACCAGACCGTCTTCT 472 
HUMAN      GCTCCCACATGGACCCCCGGGGCAACTCGGAGCTGCTCTACCACAACCAGACTGTCTTCT 373 
PORCINE    GTTCCCACATGGATCCCCTGGGTAACTCAGAGCTGCTGTACCACAACCAGACCGTCTTCT 388 
MURINE     GCTCCCACATGGACCCGCTGGGCAACTCCGTCCCACTTTACCACAACCAGACGGTCTTCT 473 
           * *********** ** * *** ***** *: * .** *****                  
 
Figure 3.4  Alignment of sheep IL-25 nucleotide sequence with cattle (XM_605190.2), 
human (AF458059.1), pig (EF584511.1), and mouse (NM_080729.3) sequences; with 
alignment scores against ovine transcripts of 97 %, 84 %, 84 %, and 81 % respectively.  
(*) indicates identical nucleotide bases in all sequences. 
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OVINE      --------------------------------TCTACAGTGAACTGGAAGGAGCTACCAT 28 
BOVINE     GGTCCATCTCACAGCGAGCACAAGTTCATCTGTCTACAGTGAACTGGAAGGAACTACCAT 60 
HUMAN      -------------GCAGGCACAAACTCATCCATCCCCAGTTGATTGGAAGAAACAACGAT 47 
PORCINE    --TCCATCTCTCAGCAAGCTCCAGCTCATCCATCTGCAGTACATCAGGAGAAACTACGAT 58 
MURINE     -ATCCACCTCACACGAGGCACAAGTGCACCCAGCACCAGCTGATCAGGACGCGCAAACAT 59 
                                            *  ***   *  .*.* ...*:*. ** 
 
OVINE      GGCGTCTATGAGAACTGCCTCTATGTCACTGCTACT------GCTTCTGAGTCTGGTGGC 82 
BOVINE     GGCTTCTATGAGAACTTCATCTATGTCACTGCTACT------GCTTCTGAGTCTGGTGGC 114 
HUMAN      GACTCCTGGGAAGACCTCATTGGTGTCACTGCTACT------GCTGCTGAGCCTGGAGGC 101 
PORCINE    GACTCCTGTGAGATCCTCGTCCCTGTCACTGCTGCT------TCTGCTGAGCCTGGTGGC 112 
MURINE     GAGTCCAGGGAGAGCTTCATCTGTGTCTCTGATGCTGTTGCTGCTGCTGAGCCTGGCGGC 119 
           *.   *:. **.. *  * *   ****:***.*.**       ** ***** **** *** 
 
OVINE      TCTTGTGAAGGCAGGGGTCATCATCCCACAGAGTCCAGGCTGCCCACCTACTGAGGACAA 142 
BOVINE     TCTTGTGAAGGCAGGAGTCATCATCCCACAGAGTCCAGGCTGCCCACCTACTGAGGACAA 174 
HUMAN      CATAGTGAAGGCAGGAATCACAATCCCACGAAATCCAGGATGCCCAAATTCTGAGGACAA 161 
PORCINE    TCTCGTGAAGGCGGGAATCATGATCCCACAAAGTCCAGGATGCCCAAAAACTGAGGACAA 172 
MURINE     TACAGTGAAGGCAGCAGCGATCATCCCTCAAAGCTCAGCGTGTCCAAACACTGAGGCCAA 179 
            .  ********.* ..  *  *****:*..*.  ***  ** ***.. :******.*** 
 
OVINE      GAACTTCCCACAGCATGTGAGGGTCAACCTGAACATCGTTAAC---CGGAACACGAACTC 199 
BOVINE     GAACTTCCCACAGCATGTGAGGGTCAACCTAAACATCGTTAAC---CGGAGCACAAACTC 231 
HUMAN      GAACTTCCCCCGGACTGTGATGGTCAACCTGAACATCCATAAC---CGGAATACCAATAC 218 
PORCINE    GAACTTCCCTCAGCATGTAAGGGTCAACTTGAACATCTTGAAC---CGGAGCACACCTGC 229 
MURINE     GGACTTCCTCCAGAATGTGAAGGTCAACCTCAAAGTCTTTAACTCCCTTGGCGCAAAAGT 239 
           *.******  *.*..***.* ******* * **..** : ***   *  .. .* ..    
 
OVINE      CAG------AAGGCCCACCGATTATCACAAGCGCTCCACCTCACCTTGGACCCTCCACCG 253 
BOVINE     CAG------AAGGCCCACCGATTATCACAAGCGCTCCACCTCACCTTGGACTCTCCACCG 285 
HUMAN      CAATCCCAAAAGGTCCTCAGATTACTACAACCGATCCACCTCACCTTGGAATCTCCACCG 278 
PORCINE    CAG------ACGGCCCTCAGATTACTCCAAACGCTTCACCTCACCATGGACTCTCCAACG 283 
MURINE     GAGCTCCAGAAGGCCCTCAGACTACCTCAACCGTTCCACGTCACCCTGGACTCTCCACCG 299 
            *.      *.** **:*.** **   *** ** * *** ***** ****. *****.** 
 
OVINE      CAATGAGGACCCTGAGAGGTACCCCTCTGTGATCTGGGAGGCCAAGTGCAGCCACTCAGG 313 
BOVINE     CAATGAGGACCCTGAGAGGTACCCCTCTGTGATCTGGGAGGCCAAGTGCAGCCACTCAGG 345 
HUMAN      CAATGAGGACCCTGAGAGATATCCCTCTGTGATCTGGGAGGCAAAGTGCCGCCACTTGGG 338 
PORCINE    CAACGAGGACCCCGAGAGGTACTCCTCCGTGATCTGGGAGGCCAAGTGCAGCCACTCGGG 343 
MURINE     CAATGAAGACCCTGATAGATATCCCTCTGTGATCTGGGAAGCTCAGTGCCGCCACCAGCG 359 
           *** **.***** ** **.**  **** ***********.** .*****.*****  . * 
 
OVINE      CTGTATCAATGCTGAAGGGAAGGTGGACCACCACATGAACTCTGTCACCATCCAGCAAGA 373 
BOVINE     CTGTATCAATGCTGAAGGGAAGGTGGACCATCACATGAACTCTGTCACCATCCAGCAAGA 405 
HUMAN      CTGCATCAACGCTGATGGGAACGTGGACTACCACATGAACTCTGTCCCCATCCAGCAAGA 398 
PORCINE    CTGTATCAATGCTGAAGGGAAGGAAGATCATCACATGAACTCTGTCCCCATCCAGCAAGA 403 
MURINE     CTGTGTCAATGCGGAGGGAAAGCTGGACCACCACATGAATTCTGTTCTCATCCAGCAAGA 419 
           *** .**** ** ** **.**  :.**  * ******** ***** . ************ 
 
OVINE      GATCCTGGTCCTTCGAAGGGAGTCTCAGCACTGCCCTCACTCCTTCCGGCTGGAGAAGAT 433 
BOVINE     GATCCTGGTCCTCCGAAGGGAGTCTCAGCACTGCCCTCACTCCTTCCGGCTGGAGAAGAT 465 
HUMAN      GATCCTGGTCCTGCGCAGGGAGCCTCCACACTGCCCCAACTCCTTCCGGCTGGAGAAGAT 458 
PORCINE    GATCTTGGTCCTGCGAAGGGAGCCTCGCCACTGCCCCAACTCCTTCCGGCTGGAGAAAGT 463 
MURINE     GATCCTGGTCCTGAAGAGGGAGCCTGAGAGCTGCCCCTTCACTTTCAGGGTCGAGAAGAT 479 
           **** ******* .. ****** **   ..******  :*:* ***.** * *****..* 
 
Figure 3.5  Alignment of sheep IL-17A nucleotide sequence with cattle (NM_001008412.1), 
human (NM_002190.2), pig (NM_001005729.1), and mouse (NM_010552.3) sequences; 
with alignment scores against ovine transcripts of 97 %, 83 %, 82 %, and 74 % respectively.  (*) 
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OVINE      GCTGGTGGCCGTGGGCTGCACCTGTGTCACCCCCATTGTCCGCCATGTGGCTTAA---GA 490 
BOVINE     GCTGGTGGCCGTGGGCTGCACCTGCGTCACCCCCATTGTCCGCCATTTGGCTTAA---GA 522 
HUMAN      ACTGGTGTCCGTGGGCTGCACCTGTGTCACCCCGATTGTCCACCATGTGGCCTAA---GA 515 
PORCINE    GATGGTGACAGTGGGCTGCACCTGTGTCACCCCCATCGTCCGCCATATTTCTTAA---GA 520 
MURINE     GCTGGTGGGTGTGGGCTGCACCTGCGTGGCCTCGATTGTCCGCCAGGCAGCCTAAACAGA 539 
           ..*****   ************** ** .** * ** ****.***     * ***   ** 
 
OVINE      GCTTTCTGC--------------------------------------------------- 499 
BOVINE     GCTTTCTGCCTGACCCCTAC---TCCCCAAATTAGTTAGGTTTCCTGGGGAGTAGACCCA 579 
HUMAN      GCTCTGGGGAG--CCCACAC---TCCCCAAAGCAGTTAGACT--ATGGAGAGCCGACCCA 568 
PORCINE    GCTTCTAGTCTGACCCCTGC---TCCCCAAATCAGTTAGGCTTTCAGGGGAGTAGACCCA 577 
MURINE     GACCCGCGGCTGACCCCTAAGAAACCCCCACGTTTCTCAGCAAACTTACTTGCATTTTTA 599 
                *.     *                                                     
 
Figure 3.5 cont’n.  Alignment of sheep IL-17A nucleotide sequence with related 
species. 
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3.3 Sequence verification of ovine transcripts 
PCR products were cloned and sequenced to generate plasmids for optimizing the real 
time RT-qPCR assay.  The predicted sequences of sheep that were derived from bovine 
sequences were aligned with the expected sequences in related species (Figures 3.1-5) 
using ClustalW2 (Larkin et al., 2007).  These sequences formed part of the partial and 
full length sequences of IL-21and IL-23A, and the two variants of IL-25 produced by 
our research group (Gossner et al., 2011a).  Details on the analyses of variants of IL25 
sequences are fully illustrated in Figure 1, Appendix 1.  The genomic organization of 
these variants are also shown in Figure 2, Appendix 1. 
3.4   Primer optimization 
All relevant aspects that could potentially influence the successful run of RT-qPCR 
assay were considered in developing the assay.  A summary on the primer and 
magnesium concentration, including the annealing temperature that worked optimally 
for each gene is presented in Table 3.3. 
Determination of the workable primer concentration for RT-qPCR is required as this 
component’s limited or excessive availability in the reaction affects not only the product 
yield but also primer dimer formation (Bustin, 2004; Nolan et al., 2006).  Lower primer 
concentration promotes specificity of the PCR and hence is preferred over a higher 
concentration without compromise to the efficiency of the reaction.   
To determine the best primer concentration for each gene, 100-1000 nM primer 
concentrations between forward and reverse primers were set up initially (Figure 3.6A).  
A no-template control was included in the matrix to check for primer dimer or non-
specific amplification. A standard curve, made from six serial dilutions of linearized 
Chapter 3  Development of RT-qPCR assay 
89 
 
plasmids with the insert of the target gene was also set up.   Any five concentrations 
with the lowest Cq were included in the second and final run where the concentration 
with the lowest Cq was selected (Figure 3.6B).  In cases where different concentrations 
had similar Cqs, the lower concentration was selected.  Figure 3.6 shows the standard 
curve generated with optimized primer concentration.  The optimized primer 
concentration for each gene of interest is shown in Table 3.3.  
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A. Initial primer concentration optimization with standard curve 
 
 




Figure 3.6  Optimization of primer concentration.  Example of how the primer 
concentration was optimized for all transcripts.  Initial optimization run included  
primer concentrations (A) which ranged from 100900 nm (fine lines) plotted against a 
standard curve (lines with dots).  From this run, five concentrations were selected in the 
final run (B); from which the concentration that obtained the lowest Cq and 
corresponding single peak melt curve was selected. 
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3.5   Magnesium optimization 
Magnesium is an essential component of PCR as it promotes the activity of the Taq 
polymerase (Bustin, 2004).  High magnesium concentration results to greater product 
yield but compromises the fidelity of enzymes, thereby causing non-specific 
amplification.  On the other hand, low concentration of this component increases the 
specificity of the reaction but the quantity of the PCR product becomes reduced.  It is 
therefore paramount to optimize the magnesium concentration of the RT-qPCR to 
ensure the sensitivity, specificity and reproducibility of the assay. 
Each primer pair and template has a different optimal magnesium concentration.  A 
standard curve made from six serial dilutions of pDNA containing the gene of interest 
was set up together with increasing MgCl2 concentrations that ranged from 2.0-5.0 mM. 
Figure 3.7 illustrates the difference in the magnesium concentration required for an 
optimized RT-qPCR in a particular gene.  The ideal MgCl2 concentration was the 
concentration with the lowest Cq and with amplicon-specific product as revealed in the 
melt curve (not shown). 
3.6   Temperature optimization 
The annealing temperature and time settings could affect successful priming and 
amplification of product.  Optimum temperature allows primer to anneal efficiently to 
their targets, preventing non-specific annealing and primer-dimer formation (Bustin,  
2004; Taylor et al., 2010). Too low temperature could lead to production of products 
other than the target as a result of mispriming.  Similarly, too high temperature results in 
inefficient priming.  The optimized annealing temperature for each gene is shown in 
Table 3.3. 
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A. Optimized Mg concentration of IL7R at low concentration 
 
B.  Optimized Mg concentration of IL23A at high concentration 
 
 
Figure 3.7  Optimization of magnesium concentration.  Example of different 
magnesium concentration optimum for a particular transcript. Standard curve from 
pDNA ( lines with dots) alongside different concentrations of MgCl2 (thick lines).  In 
IL-7R (A), the lowest Cq is with the lowest magnesium concentration of 2 mM (pink) 
and 2.5 mM (purple).  Higher concentration at 4 mM (light blue) is not optimum.  IL-
23A (B) works best at 3 mM (pink) and poorly at 2 mM (green). 
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3.7   cDNA dilution optimization 
The use of linearized pDNA in constructing standard curves allows repetitive assays 
inherent in the optimization step.  Running the assay with cDNA samples may limit the 
repetition step as there is usually limited source of the RNA.  Generating a standard 
curve from serial dilutions of cDNA will provide the true efficiency of RT-qPCR runs 
with the cDNA samples under question.  This step also ensures that the concentration 
range used matches the expected concentration of the unknown sample. 
To optimize the cDNA sample dilution for the RT-qPCR assay, a range of dilutions for 
each gene in both lymph node and abomasum were set up (Figures 3.8 A &B).  This is 
important especially if there is a limited cDNA material available.  For example, 1:40 
dilution of a template cDNA may be used over 1:10 without compromising the 
efficiency of the PCR run.  Subsequently, the selected concentration (on the basis of Cq 
and melt curve) of cDNA was run alongside standard curve from pDNA to validate its 
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A. Inhibited cycling conditions in concentrated cDNA of YWHAZ  in ABM 
 
 
B.  Similar expression levels with different cDNA dilution of SDHA in ALN 
 
 
C.  Optimum cDNA dilution of TGFB1 within quantifiable range 
 
Figure 3.8  cDNA dilution optimization   A standard curve was constructed for each 
gene using serial dilutions of pooled cDNA from lymph node and abomasum.  
Inhibition could be evident in too concentrated template cDNA (A) as pointed in thick 
arrow, or vaguely quantifiable after a certain point of dilution (B) in thin arrows, as they 
stick together even with different concentrations.  Selected dilution of a gene (dashed 
arrow) with the standard curve (C) showing its expression within quantifiable range.  
Lines marked with stars are no-template controls. and lines with cross points represent a 
cDNA dilution.  
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3.8   Construction of standard curves from pDNA  
Amplicon-specific standard curves were generated for each gene of interest.  Six serial 
dilutions of linearized plasmids diluted 1 in 7 was set up for each gene.  An optimized 
standard curve should meet the following criteria: r2 of >0.98, amplification efficiency 
of as close to 100%, and a single peak in the melt curve to confirm specificity.  The 
efficiency of the PCR is a measure of the rate at which the polymerase converts the 
reagents in the reaction to amplicon; ideally at a rate at which the number of copies 
double after each cycle (Bustin, 2004; Bustin et al., 2009).  The r2 (coefficient of 
determination) is derived from the equation of the linear regression line constructed 
from the starting quantity of the template against the Cq values (Taylor et al., 2010).  It 
indicates how good the line fits the data.  The specificity of the reaction was represented 
by a single sharp peak in the melt curve.  This was confirmed further by running the 
samples on agarose gel to reveal that the product was the expected size. 
All the parameters required to ensure the reliability of real time RT-qPCR assay 
specified in the MIQE guidelines were completed. The efficiency of the reaction for all 
genes was at least 90%, the r2 was >0.98, and melt curves yielded single peaks. These 
features are exemplified in Figure 3.9 and 3.10 showing the difference between a non-
optimized and optimized standard curve.  Details on the optimized conditions for each 
gene are presented in Table 3.3. 
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A. Standard curve plot of fluorescence versus cycle 
 
B. Quantification analysis.  Concentration versus threshold cycle (CT) 11
 
C. Melt curve analysis 
 
Figure 3.9  Construction of a non-optimized plasmid DNA standard curve.  
Amplification plot of standard curves (A) with six serial dilutions of linearized pDNA 
(shown in dotted colour lines) and a no-template control (represented by gray line with 
asterisk).  The uneven gaps between serial dilutions contribute to the low efficiency in 
the standard curve (B).  Single peak in the melt curve (C) indicates a single product but 
the ‘shoulder’ suggests non-specific amplification at higher dilution. 
                                                            
11 Now appropriately termed quantification cycle (Cq) based on Minimum Information for Publication of 
Quantitative Real-Time PCR Experiments (MIQE) guidelines 
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A. Standard curve plot of fluorescence versus cycle 
 
B. Quantification analysis.  Concentration versus threshold cycle (CT) 
 
C.  Melt curve analysis 
 
Figure 3.10  Construction of an optimized plasmid DNA standard curve.  Optimization 
was performed on the same gene presented in Figure 1 with six serial dilutions of 
pDNA (shown in dotted colour lines) and a no-template control (represented by black 
line with asterisk).  Amplification plot of standard curves (A) of the same gene in 
Figure 1 shows the earlier cycle at which the first standard achieved fluorescence signal.  
The efficiency is better at 96.0 % in the standard curve (B).  The background noise 
caused by non-specific amplification was reduced as shown in the melt curve (C).




Table 3.3.  Summary of optimized RT-qPCR assay reaction components and cycling conditions. 
Gene 
Primer conc (nm) 
For/Rev  MgCl2 conc (mM) Anneal temp (C) Reaction efficiency Range of Cq values R2  
IL-2 600  2.0  66  1.02  10.68-24.36  0.99 
IL-4 600  2.0  62  1.09  09.20-22.39  0.99 
IL-6 500  4.0  62  0.92  12.45-27.38  0.99 
IL-7R 600  2.0  63  0.99  11.61-25.90  0.99 
IL-10 500  2.0  63  0.96  17.15-31.60  0.96 
IL-12p40 500  2.0  63  0.93  13.75-28.37  0.99 
IL-17A 600  2.0  62  0.96  15.13-29.56  0.99 
IL-21 600  2.0  62  0.94  16.61-31.89  0.99 
IL-23A 700  3.0  62  0.98  12.14-26.74  0.99 
IL-25 450  2.5  62  0.99  10.74-24.73  0.99 
EBI3 1000  2.0  64  1.01  19.54-33.91  0.99 
FOXP3 500  2.0  63 0.93  11.32-26.37  0.99 
IFN 250  2.0  62  0.98  16.63-30.64  0.99 
TGFβ 500  2.0  63  0.99  10.23-24.38  0.99 
SDHA 300  2.0  62  0.90  10.25-33.09  0.99 
YWHAZ 600  3.0  62  0.95  9.98-31.58  0.99 





I have developed an optimized RT-qPCR to quantify the expression of a panel of 
cytokines and markers in the lymph nodes and abomasum of sheep.  The assay was 
used to characterize the immune response to Teladorsagia circumcincta infection of 
lambs which are known to be resistant or susceptible to the worm. 
Ovine sequences of the genes targeted for the assay were generated and verified.  All 
optimization steps conforming to the MIQE guidelines were undertaken to ensure the 
reliability of the real time RT-qPCR assay. 
The workable assay for the different genes has primer and magnesium concentration 
that ranged from 250-1000 nm and 24 mM respectively, and annealing temperature 
of 62ºC66ºC.  The cDNA template that will be used for the assay was optimized at 
a ratio that range from 1:10 to 1:40.  At these conditions, all RT-qPCR reactions have 
an efficiency of >90% and r2 of >0.98.   
 
 




Chapter 4 Gene expression analysis and histopathology of 


















Genetic resistance to GI worms seems to operate through the development of an 
acquired immune response (Stear et al.,  1999b), chiefly with the production of IgA 
and IgE antibodies (Huntley et al., 1998; Miller,  1996; Stear et al., 2009; Stear et al., 
1996). Consequently, it takes both parasite exposure and time before resistance to 
nematode challenge develops.  The original phenotypic study (Beraldi et al.,  2008), 
from which the current project developed, has shown that trickle infection with T. 
circumcincta led to a spectrum of response based on abomasal worm numbers, FEC 
and IgA antibody levels. Low FEC and adult worm numbers were significantly 
associated with high IgA antibody levels (Beraldi et al., 2008), suggesting that IgA is 
responsible for host control of helminth infection by inhibition of worm development 
and reduction in egg production (Gill et al., 1993b; Kanobama et al., 2002; Smith, 
2007a; Stear et al., 1999).  It also prevents larval establishment and therefore reduces 
tissue injury from helminth-induced inflammation (Bisset et al., 1996; Pernthaner et 
al., 2005b; Pettit et al., 2005; Stear et al., 1995; Strain et al., 2002). 
 The critical role of T cells in helminth immunity has been well documented. 
Protection with gastrointestinal parasites is a consequence of the differentiation of 
CD4+ T-helper lymphocytes into TH2 cells (Balic et al., 2000b; Lacroux et al.,  
2006). It is supposed that the effector mechanisms in lambs that clear T. circumcincta 
infection are due largely to IL-4, IL-5, and IL-13.  These cytokines have been shown 
to promote B cell proliferation and IgE and IgA production (Kooyman et al., 2000; 
Stear et al.,  2004). However, there are ambiguities in the distinct segregation of TH 
cell subsets associated with resistance and susceptibility in many host and nematode 
species. Modified TH2/TH1 response, Treg activation and its opposing balance with 




TH17 have been linked with host response to parasites (Bettelli et al., 2006; Craig et 
al., 2007; MacKinnon et al., 2009; Wen et al., 2011).  It is highly probable that T 
cells have a major influence on how the host effectively eliminates worm infection as 
seen in mice and humans. In selected sheep lines, nematode resistance was abrogated 
following treatment with anti-CD4 monoclonal antibody (Gill et al., 1993a; Pena et 
al., 2006).  
It was also hypothesized that the immunological response in the development of 
resistance and susceptibility to T. circumcincta is associated with the different TH 
cell subsets. With the same group of animals used for histopathology, 14 cytokines 
and genes related with the differential activation of TH1, TH2, TH17, and Treg 
subsets were evaluated for their distinctive expression in the most resistant and most 
susceptible lambs. Significant differences in expression of any of the 14 genes in the 
abomasal lymph node and mucosa shall formed the basis in selecting genes for 
further study. 
  




4.2 Histopathology of abomasum 
Representative samples of abomasal tissues from 15 lambs used in relative 
quantification analysis were characterized for histopathologic changes. These 
consisted of five each of uninfected controls and infected resistant and susceptible 
lambs. Improperly fixed tissues of some samples were excluded as they showed 
some degrees of deterioration that would render them unsuitable for 
histopathological examination. Enumeration of mucosal mast cells was not 
performed because of very weak or non-specific staining observed in tissues stained 
with toluidine blue. Uninfected controls did not show any remarkable lesion; the 
mucosal epithelium was generally intact and the structures were apparently normal 
(Figure 4.1). However, very mild inflammation characterised by small foci of 
lymphocytic infiltrates in the lamina propria and the basal layer were noted in 
sections from one lamb. In resistant animals, minor pathological changes were noted 
with low level lymphocytic infiltrate and few eosinophils and neutrophils associated 
with the gastric glands (Figure 4.2); pre-adult stages of the nematode were not 
detected within the glands. Oedema was also observed in some areas with 
vacuolation in the mucosal layer surrounded with few lymphocytes, neutrophils, 
eosinophils, and cellular debris suggestive of larval migration (Figure 4.3). In the 
abomasal mucosa of susceptible lambs, major pathological changes were associated 
with extensive infiltration primarily of lymphocytes, and few eosinophils and 
neutrophils. These aggregates of cells covered larger areas of the mucosa and even 
extended into the submucosal layer (Figure 4.4 A and B). Few plasma cells were also 
found in these sites.  
 












Figure 4.1  H&E section of the abomasum from uninfected control sheep showing 


















Figure 4.2  H&E section of the abomasum from infected resistant sheep showing 
focal area of lymphocytic infiltration (arrow) (100X). 
   











Figure 4.3 H&E sections of the abomasum from susceptible sheep showing mucosal 

















A      B 
 
Figure 4.4 H&E section of the abomasum from infected susceptible lambs showing 
oedema (OE) in mucosal layer (A). Vacuolations (V) were evident but were empty of 
pre-adult stages (B). These are surrounded with lymphocytes, neutrophils, 
eosinophils, and cellular debris (100X).  




4.3 Relative transcript expression in resistant and susceptible sheep 
4.3.1  Fold change in abomasal lymph node 
Real time RT-qPCR analysis was performed in resistant and susceptible lambs on 14 
genes. Fold changes between groups and the P-values are illustrated in Figure 4.7 
and summarized in Table 4.1. 
Statistical analysis was performed on fold changes between three groups only on 11 
genes. IL4, IL25 and IL17A were excluded from the analysis because their 
quantification cycle (Cq) values were outside the standard curve (Figure 4.5).  This 
indicates that their transcript levels were outside the dynamic range of linearity of the 
assay and their expression is too low to be accurately quantified. Expression levels 
should at least be within the quantifiable range as exemplified in Figure 4.6. 
Significant differential expression between groups was obtained for IL6, IL21, EBI3, 
FOXP3 and TGFB1. No significant differences were found with any comparisons for 
IL2, IL7R, IL10, IL12B, IL23A, IL25 and TGFB1.  
There was significant up-regulation of IL6 and IL21 in susceptible vs resistant as 
illustrated in Figure 4.7. The expression of both genes was higher in susceptible vs 
resistant with fold changes of 1.95 for IL6 (P = 0.01) and 2.24 for IL21 (P = 0.03).  
Similar trend was observed in susceptible vs control where susceptible had 
significantly higher IL6 and IL21 expression with fold changes of 2.30 (P < 0.01) 
and 2.06 (P = 0.03) respectively. Resistant vs control showed no significant 
differences for IL6 and IL21. Fold changes in resistant vs control for IL6 and IL21 
were 1.25 (P = 0.96) and -1.01 (P = 0.99) respectively. 




Table 4.1  Relative quantification of mRNA transcripts in abomasal lymph node 
 
 Susceptible vs Control Resistant vs Control Susceptible vs Resistant 
Gene fold change* P-value fold change P-value fold change P-value 
IL-2 1.58 ± 0.51 0.20 1.31 ± 0.66 0.60 1.32 ± 0.43 0.68 
IL-4 ND  ND  ND  
IL-6 2.30 ± 0.43 <0.01 1.25 ± 0.45 0.88 1.95 ± 0.36 0.01 
IL-7R 1.04 ± 0.28 0.10 -1.01 ± 0.54 0.96 1.17 ± 0.31 0.98 
IL-10 1.73 ± 0.60 0.16 1.51 ± 0.29 0.42 1.16 ± 0.40 0.78 
IL-17A ND  ND  ND  
IL-12B -1.23 ± 0.25 0.74 1.15 ± 0.69 0.90 -1.25 ± 0.24 0.48 
IL-21 2.06 ± 0.78 0.03 -1.01 ± 0.48 0.99 2.24 ± 0.85 0.03 
IL-23A 1.40 ± 0.19 0.23 1.19 ± 0.36 0.76 1.22 ± 0.16 0.58 
IL-25 ND  ND  ND  
EBI3 -2.56 ± 0.19 0.02 -1.19 ± 0.46 0.63 -1.85 ± 0.27 0.10 
FOXP3 1.68 ± 0.33 0.04 1.91 ± 0.43 <0.01 -1.11 ± 0.18 0.59 
IFN -1.66 ± 0.23 0.04 -1.22 ± 0.22 0.40 -1.32 ± 0.29 0.38 
TGFβ 1.51 ± 0.28 0.22 1.46 ± 0.49 0.16 1.08 ± 0.20 0.98 
 
* Fold change is the ratio of normalized mean expression between groups. Means of 
the non-infected controls were used as the calibrator and were arbitrarily assigned a 
value of 1.0 (using the 2-Cq method) and compared with the infected animals. ND 
- not detected; IL-4, IL-17A and IL-25 levels were outside the dynamic range of 
linearity of the assay and were too low to be accurately quantified and therefore valid 
comparisons could not be made. Bold is P < 0.05.  










Figure 4.5 Amplification plots of lowly-expressed IL4 and IL25 (A &B) in 15 
lymph node samples and IL17A (C) in pooled samples of susceptible lambs 
(replicate view). Lines with dots are pDNA standards and undotted lines represent 
control (red), resistant (blue) and susceptible (green) lambs with Cq values >35 
indicating levels outside the dynamic range of quantifiable expression. No-template 
controls are represented by lines with asterisks (*). 
 




A. IL21 expression in abomasal lymph node 
 
 
B. TGFβ expression in abomasal mucosa 
 
Figure 4.6 Amplification plots of genes within the quantifiable range with relative 
expression RT-qPCR. 15 lymph node samples representing control (red), resistant 
(blue) and susceptible (green) lambs are shown in thin lines. pDNA standards are 
represented by three thick lines. Cq values are < 35 indicating levels within the 
dynamic range of quantifiable expression for most of the samples. 
  










































































Figure 4.7  Relative expression of genes in the abomasal lymph node (ALN) of non-
infected control (n=5) and infected resistant (n=5) and susceptible (n=5) sheep. 
Results are presented in fold change relative to the calibrator (mean of uninfected 
control) which were arbitrarily assigned a value of 1.0 (using the 2-Cq method). 
Brackets indicate statistical difference by one way ANOVA with Tukey Kramer’s 
post hoc test at P < 0.05. 
   




The fold change comparisons of EBI3, FOXP3 and IFNG between the three groups 
are displayed in Figure 4.7. EBI3 expression was lowest in susceptible lambs 
resulting in a significant -2.56 fold change in susceptible vs control comparison (P = 
0.02). EBI3 levels in resistant vs control had fold changes of -1.19 and -1.85 in 
susceptible vs resistant which were both non-significant at P > 0.10.  
There was a trend towards significant up-regulation in FOXP3 expression for both 
resistant and susceptible vs control. FOXP3 levels were elevated in susceptible (1.68 
fold change; P = 0.04) and resistant (1.91 fold change, P < 0.01) vs control. There 
was no significant difference in FOXP3 expression in resistant vs susceptible with 
fold change of -1.11 (P = 0.59).  
Statistically significant IFNG levels were found in susceptible vs control (fold 
change -1.66, P = 0.04).  All other group comparisons for IFNG were not significant. 
Fold changes were measured at -1.22 (P = 0.40) in resistant vs control and -1.32 (P = 
0.38) in susceptible vs control. 
No significant differences were found across all group comparisons which include 
IL2, IL7R, IL10, IL12B, IL-23A, and TGFB1. IL2 had expression levels at1.3-fold 
change difference in resistant vs control (P = 0.60) and susceptible vs resistant (P = 
0.68); susceptible lambs had a fold change of 1.58 (P = 0.20) vs control. There was 
only a slight difference in IL-7R expression with susceptible having fold changes of 
1.04 (P = 0.10) vs control and 1.17 ± (P = 0.98) vs resistant.  Resistant lambs showed 
almost parallel levels of IL7R compared to control group with fold change of -1.01 
(P = 0.96).  




There was consistent non-significant changes (P<0.05) in the expression of IL10, 
IL23A, and TGFB1 across all comparisons. IL10 levels had fold changes of 1.73 (P 
= 0.60) in susceptible vs control, and 1.16 (P = 0.78) vs resistant. A 1.51-fold 
difference was noted in resistant vs control but were not statistically significant (P = 
0.42).  Fold changes of IL23A were 1.40 (P = 0.23) in susceptible vs control, 1.19 (P 
= 0.76) in resistant vs control, and 1.22 (P = 0.58) in susceptible vs resistant.   
Analysis on the expression levels of TGFB1 yielded fold changes of 1.51 (P = 0.22) 
in susceptible vs control and 1.46 (P = 0.16) in resistant vs control. TGFB1 
transcripts in susceptible vs resistant had fold change of 1.08 (P = 0.98). IL12B in 
susceptible had fold change of about -1.20 vs control and resistant; no significant 
difference was noted in these comparisons at P > 0.25. On the other hand, resistant 
lambs had a fold change of 1.15 vs control which was also not statistically significant 
(P = 0.48).  
4.3.2  Fold change in abomasal mucosa  
Only six genes were included in the expression analysis of the abomasal mucosa 
since eight others were outside the level of detection as defined in 4.2.1. Table 4.2 
shows the differential expression of IL6, IL7R, IL10, EBI3, IFNG, and TGFB1 in the 
abomasum of uninfected control and infected resistant and susceptible groups.  
Statistically significant differences between groups were noted for IL6 and TGFβ1 
(Figure 4.9). No significant differences were found with any comparison for IL7R, 
IL10, EBI3, and IFNG.  
   




Table 4.2 Relative quantification of mRNA transcripts in abomasal mucosa 
 















IL6 4.44 ± 1.91 <0.01 2.48 ± 0.81 0.23 1.79 ± 2.36 0.07 
IL7R -1.33 ± 0.19 0.33 1.00 ± 0.41 0.74 -1.33 ± 0.45 0.74 
IL10 1.00 ± 0.30 0.66 -1.54 ± 0.18 0.19 1.53 ± 1.63 0.60 
EBI3 -1.43 ± 0.40 0.33 -1.16 ± 0.35 0.70 -1.22 ± 1.12 0.78 
IFN 2.03 ± 1.30 0.89 1.44 ± 0.76 0.94 1.41 ± 0.70 0.70 
TGFβ1 2.53 ± 0.35 <0.01 1.35 ± 0.32 0.41 1.88 ± 0.12 <0.01 
* Fold change is the ratio of normalized mean expression between groups. Means of 
the non-infected controls were used as the calibrator and were arbitrarily assigned a 
value of 1.0 (using the 2-Cq method) and compared with the infected animals. Bold 
is P < 0.05.  
   






































Figure 4.8 Relative expression of genes in the abomasal mucosa (ABM) of non-
infected control (n=5) and infected resistant (n=5) and susceptible (n=5) sheep. 
Results are presented in fold change relative to the calibrator (mean of uninfected 
control) which were arbitrarily assigned a value of 1.0 (using the 2-Cq method). 
Brackets indicate statistical difference by one way ANOVA with Tukey Kramer’s 
post hoc test at P < 0.05. 
   




IL6 was highest in susceptible with significant (P < 0.01) 4.44 fold change vs 
control.  Susceptible had a fold change of 1.79 vs resistant which was marginally 
non-significant (P = 0.07). A statistically non-significant (P = 0.23) difference in fold 
change was also observed in IL6 expression in resistant vs control with a fold change 
of 2.48.  It must be noted that some Cq values of IL6 for 15 samples in the abomasal 
mucosa were in the borderline of standard curve plots but were still included in the 
analysis as most samples were quantifiable. Consequently, variations were observed 
as reflected in the high standard deviation of the fold change between susceptible and 
resistant. 
Significant up-regulation in TGFB1 expression was observed in susceptible lambs 
resulting in fold changes of 2.53 (P <0.01) vs control and 1.88 (P <0.01) vs resistant. 
There was no significant difference (P = 0.41) between resistant and control with 
1.35 fold change. 
Levels of EBI3 expression in all between-group comparisons were not statistically 
significant. Fold changes were -1.43 (P = 0.33) in susceptible vs control, -1.16 (P = 
0.70) in resistant vs control and -1.22 (P = 0.78) in susceptible vs resistant. For IL7R, 
susceptible had similar fold change difference of -1.33 vs control and resistant which 
was non-significant at P = 0.33 and P = 0.74 respectively. In resistant vs control, the 
fold change was 1.00 (P = 0.74). 
No significant differences were noted across all comparisons for both IL10 and 
IFNG. Fold change comparisons of IL10 expression between groups varied from 
1.00 in susceptible vs control, -1.54 in resistant vs control and 1.53 in susceptible vs 
resistant. All these comparisons were non-significant at P > 0.19. Fold changes for 




IFNG were 2.03 in susceptible vs control (P = 0.89), 1.41 in susceptible vs resistant 
(P = 0.70) and 1.44 in resistant vs control (P = 0.94). 
4.4 Summary and conclusion 
The section aimed to determine the histopathology and fold change difference among 
15 uninfected and infected resistant and susceptible lambs. This formed the basis in 
identifying transcripts included to produce copy number measurements that were 
correlated with phenotype data in all 55 lambs. 
Major histopathologic changes were associated with massive lymphocytic aggregates 
in the abomasal mucosa and submucosa of susceptible lambs.  Low level 
lymphocytic infiltrates were found in resistant lambs, while uninfected lambs 
(control) had no apparent associated lesions. 
The study has determined the relative expression of 14 cytokines and markers in the 
abomasal lymph node and abomasal mucosa in a cohort of lambs with genetic 
predilection for resistance and susceptibility to T. circumcincta.   
There was a significant differential expression in the abomasal lymph node for IL6 
and IL21 being two-fold higher in the susceptible lambs compared with resistant 
lambs. FOXP3 was significantly up-regulated by two-fold in infected lambs 
compared with uninfected controls, but not between resistant and susceptible. Other 
observed differences in expression involved EBI3 and IFNG which were both down-
regulated by two-fold in susceptible lambs compared to uninfected controls. There 
were no significant differences in any comparisons for IL2, IL7R, IL10, IL12B, 




IL23A, and TGFB1. IL4, IL17A and IL25 are too lowly expressed to be quantified 
accurately.   
The expression of only six genes out of the targeted 14 mRNA transcripts in the 
abomasal mucosa was successfully determined as the rest were below the threshold 
of accurate detection. TGFB1 had significantly higher levels in susceptible lambs by 
two-fold relative to resistant. There was an upregulated expression of TGFB1 and 
IL6 in susceptible lambs compared to control with fold changes of 2.5 and 1.9 
respectively. 
Based on the relative quantification analysis by RT-qPCR in the abomasal lymph 
node and abomasal mucosa, IL6, IL21, EBI3, IL23A, and TGFB1 were selected for 
absolute RT-qPCR and correlation analysis with phenotype data. The differential 
expression of IL6, IL21 and EBI3 suggests a TH17 response so it was deemed 
necessary to also look at IL23A and TGFB1 copy number transcripts despite its non-
significant difference between group comparisons. 
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Analysis on the differential expression of 14 cytokines at extremes of the response 
spectrum suggests that susceptibility is correlated with the activation of pro-
inflammatory TH17 cells. From these experiments IL6, IL21, IL23A, EBI3 and 
TGFB1 were selected for further expression analysis. IL6 and IL21 were chosen 
because their expression was significantly increased in the ALN of susceptible lambs 
in comparison to resistant lambs (Table 4.1). EBI3 (as IL35) is a known inhibitor of 
TH17 and was considered for further investigation as it was significantly reduced in 
the ALN in the susceptible lambs in comparison to uninfected controls. TGFB1 (as 
TGFβ) was significantly increased in the abomasal mucosa of susceptible lambs and 
plays a critical role in CD4+ T cell differentiation including the development of 
TH17 cells (with IL6) (Bettelli et al.,  2006). Although IL23A did not show 
significant changes in the fold-change analysis it was included because of its critical 
importance in the expansion and maintenance of TH17 cells (Boniface et al., 2008; 
Tang et al., 2012).  In this section, the immunological response was investigated 
more closely by looking at the differential expression of five cytokines in the full 
cohort of 55 lambs. 
The significant relationship between IgA antibody levels, FEC, adult worm count, 
worm length and fecundity in T. circumcincta infection has already been identified 
(Beraldi et al., 2008; Smith et al., 1983; Stear et al., 1995).  However, how these 
factors relate to the development of acquired protective immunity as reflected in 
differentially expressed genes has not been elucidated and was explored in this 
section.  
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The aim of the study was to investigate further any significant relationship between 
resistant and susceptible lambs in the five cytokines linked with TH17 response.  
Absolute quantification analysis was performed to measure transcript expression in 
the full cohort of resistant and susceptible lambs for five genes. It was hypothesised 
that the expression of IL6, IL21, EBI3, TGFB1 and IL23A levels are correlated with 
the individual physiological parameters.  In order to ascertain the relationship, copy 
number measurements of 45 infected lambs were correlated with adult worm count, 
FEC, IgA levels and body weight.  Differences in gene expression and its correlation 
with phenotype could provide insights into the immunological basis of resistance to 
T. circumcincta. It also offers a comprehensive view of the dynamics of T-cell 
immunity as it relates to immunology, pathology and physiology of a mature 
protective immune response.  
5.2 Absolute quantification by Real-time RT-qPCR in ALN 
5.2.1  Experimental set-up 
All 55 animals were included in absolute quantification analysis (Table 5.1). These 
were analysed in four groups: 10 uninfected controls (zero FEC and adult worm 
count); a resistant group of 15 lambs with the lowest adult worm count and FEC 
(mean adult worm count = 59; mean FEC = 2); the 15 most susceptible lambs with 
the highest adult worm count and FEC (mean adult worm count = 5,167; mean FEC 
= 288); and 15 intermediate sheep with mean adult worm count = 1,508; mean FEC 
= 82 (Table 5.1). 
All samples were run in triplicates for three sets of cDNA templates from 
independent reverse transcription reactions. With this set up, it was not possible to 
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perform analysis of the samples for each gene in a single run as the number of 
samples could not be accommodated in either a 72 or 100 well rotor disc. To ensure 
that inter-run differences will not influence the copy numbers generated from each 
run, samples for each gene were analysed on the same day using the same standard 
dilution plasmids for each gene. In addition, the same threshold levels were applied 
for each gene in generating raw copy numbers. 
5.2.2  Copy numbers of mRNA transcripts in the ALN 
Copy numbers for each transcript were calculated as described in Section 2.4.2. 
Table 5.2 shows the mRNA transcript expression in copy number measurements and 
the statistical analysis (Table 5.3) of the ALN in 55 lambs. Significant differences in 
transcript expression between any of the groups were observed only with IL6, IL21 
and IL23A (Figure 5.1). TGFB1 and EBI3 did not show any differential expression 
among any group comparisons (Figures 5.1).  
The copy number of IL6 transcripts in the resistant group was 10,550 ± 2,941 (± SD) 
per μg of total RNA, significantly lower than the susceptible 14,299 ± 4,447 (P = 
0.02). IL6 levels in the intermediate group were 9,108 ± 2,983, significantly lower 
than both the uninfected controls with 13,525 ± 3,398 (P = 0.02) and the susceptible 
group (P = 0.02), but not significantly different to the resistant animals (P = 0.67). 
Both IL21 and IL23A had a graded increase from the resistant to the susceptible 
group. IL21 levels in the uninfected controls were 5,159 ± 2,218 and in the resistant, 
intermediate and susceptible groups were 4,611 ± 1,407; 6,065 ± 2,715 and 7,894 ± 
2,433 respectively. In all group comparisons for IL21, only the susceptible group 
showed significantly higher transcript levels compared to both the control (P = 0.02) 
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and resistant (P < 0.01) groups.  IL23A levels in the controls were 522 ± 297, and in 
the resistant, intermediate and susceptible were 274 ± 115, 425 ± 283 and 773 ± 618 
respectively; only the resistant and susceptible comparison was significantly different 
(P < 0.01).  
There was no significant difference in any group comparison for EBI3 and TGFB1. 
Transcript levels of EBI3 varied from 9,282 ± 2,785 in the control group to 9,826 ± 
4,405 in susceptible, 10,781 ± 4,405 in intermediate, and 9,377 ± 3,744 in resistant 
animals. There were comparable levels of TGFB1 in all four groups which had copy 
numbers of 255,521 ± 34,753 in the controls, 287,122 ± 59,198 in the resistant, 
258,582 ± 112,920 in the intermediate, and 264,658 ± 28,484 in the susceptible 
lambs. There were no significant differences between the four groups for either EBI3 
or TGFB1 at P > 0.68.  
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Copy numbers per g total RNA 
  IL6 IL21 IL23A EBI3 TGFB1 
Uninfected Control    mean adult worm count = 0, mean FEC = 0. 
0 0 0 0.027 35.5 14848 5812 1233 6217 277905 
0 0 0 0.020 36 15740 1579 632 15224 273238 
0b 0 0 0.177 36 11569 6316 372 10112 261563 
0 b 0 0 0.025 34.5 11545 3695 737 11085 255047 
0 0 0 0.015 29 12031 3152 416 6638 264836 
0 b 0 0 0.288 27.5 19852 8863 560 11398 235090 
0 b 0 0 0.13 30 17499 4358 297 9455 219535 
0 b 0 0 0.031 36 12800 7373 202 7415 311237 
0 0 0 0.146 33 8827 3762 416 8275 271048 
0 0 0 0.077 32 10543 6682 350 7005 185708 
Resistant   mean adult worm count = 59, mean FEC = 1.67. 
1 b 0 0 1.195 30 14505 5230 398 9278 285751 
2 0 0 0.630 29 6236 3697 218 5605 319857 
3 b 0 0 0.798 36 15049 3593 271 10475 382993 
4 b 0 0 0.633 28 15805 7102 352 4134 380748 
5 b 0 0 0.077 30 9593 1847 415 12614 340326 
6 b 0 0 0.373 32 7643 4567 483 9750 285727 
7 0 0 0.384 25 8151 3277 374 19023 242788 
8 0 0 1.695 15 9121 3667 177 11453 210377 
9 0 0 1.066 27 11025 7259 329 13117 210896 
Chapter 5                               Correlation of gene expression with phenotype 
126 
 










Copy numbers per g total RNA 
  IL6 IL21 IL23A EBI3 TGFB1 
10 80 0 0.856 30 7651 4549 272 6985 317280 
11 100 0 0.126 29 7577 4494 224 7408 200657 
12 100 0 0.547 32.5 11819 4186 134 7892 241734 
13 100 25 0.154 34 12040 5403 81 7904 306587 
14 200 0 0.782 27 10802 5658 232 9783 253920 
15 300 0 0.706 29 11237 4642 151 5231 327194 
Intermediate   mean adult worm count = 1508, mean FEC = 82. 
16 400 0 0.706 39 6150 4006 293 7901 247866 
17 420 75 0.232 26 11377 9367 92 7268 267654 
18 200 25 0.232 27.5 6463 7099 900 11941 172305 
19 600 0 0.596 20 8101 5210 887 12495 185710 
20 900 0 0.804 37 7826 4899 830 4309 172130 
21 800 0 0.703 26 10711 5189 499 9157 198136 
22 1200 0 0.142 35 10405 4737 405 16643 240921 
23 1700 175 0.210 26 12801 13262 393 6642 235585 
24 1200 0 0.161 28 14711 2135 746 10501 635008 
25 2400 0 0.732 26 3336 5405 344 11582 190601 
26 2300 175 1.510 34 11517 8153 174 3415 260633 
27 2400 475 0.539 35 5971 7441 198 14135 223056 
28 2400 75 0.183 31 9803 5942 131 11252 303635 
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Wt (kg) Copy numbers per g total RNA  
  IL6 IL21 IL23A EBI3 TGFB1 
29 2600 100 0.259 36 7731 3591 199 16544 315039 
30 3100 125 0.468 37.5 9719 4543 282 17926 230453 
Susceptible   mean adult worm count = 5167, mean FEC = 288. 
31 3300 175 0.245 36.5 9208 11363 442 4387 251554 
32 2900 225 0.219 30 19950 9988 2692 9936 316898 
33 3800 100 0.073 35 16834 6704 1205 11897 270513 
34 3900 250 0.840 35 13298 8004 1275 10973 273123 
35 4200 275 0.060 28 12317 6188 1041 10722 296247 
36 4700 150 0.033 34 12604 4217 800 11879 309652 
37 5400 75 0.697 38 24497 8343 399 18275 227351 
38 5300 250 0.151 27.5 16951 10784 522 10585 254183 
39 4000 125 0.035 29 9193 5681 319 14154 240377 
40 6000 200 0.126 34 9966 6403 498 16722 215693 
41 b 6000 200 0.451 36 10526 5708 247 5460 284781 
42 b 5200 525 0.155 37 17829 8497 467 5843 250540 
43 b 6200 200 0.047 27 17534 7250 658 5404 269353 
44 b 5300 950 0.209 22 11700 6381 661 6703 251621 
45 b 11300 625 0.141 37 12073 12900 371 4455 257977 
aLambs ranked according to adult worm count in the total abomasal contents at post-mortem.and FEC (eggs per gram wet faeces) at final collection  
bLambs selected for the fold-change analysis; c anti-T. circumcincta IgA concentrations calculated relative to standard curve 
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Table 5.2  Cytokine transcript expression in the gastric lymph node of T. 
circumcincta infected sheep (Copy number per g total RNA) 
 Control Resistant Intermediate Susceptible 
IL6 13525 ± 3398 10550 ± 2941 9108 ± 2983 14299 ± 4447 
IL21 5159 ± 2218 4611 ± 1407 6065 ± 2715 7894 ± 2433 
IL23A 522 ± 297 274 ± 115 425 ± 283 773 ± 618 
EBI3 9282 ± 2785 9377 ± 3744 10781 ± 4405 9826 ± 4404 
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Table 5.3  Cytokine transcript expression in the gastric lymph node of T. 
circumcincta infected sheep (P-value of between-group comparisons) 
 Control Resistant Intermediate 
IL6    
Resistant 0.17   
Intermediate 0.02 0.67  
Susceptible 0.95 0.02 <0.001 
IL21    
Resistant 0.93   
Intermediate 0.76 0.30  
Susceptible 0.02 <0.01 0.13 
IL23A    
Resistant 0.39   
Intermediate 0.92 0.70  
Susceptible 0.38 <0.01 0.07 
EBI3    
Resistant 1.00   
Intermediate 0.79 0.77  
Susceptible 0.99 0.99 0.91 
TGFB1    
Resistant 0.69   
Intermediate 1.00 0.68  
Susceptible 0.99 0.82 0.99 
Groupings were based on worm burden parameters as used in the experiment 
(Beraldi et al, 2008): control (n=10, mean adult worm count =0, mean FEC = 0), 
resistant (n=15, mean adult worm count =59, mean FEC = 1.67), intermediate (n=15, 
mean adult worm count =1508, mean FEC = 82), and susceptible (n=15), mean adult 
worm count =5167, mean FEC = 288).  Bold is P < 0.05. 

























































































































Figure 5.1  Copy numbers of gene transcripts in the abomasal lymph node of 
control, resistant, intermediate, and susceptible.   Error bars are standard error of the 
mean (SEM) and brackets represent significant difference between group 
comparisons at P < 0.05 (*), P < 0.01 (**), and P <0.001 (***).  Significant 
differences between resistant and susceptible lambs in IL6, IL21 and IL23A 
expression are shown 
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5.3 Absolute quantification RT-qPCR in abomasal mucosa 
IL6 and TGFB1 were chosen for copy number measurement in all 55 animals based 
on fold change comparisons of gene transcripts in the abomasal mucosa. Results are 
presented in Table 5.4. 
5.3.1  Copy numbers of mRNA transcripts in abomasal mucosa 
The expression level of TGFB1 transcripts in the susceptible group was 40,686 ± 
11,964 and was significantly different (P < 0.04) to TGFB1 levels in the intermediate 
group (25,472 ± 7,910).  Other TGFB1 and IL6 group comparisons did not show any 
significant differences (Figure 5.2).  TGFB1 had copy numbers of 32,244 ± 19,250 in 
control and 31,125 ± 19,622 in resistant.  IL6 showed low and highly variable copy 
numbers in control (1,516 ± 1,297), resistant (2,090 ± 3,841), intermediate (626 ± 












Chapter 5                               Correlation of gene expression with phenotype 
132 
 
Table 5.4  Cytokine transcript expression in the abomasal mucosa of T. circumcincta 
infected sheep 
A. Copy number per g total RNA 
 Control Resistant Intermediate Susceptible 
IL6 1516 ± 1297 2090 ± 3841 626 ± 327 
 
2928 ± 2428 
 
TGFβ 32244 ± 19250 31125 ± 19622 25472 ± 7910 40686 ± 11964 
 
B.  P values of between-group comparisons  
 Control Resistant Intermediate 
    
IL6    
Resistant 0.94   
Intermediate 0.81 0.37  
Susceptible 0.50 0.78 0.06 
TGFβ1    
Resistant 0.99   
Intermediate 0.69 0.74  
Susceptible 0.52 0.32 0.04 
 
Groupings were based on worm burden as used in the experiment (Beraldi et al, 
2008): control (n=10, mean adult worm count =0, mean FEC = 0), resistant (n=15, 
mean adult worm count =59, mean FEC = 1.67), intermediate (n=15, mean adult 
worm count =1508, mean FEC = 82), and susceptible (n=15), mean adult worm 
count =5167, mean FEC = 288).  Bold is P ≤ 0.05. 
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IL6 TGFB1 IL6 TGFB1 
Uninfected control  
(mean AWC = 0, FEC = 0) 
Infected intermediate  
(mean AWC = 1508, FEC = 82)   
0 30542 2005 16 18861 649 
0 33438 451 17 40397 1095 
0 85328 1081 18 36487 1399 
0 18162 765 19 39243 1050 
0 28409 1600 20 11513 220 
0 28896 774 21 17602 372 
0 22921 4532 22 30730 826 
0 19716 2719 23 25778 694 
0 27460 233 24 24269 658 
0 27563 1003 25 24913 431 
Infected resistant  
(mean AWC = 59, FEC = 1.67) 
26 24832 331 
1 35863 1389 27 18108 301 
2 19601 15848 28 22095 399 
3 8086 967 29 24601 430 
4 39872 882 30 22645 530 
5 16570 684 Infected susceptible 
(mean AWC = 5167, FEC = 288) 
6 18653 674 31 32431 539 
7 15755 677 32 23906 473 
8 16055 1474 33 42873 1384 
9 21185 782 34 46871 4197 
10 81533 1911 35 67306 2480 
11 35172 1469 36 55097 3138 
12 25147 680 37 36724 193 
13 27684 742 38 41591 2905 
14 61492 2362 39 26230 1349 
15 44207 803 40 42629 7536 
   41 42244 5309 
   42 55352 4809 
   43 37461 7360 
   44 29454 1027 
   45 30125 1226 
Lambs ranked according to adult worm count (AWC) in the total abomasal contents 
at post-mortem and average faecal egg count (FEC) at the last week of data 
collection (Beraldi et al., 2008). 
 















































































Figure 5.2.  Copy numbers of gene transcripts in the abomasal mucosa of control 
(n=10, mean adult worm count =0, mean FEC = 0), resistant (n=15, mean adult 
worm count =59, mean FEC = 1.67), intermediate (n=15, mean adult worm count 
=1508, mean FEC = 82), and susceptible (n=15), mean adult worm count =5167, 
mean FEC = 288).  Error bars represent the standard error of the mean (SEM).  No 
significant differences between groups were found.    
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5.3.2 Correlation of transcript expression in the ALN and abomasal 
mucosa with physiological parameters 
Fold change analysis revealed increased expression of IL6 and IL21 in the abomasal 
lymph node as well as IL6 and TGFB1 in the abomasal mucosa of the susceptible 
group of lambs in comparison to resistant animals (Section 4.4).  It was proven in 
both fold change data and absolute copy number analysis that IL6 and IL21 are 
differentially expressed in the abomasal lymph nodes in resistant and susceptible 
lambs. The absolute quantification analysis has enabled the investigation of the 
relationship between cytokine transcript copy number and parameters used in 
assessing the phenotype characteristics of the lambs, which included FEC, adult 
worm count, worm-specific IgA levels, and body weight. 
Using Spearman’s rank analysis, significant correlations were observed (Table 5.6) 
in the quantitative expression of cytokine transcripts in the abomasal lymph node 
with FEC, adult worm count, and IgA. There was a positive correlation of IL6 (ρ = 
0.408, P = 0.005), IL21 (ρ = 0.651, P < 0.0001), and IL23A (ρ =0.306, P < 0.041) 
transcript levels with FEC (Figure 5.3).  Similarly, adult worm count was positively 
correlated with expression of IL6 (ρ = 0.348, P = 0.019), IL21 (ρ = 0.537, P = 
0.0001) and IL23A (ρ = 0.378, P = 0.010) (Figure 5.4). In contrast, significant (P = 
0.039) negative correlation (ρ = -0.308) was observed between IgA antibody levels 
and IL23A copy number (Figure 5.5). There were no significant correlations found in 
EBI3 and no significant correlations were established between IL6 (P ≥ 0.167) and 
IL21 (P ≥ 0.167) measurements with IgA and body weight respectively (Figures 5.7 
and 5.8). 
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There was significant positive correlations found in TGFB1 transcript levels in the 
abomasal mucosa with adult worm count (ρ = 0.425, P = 0.004) and FEC (ρ = 0.007, 
P = 0.034). TGFB1 was negatively correlated with IgA (ρ = 0.256) but this was not 
statistically significant at P = 0.09 (Figure 5.6).  No significant association was also 
noted in the expression of TGFB1 and body weight (P = 0.97).  The correlation 
coefficient of IL6 (ρ = -0.274) with IgA suggests a negative correlation but this was 
marginally non-significant (P = 0.07); non-significant negative correlation was also 
noted between IL-6 and body weight (ρ = -0.198, P = 0.193) (Figure 5.7). No 
significant correlations were established for IL6 copy number and either adult worm 
count (ρ = 0.142) or FEC (ρ = 0.156) at P ≥ 0.305). 
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Table 5.6  Correlation analysis of phenotypic parameters with cytokine transcript 




FEC IgA Body weight 
 ρa P value ρ P value ρ P value ρ P value 
           Abomasal lymph node 
IL6 0.348 0.019 0.408 0.005 -0.210 0.167 0.066 0.664 
IL21 0.537 0.0001 0.651 <0.0001 -0.135 0.377 0.031 0.838 
IL23A 0.378 0.010 0.306 0.041 -0.308 0.039 -0.054 0.723 
EBI3 0.003 0.982 -0.179 0.239 -0.164 0.283 -0.025 0.870 
TGFB1 -0.128 0.402 -0.020 0.895 -0.125 0.414 0.138 0.365 
 Abomasal mucosa 
IL6 0.142 0.353 0.156 0.305 -0.274 0.069 -0.198 0.193 
TGFB1 0.425 0.004 0.317 0.034 -0.256 0.090 0.007 0.966 
Bold; significant correlation (P ≤ 0.05) 
aρ, Spearman’s rank correlation coefficient 
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Figure 5.3 Correlation of gene copy numbers and faecal egg count (FEC) in the 
abomasal lymph node of 45 infected lambs.  There was significant positive 
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Figure 5.4  Correlation of gene copy numbers and adult worm count in the abomasal 
lymph node of 45 infected lambs.  Significant positive correlation was found 
between adult worm count and expression of IL6, IL21 and IL23A . 
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Figure 5.5  Correlation of gene copy numbers and IgA in the abomasal lymph node 
of 45 infected lambs.  IgA is relative concentration based on the standard (Beraldi et 
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Figure 5.6  Correlation of gene copy numbers and body weight (BW) in the ALN of 
45 infected lambs.  No significant correlation was found between body weight and 
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Figure 5.7  Correlation of IL6 copy numbers with phenotype data in the ABM of 45 
infected lambs.  No significant correlation was found between IL6 expression and 
any of the phenotype parameters  
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Figure 5.8  Correlation of TGFB1 copy numbers with phenotype data in the ABM of 
45 infected lambs.  There was significant positive correlation between TGFB1 
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5.4 Summary and conclusion 
Absolute quantification of cytokine transcript copy numbers were generated in 55 
lambs for five cytokine transcripts in the abomasal lymph node and two cytokine 
transcripts in the abomasal mucosa.  Group comparisons of copy numbers in the 
abomasal lymph node revealed that IL6, IL21, and IL23A had significantly higher 
transcript levels in susceptible than resistant lambs. IL6 was also significantly raised 
in susceptible than in the intermediate group. Animals in the control group had 
increased expression of IL6 and IL21 compared with the intermediate and 
susceptible groups. No significant differences were found with any group 
comparisons for EBI3 and TGFB1. Comparisons between groups on copy number 
measurements in the abomasal mucosa revealed a significantly higher level of 
TGFB1 in susceptible compared with resistant lambs. No significant differences 
were found between groups for IL6. 
There was significant positive correlation of IL6, IL21, and IL23A expression in the 
abomasal lymph node with FEC and adult worm count. IL23A was negatively 
correlated with IgA. Body weight was not significantly correlated with any of the 
gene transcripts. There were no significant correlations found in EBI3 and TGFβ1 
with any of the phenotypic parameters. Significant positive correlations were seen 
between TGFB1 copy numbers in the abomasal mucosa with adult worm count and 
FEC.  
 





Chapter 6 Identification of genetic markers for resistance   
   





It is well established that much of the variation of resistance to gastrointestinal 
parasitic nematodes in sheep is under genetic control (Bishop and Stear, 2003; Gray,  
1997; Ingham et al., 2008; Stear et al., 1997; Windon, 1996).  The ultimate aim of 
the project is to enable the selection of lambs resistant to T. circumcincta. The 
current criteria for selection are a number of indicator traits, primarily FEC(Davies et 
al., 2005; Gill, 1991; Stear et al., 2006a) and pathological parameters, including 
eosinophilia (Stear et al., 2002) and IgA antibody levels (Davies et al., 2006; Stear et 
al., 1997; Strain et al., 2002).  However, such phenotypic markers are quite difficult 
to establish as it necessitates challenge infection with the parasite.  This process does 
not only compromise the animal’s productivity but also requires longer time to 
evaluate the indicator trait (Davies et al., 2005).  In addition, phenotypic parameters 
may be influenced by several factors such as time after infection, season, age, and 
nutritional status as reviewed by Stear et al. (2007b) and therefore would require 
careful assessment of the index of trait heritability.  
Single nucleotide polymorphisms could be used as genetic markers for resistance that 
can be validated with phenotype markers as mutations in particular loci of a gene 
may alter the gene product and gene expression or regulation.  Examples are IFNG 
(Coltman et al., 2001b; Matika et al., 2011) and IL-4 (Benavides et al., 2009) genes 
where polymorphism conferring increased resistance to gastrointestinal nematode 
parasites has been located.  
Genetically-controlled resistance of sheep has an immunological basis (Gill, 1991), 
thus differential expression of genes involved in the polarization of an immune 




response is useful in determining candidate genes as markers.  The strategy used in 
this study was to identify candidate genes as markers based on their immunological 
association with resistance.   
In this section, we evaluated two parameters in identifying genetic markers that are 
associated with resistance to T. circumcincta.  First, we aimed to detect SNPs in IL21 
gene and its receptor IL21R.  We have shown that IL21, IL6 and IL23A are 
differentially expressed in resistant and susceptible lambs suggesting a link between 
susceptibility and the activation of the inflammatory TH17 T cell subset.  We 
focused our interest on IL21 which plays a major role in the maintenance of TH17 
response cells (Korn et al., 2009).  IL21 was up-regulated by > two-fold in 
susceptible lambs and was also significantly positively correlated with both adult 
worm numbers and faecal egg count.  It was hypothesized that this response has a 
genetic basis and that polymorphisms (SNPs) of the IL21 and/or, IL21R genes are 
linked to phenotypic parameters of susceptibility. If so, these could be utilized as 
selectable genetic marker for resistance to T. circumcincta.   
Initially, I generated the ovine sequence for the coding regions of IL21 and IL21R 
genes prior to identification of any sequence variations.  High resolution melt 
analysis was used to identify these sequence variations in IL21 and IL21R.  This 
technique, which is used for mutation scanning and genotyping, allows 
characterization of the DNA based on the transition from double stranded to single 
stranded DNA with increasing temperature (Erali et al., 2008).  DNA melt is 
influenced by the amplicon size and the base constituent which is reflected in the 




temperature shift making HRM analysis a powerful tool that is sensitive enough to 
detect even a single base mutation (White and Potts,  2006). 
The second part dealt with determining if the allele Ovar-DRB1*0203, which has 
been linked with resistance to T. circumcincta, could be identified in resistant lambs 
used in the study.  This part was not included in the original thesis plan but I became 
interested with the recent finding on the association of this allele (Hassan et al.,  
2011) with resistance to T. circumcincta. Since I was doing the SNP analysis during 
that time, I decided to maximize the use of my gDNA samples,     
Ovar-DRB1*0203 is one of theloci in DRB1 allele MHC Class II.  Several allele 
types have been associated with the MHC Class II region owing to its important role 
in antigen presentation and consequent T cell activation.  Of the many MHC Class II 
genes that have been characterized in ruminants only DRB1 has been found to 
display extensive polymorphism in sheep (Dutia et al., 1994; Schwaiger et al.,  
1995).  Several alleles have also been identified within this locus and more recently it 
has been reported that Suffolk sheep that carry Ovar DRB*0203 have increased 
resistance to natural T. circumcincta infection compared to those expressing different 
alleles (Hassan et al., 2011).  It was also revealed that substitution of the most 
common allele with Ovar DRB*0203 has reduced FEC to 58-fold in six-month-old 
lambs following natural, predominantly T. circumcincta infection (Schwaiger et al.,  
1995).  Based on the phenotype data (Beraldi et al., 2008), FEC and adult worm 
count are significantly higher in susceptible lambs compared to their resistant 
counterpart.  On this premise, we aimed to identify if Ovar DRB*0203 (*1101) 
within sheep MHC Class II is expressed in resistant lambs. 




6.2 SNP analysis in IL21 and IL21R  
6.2.1  Extraction of genomic DNA from blood of lambs 
Genomic DNA was extracted from blood of the ten most resistant (lowest adult 
worm count and FEC) and ten most susceptible animals (highest adult worm count 
and FEC).  This was used as a template for identifying SNPs by HRM analysis.  The 
concentration of extracted DNA is presented in Table 6.1.  The extracted DNA was 
generally of high purity with 260/280 absorbance ratio that ranged from 1.73-1.91.  
6.2.2  PCR of IL21 and IL21R fragments 
The full length sequences of ovine IL21 and IL21R were not available and the 
bovine mRNA sequences (IL21, NM_198832.1; IL21R, NM_001193179.1) for both 
genes were utilized as templates to design primers for cloning the ovine genes.  The 
generated ovine sequence was then used to design primers for HRM analysis, which 
require short amplicon size of 100-200 bp to increase the sensitivity of the assay.  
Primers used to generate the sequences are shown in Table 6.2.  Standard cycling 
conditions were used as described in Section 1.2.3.2.  Two primer sets were needed 
to amplify the 459-base IL21 mRNA because there was no suitable single primer set 
that could span its entire coding region.  This was attributed to the characteristic 
arrangement of some bases, e.g. high G/C rich or long A/T rich areas in many 
regions making it difficult to design an ideal primer set 
   




Table 6.1  DNA sample concentration used in HRM analysis 






1 98.21 1.88 
2 88.36 1.85 
3 85.42 1.91 
4 91.05 1.86 
5 34.67 1.77 
6 27.40 1.73 
7 50.53 1.80 
8 32.3 1.85 
9 40.71 1.82 
10 34.87 1.91 
Susceptible 
 
11 84.28 1.84 
12 72.13 1.90 
13 32.14 1.84 
14 26.99 1.78 
15 83.49 1.84 
16 31.53 1.86 
17 26.61 1.86 
18 75.14 1.81 
19 33.43 1.91 








Table 6.2  Primers used to generate partial and full length coding region sequence of 
ovine IL21 and IL21R 




















IL21R F: CCTCTTTGGGATGTAACTGATG 
R: CATATGTGTCATGCCAGGTG 
 














6.2.3 Amplification of cDNA 5’ end of IL21 
The published bovine IL21 mRNA sequence in the database consisted only of the 
coding region, which did not allow me to design primers that would cover the entire 
coding region in sheep.  In order to generate these sequences, RACE was performed 
(Section 1.4.1.2) in one of the total RNA samples used in real time RT-qPCR 
(Appendix 1).  The lymph node RNA sample used was selected on the basis of its 
purity with RIN value of 7.5 and absorbance ratio for 260/280 at 2.15 and 2.04 for 
260/230.  The concentration of the RNA used was 1452.47 ng/µl. 
RACE allows amplification of full length 5’ and 3’ cDNA using known cDNA 
sequence.   The protocol ensures that only full-length transcripts are produced by 
elimination of truncated messages from the amplification process.  Dephosphorylated 
and decapped total RNA generated the mRNA into which RNA Oligo primer was 
ligated.  This provided a known priming site for the GeneRacer™ primers after the 
mRNA was transcribed into cDNA.  RACE-ready first strand cDNA with known 
priming site for 5’ end was amplified using gene-specific primers at the 5’ end 
initially and subsequently nested gene-specific primers to increase the yield and 
specificity of the PCR. These primer sets are presented in Table 6.3. 
   




Table 6.3 Primers used in amplifying 5’ cDNA ends of ovine IL21 
Accession 
number 




NM_198832.1 Reverse 5’ end   
 CGCTCACAGTGTCTCTTTACATC 193-216 72 
 TCTGGAGCTGGCAGAAATTCAGG 169-191 70 
 
Nested reverse 5’ end 
  
 CTCCATGTTCCCCGGCCACCG 4-24 72 
 GGCCACTGTCCCAGAGAAGATGACC 45-69  69 
 
   




PCR was set up for the reverse 5’ end primers as described in Section 1.4.1.3.  The 
cycling parameters used in amplifying 5’ ends of IL21 are as follows:   
   
94ºC 2 min 1 cycle 
   
94ºC 30 sec  
72ºC 30 sec  
   
94ºC 30 sec   
70ºC 30 sec  
   
94ºC 30 sec  
65ºC 30 sec 20 cycles 
68ºC 30 sec 
 
 
68ºC 10 min 1 cycle 
   
Two primer sets were tested to produce the untranslated sequences in the 5’ end of 
IL21 using RACE protocol.  If the sequence for untranslated regions of the 5’ end 
was produced then we could have subsequently worked on the 3’ end to complete the 
coding regions of IL21.  However, neither of these sets, including the nested primers 
used, generated the target product.  A faint smear on the gel was seen for the PCR 
product of one of the primer sets, which was cloned and sequenced as described in 
Section 1.2.4 but did not match the target sequence.  These observations may be 
attributed to the characteristics of the bases comprising the untranslated regions that 
would require highly specific and efficient thermo-cycling conditions.  Optimization 
of the annealing conditions may have improved the results but this was not 
performed due to time limitations.    
The main purpose in generating the ovine sequences of IL21 was to provide a 
template from which sequences of possible ovine SNPs from resistant and/or 
5 cycles
5 cycles




susceptible lambs will be aligned to.  The sequences at the 31 bases in the 5’ end and 
the 22 bases in the 3’end were not successfully generated in the 459-base long 
coding region of IL21. Nevertheless, the rest of the sequences within the coding 
region were obtained which could be utilized in identifying possible SNPs that span 
those areas. 
6.2.4  Generation of coding sequences for ovine IL21 and IL21R 
Two batches of PCR were performed for ovine IL21 and IL21R sequencing primers 
(Table 6.2) using lymph node cDNA templates sourced from two different RT 
reactions.  This was done to generate high quality consensus sequence of transcripts 
with minimal ambiguity. Products were cloned and sequenced as described in 
Section 1.2.4.  At least three independent sequences from each primer sets of IL21 
and IL21R in both PCR runs were generated.  Sequences were aligned with the 
coding regions of the bovine sequence in CLC Sequence Viewer v6.5.2 to generate a 
consensus.  Each pair of overlapping fragments of IL21 and IL21R consensus 
sequences were aligned in NeedleMan-Wunsch global alignment application 
implemented in Jemboss v 1.5 (Carver and Bleasby,  2003).  The pairs were then 
joined together to generate the full length sequence using Merger software in 
Jemboss.  Partial and full length sequences of IL21 and IL21R respectively were 
aligned with related species using ClustalW2.  The created alignments, along with 
their alignment scores are shown in Figures 6.1 and 6.2.  Ovine IL21 and IL21R 
transcripts were closely related with the bovine species with matched nucleotide 
bases of 97% and 94% respectively.  
 




6.2.5  Genomic organization of IL21 and IL21R 
The ovine IL21 and IL21R mRNA sequences were aligned with the ovine genome 
using the database in sheep genome Oar v2.0 
(http://www.livestockgenomics.csiro.au/blast/) genome sequences to identify their 
genomic organizations.  IL21 was found in chromosome 17 and consists of five 
exons and four introns as illustrated in Fig 6.3.   IL21R was located in chromosome 
24 with a total of eight exons within the coding regions (Fig 6.4).  Untranslated 
regions lie in the first exon of the 5’ end and part of the last exon of the full length 
sequence.   
   




OVINE      ----------------------------------------TGAATTTCTGCCAGCTCCAG 20 
BOVINE     TTGTTGATCAGCTGAAAAACTATGTGAATGACTTGGATCCTGAATTTCTGCCAGCTCCAG 190 
HUMAN      TTGTTGATCAGCTGAAAAATTATGTGAATGACTTGGTCCCTGAATTTCTGCCAGCTCCAG 238 
PORCINE    CTGTTGATCAGCTGAAAAATTATGTTCATGACTTGGACCCTGAATTGCTGCCAGCTCCAG 190 
MURINE     TTGTTGAACAGCTGAAAATCTATGAAAATGACTTGGATCCTGAACTTCTATCAGCTCCAC 225 
                                                   **** * **. ********  
 
OVINE      AAGATGTAAAGAGACACTGTGAGCGGTCAGCTTTTTCATGTTTTCAGAAGGTTCAACTAA 80 
BOVINE     AAGATGTAAAGAGACACTGTGAGCGGTCAGCTTTTTCATGTTTTCAGAAGGTTCAACTAA 250 
HUMAN      AAGATGTAGAGACAAACTGTGAGTGGTCAGCTTTTTCCTGCTTTCAGAAGGCCCAACTAA 298 
PORCINE    AAGATGTACAGAGACACTGTGAGCAGTCAGCTTTTTCATGTTTTCAGAAGGTCGAACTAA 250 
MURINE     AAGATGTAAAGGGGCACTGTGAGCATGCAGCTTTTGCCTGTTTTCAGAAGGCCAAACTCA 285 
           ******** **. ..******** .  ******** *.** **********   ****.* 
 
OVINE      AGTCAGCAAATAATGGAGACAACGAAAAGATAATCAACATACTAACTAAACAGCTGAAGA 140 
BOVINE     AGTCAGCAAATAATGGAGACAACGAAAAGATAATCAACATATTAACTAAACAGCTGAAGA 310 
HUMAN      AGTCAGCAAATACAGGAAACAATGAAAGGATAATCAATGTATCAATTAAAAAGCTGAAGA 358 
PORCINE    AGTCAGCAAATACGGGAGACAATGAAAAGATAATCAATGTATTAATAAAACAGCTGAAGA 310 
MURINE     AGCCATCAAACCCTGGAAACAATAAGACATTCATCATTGACCTCGTGGCCCAGCTCAGGA 345 
           ** ** **** .. ***.**** .*.* .:*.****: .:.  ..  ....**** *.** 
 
OVINE      GGAAACTGCCTCCCACAAATGCAGGGAGAAGACAGAAACATGAACTAACATGTCCTTCTT 200 
BOVINE     GGAAACTACCTGCCACAAATACAGGGAGAAGACAGAAACATGAAGTAACATGTCCTTCTT 370 
HUMAN      GGAAACCACCTTCCACAAATGCAGGGAGAAGACAGAAACACAGACTAACATGCCCTTCAT 418 
PORCINE    GGAAACTACCTCCCACAAATGCAGGGAGAAGACAGAAACATGGGCTAACATGTCCTACAT 370 
MURINE     GGAGGCTGCCTGCCAGGAGGGGAGGAAAGAAACAGAAGCACATAGCTAAATGCCCTTCCT 405 
           ***..* .*** *** .*. . ***.*..*.******.** . .  :*.*** ***:* * 
 
OVINE      GTGATTCTTATGAGAAAAAGCCACCCAAGGAATACCTAGAAAGACTGAAATCGCTCATCC 260 
BOVINE     GTGATTCTTATGAGAAAAAACCACCCAAGGAATACCTAGAAAGACTGAAATCACTCATCC 430 
HUMAN      GTGATTCTTATGAGAAAAAACCACCCAAAGAATTCCTAGAAAGATTCAAATCACTTCTCC 478 
PORCINE    GTGATTCGTATGAGAAAAAACCAATCAAAGAATTCCTAGAAAGACTGAAATCGCTCATCC 430 
MURINE     GTGATTCGTATGAGAAAAGGACACCCAAAGAATTCCTAGAAAGACTAAAATGGCTCCTTC 465 
           ******* **********...**. ***.****:********** * **** .** .* * 
 
OVINE      AAAAG------------------------------------------------------- 265 
BOVINE     AAAAG------------------------------------------------------- 435 
HUMAN      AAAAGGTATCTACCTTAAGTTTCATTTGATTTTCTGCTTTATCTTTACCTATCCAGATTT 538 
PORCINE    AAAAG------------------------------------------------------- 435 
MURINE     AAAAG------------------------------------------------------- 470 
           *****                                                        
 
OVINE      -----------------------------------AT----------------------- 267 
BOVINE     -----------------------------------ATGATTCATCAGCATCTGTCCTAG- 459 
HUMAN      GCTTCTTAGTTACTCACGGTATACTATTTCCACAGATGATTCATCAGCATCTGTCCTCTA 598 
PORCINE    -----------------------------------ATGATTCATCAGCATCTGTCCTAG- 459 
MURINE     -----------------------------------ATGATTCATCAGCATCTCTCCTAGA 495 
                                              **                        
 
Figure 6.1 Alignment of sheep IL21 nucleotide sequence with cattle 
(NM_198832.1), human (NM_001207006.1), pig (NM_214415.1), and mouse 
(NM_021782.2) sequences; with alignment scores against ovine transcripts of 97 %, 
86 %, 91 %, and 72 % respectively.  (*) indicates identical nucleotide bases in all 
sequences 
  




OVINE      CCCCAATACCAAGCCCAGCTGCCACCCCTGGGAGACCACCGGACTGCCCGGAGCCCAGAG 60 
BOVINE     ------------------------------------------------------------ 
EQUINE     ------------------------------------------------------------ 
HUMAN      ----ATGAGCTGTCGCTGCATCTTTCTCATG------------AAGCACGGGGAACGGGT 44 
MURINE     ------------------------------------------------------------ 
                                                                             
 
OVINE      AAAATGGATTTCTGAGAAAGAAGTAGAACAGCAGGCTCCGGGAGGCAGCATGCCGTGTGC 120 
BOVINE     -------------------------------------------------ATGCCGTGTGC 11 
EQUINE     -------------------------------------------------ATGCTGTGTGG 11 
HUMAN      CGGATG---------------------------GCCCGTGGGAGTCAGCATGCCGCGTGG 77 
MURINE     -------------------------------------------------ATGCCCCGGGG 11 
                                                            ****   * *  
 
OVINE      CTGGGCTGCGACTTTGCTCCTGCTAATGCTCCAGGGAACCTGGGGCTGCTCCAACCTCGT 180 
BOVINE     CTGGGCTGCGACTTTGCTCCTGCTAATGCTCCAGGGAACCTGGGGCTGCTCCAACCTCGT 71 
EQUINE     CTGGGCTATCCCTTGGCTCCTGCTGATGCTCCAGGGTGCCTGGGGCTGCTCAGACCTTGT 71 
HUMAN      CTGGGCCGCCCCCTTGCTCCTGCTGCTGCTCCAGGGAGGCTGGGGCTGCCCCGACCTCGT 137 
MURINE     CCCAGTGGCTGCCTTACTCCTGCTGATTCTCCATGGAGCTTGGAGCTGCCTGGACCTCAC 71 
           *  .*  .   * * .********..* ***** **:.  ***.*****   .**** .  
 
OVINE      CTGCTACACCGATTACATCGAGACTATCACCTGCATCCTGGAGACATGGGCCGGGCACCC 240 
BOVINE     CTGCTACACCGATTACATCGAGACTATCACCTGCATCCTGGACACATGGGCCAGGCACCC 131 
EQUINE     CTGCTACACCGATTACCTCCAGACGGTCACCTGTATCCTGGAGACATGGACCCTCCACCC 131 
HUMAN      CTGCTACACCGATTACCTCCAGACGGTCATCTGCATCCTGGAAATGTGGAACCTCCACCC 197 
MURINE     TTGCTACACTGACTACCTCTGGACCATCACCTGTGTCCTGGAGACACGGAGCCCCAACCC 131 
            ******** ** ***.** .*** .*** *** .******* * . **. *   .**** 
 
OVINE      CGACTCGCTCACCCTCACCTGGCATGACACATTTGAAGAACTGGAGGATGAAGTCACCTC 300 
BOVINE     CGACTCGCTCACCCTCACCTGGCATGACACATATGGAGAACTGGAGGATGAAGTCACCTC 191 
EQUINE     TGGCACGCTCGTCCTCGCCTGGCAAGACTCGTACGGAGAACTGGAGGATGAGGTCACCTC 191 
HUMAN      CAGCACGCTCACCCTTACCTGGCAAGACCAGTATGAAGAGCTGAAGGACGAGGCCACCTC 257 
MURINE     CAGCATACTCAGTCTCACCTGGCAAGATGAATATGAGGAACTTCAGGACCAAGAGACCTT 191 
            ..*: .***.  ** .*******:**  ..*: *..**.**  ****  *.*  ****  
 
OVINE      CTGCAGCCTCCTCCAGTCCACCCACAATGCCACCCATGCGGAGTACACGTGCCACATGAA 360 
BOVINE     CTGCAGCCTCCTCCGGTCCACCCACAACGCCACCCACGTGGAGTACACGTGCCACATGAA 251 
EQUINE     CTGCAGCCTCGGCCGCTCCACCCACAACGCCACGCACACAGAGTACACGTGCCACATGGA 251 
HUMAN      CTGCAGCCTCCACAGGTCGGCCCACAATGCCACGCATGCCACCTACACCTGCCACATGGA 317 
MURINE     CTGCAGCCTACACAGGTCTGGCCACAACACCACACATATATGGTACACGTGCCATATGCG 251 
           *********.  *.. ** . ****** .**** ** .     ***** ***** *** . 
 
OVINE      AGTGTTCTCCCTCGTGGCTGACGACTTCTTCAATGTAAGCATGACAGACCCATCCGGCAA 420 
BOVINE     TGTGTTCCGCCTCATGGCTGACGACTTCTTCAATGTAAGCATGACAGACCCATCCGGCAA 311 
EQUINE     CGTGTTCCCCTTCATGGCCGACGACATCTTCACTGTCAACATGACAGACCAGTCTGGCAA 311 
HUMAN      TGTATTCCACTTCATGGCCGACGACATTTTCAGTGTCAACATCACAGACCAGTCTGGCAA 377 
MURINE     CTTGTCTCAATTCCTGTCCGATGAAGTTTTCATTGTCAATGTGACGGACCAGTCTGGCAA 311 
             *.*    . ** ** * ** **. * **** ***.*. .* **.****..** ***** 
 
OVINE      CTACTCCAAGGAGTGTGGCAGCTTTATGGTGGCTGCGAGCATCAAGCCATCTCCCCCTTT 480 
BOVINE     CTACTCCCAGGAGTGTGGCAGCTTTATAGTGGCTGCGAGCATCAAGCCATCTCCCCCTTT 371 
EQUINE     CCACTCCCAGGAGTGCGGCAGCTTTGTCCTAGCGAAGAGCATCAAGCCATCTCCCCCTTT 371 
HUMAN      CTACTCCCAGGAGTGTGGCAGCTTTCTCCTGGCTGAGAGCATCAAGCCGGCTCCCCCTTT 437 
MURINE     CAACTCCCAAGAGTGTGGCAGCTTTGTCCTGGCTGAGAGCATCAAACCAGCTCCCCCCTT 371 
           * *****.*.***** ********* *  *.** ..*********.**. ******* ** 
 
Figure 6.2 Alignment of sheep IL21R nucleotide sequence with cattle 
(NM_001193179.1), horse (XM_001496989.1), human (NM_181079.4), and mouse 
(NM_021887.2) sequences; with alignment scores against ovine transcripts of 94 %, 








OVINE      CAACGTGACCGTGAGCTTCTCCGGAAATTATAACATCTCCTGGAGTTCCAGTTCCAGTTC 540 
BOVINE     CAACGTGACCGTGAACTTCTCCGGATATTATAATGTCTCTTGGAGTTCCAGTTCCAGTTT 431 
EQUINE     CAACGTGACCGTGACCTTCTCGGGACTTTACAACATCTCCTGGAGCTCCAGTTACGATTC 431 
HUMAN      CAACGTGACTGTGACCTTCTCAGGACAGTATAATATCTCCTGGCGCTCAGATTACGAAGA 497 
MURINE     GAACGTGACTGTGGCCTTCTCAGGACGCTATGATATCTCCTGGGACTCAGCTTATGACGA 431 
            ******** ***. ****** ***   ** .* .**** *** . **.. **. ..    
 
OVINE      CAGTCCCAGGGACCTTGTCTACGCCCTGAAGGACAAACTTCAGTATGAGCTGCGGTACAG 600 
BOVINE     CAGTCCCAGTGACCGTGTCTATGCACTGAAGGACAAACTTCAGTATGAGCTGCGGTACAG 491 
EQUINE     CT------------------ACGGGCTGCAGGGCAAGCTTCAGTACGAGCTGCAGTACAA 473 
HUMAN      CCCTGCCT---------TCTACATGCTGAAGGGCAAGCTTCAGTATGAGCTGCAGTACAG 548 
MURINE     ACCCTCCA---------ACTACGTGCTGAGGGGCAAGCTACAATATGAGCTGCAGTATCG 482 
           .                   * .  ***..**.***.**:**.** *******.*** .. 
 
OVINE      GAAGGTTGGAGAACCCTGGGCTCAGAGTCCAGGGAGAAAGCTGATCTCAGAGGATTCCAG 660 
BOVINE     GAAGGTTGGAGAGCCCTGGGCTCAGAGTCCAGGGAGAAAGCTGATCTCAGAGGATTCCAG 551 
EQUINE     GATGCGGGGAGATCCCTGGGCTCTGAGGCCACAGAAAAGGCTGATCTCGGTGGACTCGAG 533 
HUMAN      GAACCGGGGAGACCCCTGGGCTGTGAGTCCGAGGAGAAAGCTGATCTCAGTGGACTCAAG 608 
MURINE     GAACCTCAGAGACCCCTATGCTGTGAGGCCGGTGACCAAGCTGATCTCAGTGGACTCAAG 542 
           **:    .**** ****. *** :*** **.  ** .*.*********.*:*** ** ** 
 
OVINE      AAGCGTCCTTCTCCTCCCTTTGGAGTTCCACAGCGGCTCAAACTACGAGCTGCAGGTGCG 720 
BOVINE     AAGCGTCTTTCTCCTCCCTTTGGAGTTCCACAGTGGGTCAAGCTACGAGCTGCAGGTGCG 611 
EQUINE     AAGCGTCTCCCTCGTTCCCTTGGAGTTCCGCGGAGACTCGAGCTACGAGCTGCAGGTGCG 593 
HUMAN      AAGTGTCTCCCTCCTCCCCCTGGAGTTCCGCAAAGACTCGAGCTATGAGCTGCAGGTGCG 668 
MURINE     AAACGTCTCTCTTCTCCCTGAAGAGTTCCACAAAGATTCTAGCTACCAGCTGCAGGTGCG 602 
           **. ***   **  * **  :.*******.*.. *. ** *.***  ************* 
 
OVINE      GGCAGGGCCCCAGCCCGGCTCCACCTTCCAGGGCACCTGGAGCGAATGGAGTGAGCCAGT 780 
BOVINE     GGCAGGGCCCCAGCCCGGCTCCACCTTCCAGGGGACCTGGAGCGAATGGAGTGACCCAGT 671 
EQUINE     GGCAGGGCCCCAGCCTGGCTCCTCCTTTGAGGGGACGTGGAGCGAGTGGAGTGAGCCAGT 653 
HUMAN      GGCAGGGCCCATGCCTGGCTCCTCCTACCAGGGGACCTGGAGTGAATGGAGTGACCCGGT 728 
MURINE     GGCAGCGCCTCAGCCAGGCACTTCATTCAGGGGGACCTGGAGTGAGTGGAGTGACCCCGT 662 
           ***** *** .:*** ***:* :*.*:  .*** ** ***** **.******** ** ** 
 
OVINE      CGTCTTTCACACCCAGCCGGAAGAGAGAAAGGGAGACCTGTATCTTCACCTGGTTCCCAT 840 
BOVINE     CGTCTTTCACACCCAGCCGGAAGAGAGAAAGGGAGACCTGTATCTTCACCTGGTTCCCAT 731 
EQUINE     CATCTTTCAGACACAGCCAGAAGGGAGCAAGGGAGGCTGGCACTCTGACCTGCTGTACCT 713 
HUMAN      CATCTTTCAGACCCAGTCAGAGGAGTTAAAGGAAGGCTGGAACCCTCACCTGCTGCTTCT 788 
MURINE     CATCTTTCAGACCCAGGCTGGGGAGCCCGAGGCAGGCTGGGACCCTCACATGCTGCTGCT 722 
           *.******* **.*** * *..*.*  ..*** **.*  * *   * **.** *    .* 
 
OVINE      CCTGCTCATCCTGGTCTGCCTCATCTTTGTCTTCTTGGGCCTGAAGGTCC------CTTG 894 
BOVINE     CCCGCTCATCCTGGTCTGCCTCATCTTTGTCTTCTTGGGCCTGAAGGTCC------CTTG 785 
EQUINE     CCTCCTGGTCCTCGTGCCCCCCATCCTTGTCTTCTTAGGCCTGAAGATCCACCTGCCTTG 773 
HUMAN      CCTCCTGCTTGTCATAGTCTTCATTCCTGCCTTCTGGAGCCTGAAGACCCATCCATTGTG 848 
MURINE     CCTGGCTGTCTTGAT---CATTGTCCTGGTTTTCATGGGTCTGAAGATCCACCTGCCTTG 779 
           **      *  * .*   *   .*    *  ***: ..* ******. **        ** 
 
OVINE      GAGGCCGTGGGAAAAGGTGTGGCTGCAGGTGTCCAGCCCGAAGCCCTTCTTCCAGCCCCT 954 
BOVINE     GAGGCCGTGGGAAAAGGTATGGTTGCAGGTGTCCAGCCCAAAGCCCTTCTTCCAGCCCCT 845 
EQUINE     GAGGCTGTGGAAGAAGGTCTGGGTACAGGTGCCCAGCCCAGAGCGGTTCTTTCAGCCCCT 833 
HUMAN      GAGGCTATGGAAGAAGATATGG--GCCG-TCCCCAGCCCTGAGCGGTTCTTCATGCCCCT 905 
MURINE     GAGGCTATGGAAAAAGATATGGGCACCAGTGCCCACCCCTGAGAGTTTCTTCCAGCCCCT 839 
           ***** .***.*.***.* ***  .*.. *  *** *** .**.  ***** .:****** 
 
OVINE      GTACGTGGGCCACAGCGGAGACTTCAAGAAATGGGTGGGCACACCCTTCACTGCCTCCAG 1014 
BOVINE     GTACGTGGGCCACAGCGGAGACTTCAAGAAATGGGTGGGCACACCCTTCACTGCCTCCAG 905 
EQUINE     GTACATGGGCCACAGCGGAGACTTCAAGAAATGGGTGGGCACGCCCATCACCCCCGCCAG 893 
HUMAN      GTACAAGGGCTGCAGCGGAGACTTCAAGAAATGGGTGGGTGCACCCTTCACTGGCTCCAG 965 
MURINE     GTACAGGGAGCACAGCGGGAACTTCAAGAAATGGGTTAATACCCCTTTCACGGCCTCCAG 899 
           ****. **.  .******..**************** .. .* ** :****   * **** 
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OVINE      CCTGGAGCTGAGACCCTGGAGCCCCGGGGTACACTTGGCCCTGGAGATGTGCAGCCCGTG 1074 
BOVINE     CCTGGAGCTGAGGCCCTGGAGCCCAGGGGTGCACTTGGCCCTTGAGATGTGCAGCCCATG 965 
EQUINE     CCTGGAGCTGGGACTCTGGGCTGCGGGGACACCCTCGTCCCTGGAGGTGTACAGCTGCTG 953 
HUMAN      CCTGGAGCTGGGACCCTGGAGCCCAGAGGTGCCCTCCACCCTGGAGGTGTACAGCTGCCA 1025 
MURINE     CATAGAGTTGGTGCCACAGAGTTCCACAACAACATCAGCCTT--------ACATCTG--- 948 
           *.*.*** **. .* . .*.   * . .. ....*   ** *        .** *      
 
OVINE      CCCACCGCAGGGTACAGCCAAGGGTCTGGTGCCCACAGAGCTGCCGGAACCCACAGAACT 1134 
BOVINE     CCCACCGCAGGGTGTAGTCAAGGGGCTGGTGCCCACGGAGCTGCCGGAGCCCACAGACCT 1025 
EQUINE     CCCACCACAGAGTGTGCCCAAGGGGCGGGAGCCCACGTCGCTGCCGGAGCTGGCAGACCT 1013 
HUMAN      CCCACCACGGAGCCCGGCCAAGAGGCTGCAGCTCACGGAGCTACAAGAACCAGCAGAGCT 1085 
MURINE     ----TCATTGTATCCAGCCAAGGAGAAGAAGTTCCCGGGGCTGCCGGGTCTGGAAGAGCA 1004 
                *.  * .   .  ****.. . * :*  *.*.  ***.*..*. *  ..*** *: 
 
OVINE      GGTGGAAGCTGACGGGGTGCCTGAGCCGGGCTCCTGGGGCCCAGTGCCCTCCACTGCAGG 1194 
BOVINE     GGTGGAAGCTGACGGAGTGCCTGAGCCGGGCTCCTGGGGCCCAGTGCCCTCCACTGCCGG 1085 
EQUINE     GGTAGAAGCCGACGGAGTGCAGGAGCCAGGCTCCTGGGGCCCGGCCCCCTCCATGGCCAG 1073 
HUMAN      GGTGGAGTCTGACGGTGTGCCCAAGCCCAGCTTCTGG---CCG---------ACAGCCCA 1133 
MURINE     ACTGGAGTGTGATGGAATGTCTGAGCCTGGTCACTGGTGCATAATCCCCTTGGCAGCTGG 1064 
           . *.**.   ** ** .** . .**** .*   ****   . .         .  **  . 
 
OVINE      CAGCTTGGGCAGCTCGGTTTACAGCCAGGAGAAGGACCGGCTATATGGCCTGGTGTCCAT 1254 
BOVINE     CAGCTTGGGCAGCTCGGTTTACAGCCAGGAGAAGGACCGGCTGTATGGCCTGGTATCCAT 1145 
EQUINE     CAGCTTGGGCGGTTCAACTTACAGCCAGGAGAGGGACCGACCATACGGCCTGGTATCCAT 1133 
HUMAN      GAACTCGGGGGGCTCAGCTTACAGTGAGGAGAGGGATCGGCCATACGGCCTGGTGTCCAT 1193 
MURINE     CCAAGCGG---TCTCAGCCTACAGTGAGGAGAGAGACCGGCCATATGGTCTGGTGTCCAT 1121 
            ...  **     **..  *****  ******..** **.* .** ** *****.***** 
 
OVINE      CGACACGGTGACCGTGGTGGATGCAGAGGGGCTGTGTGACTGGCCCTGCACCTGTGGGGA 1314 
BOVINE     CGACACGGTGACTGTGGTGGACGCGGAGGGGCTGTGTGGCTGGCCCTGCACCTGTGGGGA 1205 
EQUINE     CGACACGGTGACCGTGGTGGACACAGAGGGGACGTGCGCCTGGCCCTGCACCTGTGGGGA 1193 
HUMAN      TGACACAGTGACTGTGCTAGATGCAGAGGGGCCATGCACCTGGCCCTGCAGCTGTGAGGA 1253 
MURINE     TGACACAGTGACTGTGGGAGATGCAGAGGGCCTGTGTGTCTGGCCCTGTAGCTGTGAGGA 1181 
            *****.***** ***  .** .*.***** . .** . ********* * *****.*** 
 
OVINE      TGATGGCTACCCTGCCCTGAACCTGGACACTGGCCTGGAGCCTGGCCCAGGCACAGAGGA 1374 
BOVINE     CGATGGCTACCCTGCCCTAAACCTGGACACTGGCCTGGAGCCTGGTCCGGACACAGAGGA 1265 
EQUINE     CGATGGCTACCCAGCCCTGAACCTGGACACCAGCCTGGAGCCTGGCCCAGGCACCGAGGA 1253 
HUMAN      TGACGGCTACCCAGCCCTGGACCTGGATGCTGGCCTGGAGCCCAGCCCAGGCCTAGAGGA 1313 
MURINE     TGATGGCTATCCAGCCATGAACCTGGATGCTGGCCGAGAGTCTGGCCCTAATTCAGAGGA 1241 
            ** ***** **:***.*..******* .* .*** .*** * .* ** ..   .***** 
 
OVINE      TCCGCTCCTGAGCACGGAGGCCACAATCCTGTCTTGTGGCTGCGTCTCGGCCGGTGGCCC 1434 
BOVINE     CCGGCTCCTGAGCACGGGGACCACGATCCTGTCTTGTGGCTGTGTCTCGGCCGGTGGCCC 1325 
EQUINE     CCCGCTCTTGAGCACGGGGGCCACAGTCCTGTCCTGCGGCTGTGTCTCGGCCGGTGGTCC 1313 
HUMAN      CCCACTCTTGGATGCAGGGACCACAGTCCTGTCCTGTGGCTGTGTCTCAGCTGGCAGCCC 1373 
MURINE     TCTGCTCTTGGTCACAGACCCTGCTTTTCTGTCTTGCGGCTGTGTCTCAGGTAGTGGTCT 1301 
            * .*** **.  .*.*.  * .*  * ***** ** ***** *****.*  .* .* *  
 
OVINE      CG-----TGAGG----CCGGG---CAGCCTCCTTGACCGGCTAAGGCTGTCCCATGAGGA 1482 
BOVINE     CA-----TGAGG----CCGGG---CAGCCTCCTTGACCGGCTAAGGCTGTCCCATGAGGA 1373 
EQUINE     TG-----CCGGG----CTGGGGGGCAGCCTCCTTGACAGGCTAAAGCTGCCCCTTGAAGA 1364 
HUMAN      TGGGCTAGGAGGGCCCCTGGG---AAGCCTCCTGGACAGACTAAAGCCACCCCTTGCAGA 1430 
MURINE     CAGGCTTGGAGGCTCCCCAGG---CAGCCTACTGGACAGGTTGAGGCTGTCATTTGCAAA 1358 
                 .       .**    * .**   .*****.** ***.*. *.*.** . *. :**...* 
 
OVINE      TGAGGCAGATTGGACACCCGGGCCG------------------------------TCGGA 1512 
BOVINE     TGAGGCAGATTGGACACCTGGGCCG------------------------------TCGGA 1403 
EQUINE     TGAGGCAGGTTGGGTCCCAGGGTCGCCCTGGGGTGGCGG---GCGGCGAGAGGTGTCCGA 1421 
HUMAN      TGGGGAGGACTGGGCTGGGGGACTGCCCTGGGGTGGCCGGTCACCTGGAGGGGTCTCAGA 1490 
MURINE     GGAAGGGGACTGGACAGCAGACCCAACCTGGAGAACTGGGTCCCCAGGAGGGGGCTCTGA 1418 
            *..* .*. ***.     *.   .                              ** ** 
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OVINE      CAGTGAGGCAGGCTCACCTCCGGTCGGCCTGGACATGAACACGTTTGACAGCGGCTTTGC 1572 
BOVINE     CAGCGAGGCGGGCTCGCCCCCGGTCGGCCTGGACATGAACACGTTTGACAGTGGCTTCGC 1463 
EQUINE     CAGCGAGGCGGGCTCGCCCCCGGCCGGCCTGGACATGGACACGTTCGACAGCGGCTTCGC 1481 
HUMAN      GAGTGAGGCGGGCTCACCCCTGGCCGGCCTGGATATGGACACGTTTGACAGTGGCTTTGT 1550 
MURINE     GAGTGAAGCAGGTTCCCCCCCT---GGTCTGGACATGGACACATTTGACAGTGGCTTTGC 1475 
            ** **.**.** ** ** *     ** ***** ***.****.** ***** ***** *  
 
OVINE      GGACTCTGATTGGGGCAGCCCTGTGGAGAGTGACTTCAGCAGCCCCAGGGACGAGGAACC 1632 
BOVINE     GGACTCTGACTGTGGCAGCCCCGTGGAGAGTGACTTCAGCAGCCCCAGGGACGAGGAACC 1523 
EQUINE     GGGCTCCGACTGCGGCAGCCCTGTGGACTGTGACTTCACCAGCCCCAGGGATGAGGGGCC 1541 
HUMAN      GGGCTCTGACTGCAGCAGCCCTGTGGAGTGTGACTTCACCAGCCCCGGGGACGAAGGACC 1610 
MURINE     AGGTTCAGACTGTGGCAGCCCCGTGGAGACT------------------GATGAAGGACC 1517 
           .*. ** ** ** .******* ***** : *                  ** **.*..** 
 
OVINE      CCCCAGGAGCTACCTCCGACAGTGGGTGGTCACGGCCCCTTCACCTACGCCACCGGGATC 1692 
BOVINE     CCCCAGGAGCTACCTCCGACAGTGGGTGGTCATGGCCCCTCCACCTACGCCGCCGGGGTC 1583 
EQUINE     CCCCCGCAGCTACCTCCGCCAGTGGGTGGTCACGGCCCCTTCTCCTGAAGGACTCGGACC 1601 
HUMAN      CCCCCGGAGCTACCTCCGCCAGTGGGTGGTCATTCCTCCGCCACTTTCGAGCCCTGGACC 1670 
MURINE     CCCTCGAAGCTATCTCCGCCAGTGGGTGGTCAGGACCCCTCCACCTGTGGACAGTGGAGC 1577 
           *** .* ***** *****.*************   * **  *:* *  .   .  **. * 
 
OVINE      CCAGGCCAGCTAGTGATGC 1711 
BOVINE     CCAGGCCAGCTAG------ 1596 
EQUINE     CCAGGCCAGCTAG------ 1614 
HUMAN      CCAGGCCAGCTAA------ 1683 
MURINE     CCAGAGCAGCTAG------ 1590 
           ****. ******.       
 
Figure 6.2  cont’n. 
   






Figure 6.3  Genomic organization of ovine IL21 mRNA in relationship to bovine genomic DNA. Boxes represent exons and their 
corresponding size in bp.  Base positions are separated by dash.  Numbers in blue represent intronic bases (bp) in gDNA. 
 





Figure 6.4  Genomic organization of the coding region (CDS) of ovine IL21R in relationship to bovine mRNA and genomic DNA. Boxes 
represent exons with spanning base positions separated by dash.  Numbers on top are the intronic bases in the genomic DNA.
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6.2.6 Optimization of HRM analysis for IL21 and IL21R fragments 
Primers were to be designed to amplify all of the coding regions including the intron 
and exon boundaries.  With limited time left to work on identifying SNPs in IL21 
and IL21R, only one primer pair each for IL21 and IL21R was evaluated for HRM 
analysis.  Primers were designed to suit the requirements for HRM as described in 
Section 1.4.3.1.  The position of these primers relative to the coding region is 
depicted in Figure 6.5. 
In the initial HRM-PCR runs, all set ups were performed as recommended in the 
Type-it® HRM™ kit as described in Section 1.4.3.2.  The amount of genomic DNA 
template used for both genes was optimized to 4 ng per reaction.  The optimized 
cycling conditions for the sequencing primers of IL21 and IL21R fragments are 
shown in Table 6.4. 
Table 6.4  Primers used for HRM analysis 


























Figure 6.5 Schematic diagram of IL21(A) and IL21R (B) coding regions.  Boxes represent exons with corresponding bases separated by 
dash that span them.  Brackets indicate the length of the product amplified by the sequencing primers used in HRM analysis.
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6.2.7 HRM analysis of IL21 and IL21R fragments 
Fluorescence data were analysed using the tools for HRM analysis incorporated in 
the Rotorgene-Q software.  Table 6.5 shows the comparative quantification analysis 
for IL21 and IL21R fragments.  The mean Cq values of the HRM-PCR for IL21 was 
22.66 which ranged from 21.8 to 23.5.  IL21R had mean Cq values of 23.01 with a 
range of 21.9-23.9.  The reaction efficiency for IL21 was 1.78 which was close to 
IL21R with 1.80. These values are consistent with the recommended Cq of < 30 % 
and individual reaction efficiency of < 1.4 (Nguyen-Dumont et al.,  2009;Vossen et 
al.,  2009).   A single melt peak also confirmed a single amplified product (Figure 
6.9). Figure 6.6 shows the mean cycle number at which fluorescence exceeded 
background (Cq) which was < 30.  The range of < 23.5 was recorded across samples 
for IL21 fragment and < 21.9 for IL21R.  All curves reached a similar plateau height.   
The software automatically analysed the raw melting curve data and set the starting 
(pre-melt) and ending (post-melt) fluorescence signals of all data to uniform values 
to aid interpretation and analysis (Figure 6.7).  The cursors for these two points are 
defaulted to the ends of the curve but these regions were manually adjusted to 
encompass representative baseline for the pre-melt and post-melt phases.    Widening 
the normalization regions into the melt phase was avoided to ensure that curves 
normalize effectively.  The two points within these regions were used to normalize 
fluorescence of the melt plot and data outside these regions are ignored.   
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Table 6.5  Comparative quantification of HRM analysis in IL21 and IL21R 
fragments of  resistant and susceptible lambs 
Sample Group IL21 IL21R 
  Cq Efficiency Cq Efficiency 
    
1 Resistant 23.50 1.78 23.90 1.81 
2 Resistant 22.70 1.77 22.90 1.82 
3 Resistant 22.80 1.82 23.20 1.83 
4 Resistant 22.10 1.75 22.60 1.80 
5 Resistant 22.90 1.74 23.50 1.86 
6 Resistant 22.60 1.80 23.10 1.81 
7 Resistant 22.60 1.79 23.20 1.80 
8 Resistant 22.80 1.79 23.20 1.77 
9 Resistant 22.50 1.84 22.70 1.75 
10 Resistant 23.40 1.78 23.70 1.72 
11 Susceptible 22.50 1.80 22.90 1.82 
12 Susceptible 22.70 1.75 23.20 1.79 
13 Susceptible 22.60 1.80 23.10 1.76 
14 Susceptible 22.80 1.76 23.00 1.76 
15 Susceptible 22.70 1.78 22.80 1.81 
16 Susceptible 22.30 1.77 22.70 1.79 
17 Susceptible 21.80 1.78 21.90 1.78 
18 Susceptible 22.60 1.75 22.70 1.79 
19 Susceptible 22.70 1.77 23.00 1.80 
20 Susceptible 22.60 1.77 22.90 1.85 
MEAN  22.66 1.78 23.01 1.80 
 
HRM- high resolution melt 
Cq – quantification cycle 
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After normalization, samples with melt temperature difference can be visualized.  
Figure 6.8 shows samples of IL21R gene fragment (B) with marked shift in melt 
temperature compared with the rest of the samples.  No difference was detected 
across samples with IL21 (A) was detected at this stage. 
The difference plot was defined by assigning one of the samples as genotype which 
served as a reference sample to compare all other samples against.  In the example 
shown in Figure 6.6, all samples were compared to sample 54, which was close to 
the middle of the response spectrum between resistant and susceptible lambs. This 
was assigned as a positive control which was the same sample used as reference 
curve for all subsequent runs. The software groups together similar curves according 
to an adjustable sensitivity value.  In the displays shown in Figure 6.9, the 
differences between melting curve profiles are readily appreciated.   Sample 28 
(susceptible) of IL21R (Figure 6.9B) illustrates the marked difference in the melt 
curve profile compared with the rest of the samples.  The difference plot for sample 
114 (susceptible) of IL21 fragment suggests a melt curve slightly different from the 
other samples (Figure 6.9A). 
The choice of the reference curve sample could be arbitrarily chosen among the 
samples within the run for as long as this will be used in all other HRM runs with 
other fragments of the gene of interest.  However, it is ideal that one representative 
sample should be assigned as reference in comparing with the melt curves of all the 
samples.  In which case, this designated sample should be included in the HRM-PCR 
set up along with all samples to be tested (personal communication, Qiagen technical 
staff, 15 September 2011). 






Figure 6.6  Amplification curves of samples from resistant (red) and susceptible 
(blue) lambs showing the quantification cycle (Cq) of <30 and the plateau height 




Figure 6.7  High resolution melt curve plots of raw data showing a range of initial 
fluorescence readings.  Change of fluorescence for individual samples is difficult to 
discriminate in this view.  Fluorescence is high at low temperature when the products 
are double-stranded (red-arrowed bar) and shift to low (green-arrowed bar) when it 
denatures and become single stranded.  The active melt region (purple-arrowed bar) 
is designated by the pre-melt region (normalization region 1) and post melt 
(normalization region 2).  These regions are utilized in aligning the data to provide a 














B. Normalized melt graph plots of IL21R gene fragment 
 
Figure 6.8  Normalized graphs (individual samples) in HRM analysis of resistant 
(red) and susceptible (blue) lambs.  The x axis represents the normalized 
fluorescence and the y axis represents the temperature in degrees Celsius.  This view 
is generated after setting the pre- and post-melt regions which provides a clear view 
of any temperature differences across samples.  Temperature difference in samples 
pointed by arrow in a fragment of IL21R gene is evident (B) compared with a 






































B. Difference melt graph plots of IL21R gene fragment 
 
Figure 6.9  Difference melt curve plots of HRM analysis data (replicate view).  The 
x axis represents the normalized fluorescence minus reference (control) and the y 
axis represents the temperature in degrees Celsius.  Sample curves are subtracted 
from a reference curve (in this case, designated positive control sample).  This view 
emphasizes differences between melt curves for each sample (arrows) which is very 
distinct in a fragment of IL21R gene (B) compared with a fragment of IL21 (A) 
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6.2.8   SNP analysis 
Analysis of the consensus IL21R gene fragment (158 bp) of sample 28 sequences 
revealed nucleotide base substitution from G to A at position 1261 (Figure 6.11A).  
Sequence containing potential SNP is shown aligned with the sequence of a sample 
(sample 65) with no detected difference in melt curve plots which contained no SNP.  
However, the nucleotide substitution did not result to any change in the translated 
protein (Figure 6.11B).  No mutation was identified in IL21 gene fragment despite 
the slight difference in the melt curve plots observed. 
The sample where SNP was identified (sample 28), and the reference sample which 
does not have SNP (sample 65) were both taken from the susceptible group.  The 
sequences were analyzed based on the results of melt curve plots of HRM analysis 


















CACAGTGACCGTGGTGGATGCAGAGGGGCTGTGTGACTGGCCCTGCACCTGTGGGGATGA  120 
||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 






Figure 6.10  Nucleotide (A) and protein (B) sequence alignments of IL-21R 
fragment of sample with identified SNP.  Position of SNP (G to A) at base 1261 of 
reference sequence 65 against sequence 28 is shown in the nucleotide sequence 
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6.3 Identification of Ovar DRB*0203 allele  
6.3.1   Extraction of genomic DNA from blood of 15 lambs 
Genomic DNA was extracted (Section 2.8.1.5) from blood of 15 lambs representing 
5 control and 5 each of the top resistant and top susceptible animals.  The 
concentration of extracted DNA is presented in Table 6.5. 
6.3.2   Detection of Ovar DRB1*0203 
Amplification of MHC Class II Ovar DRB1*0203 was performed in 15 lambs by 
using the forward primer 5’-TCTCTGCAGCACATTTCCTGG-3’(adopted from 
Schwaiger et al, 1995) and the reverse primer 5’-CACACACACACTGCTCCACA-
3’ (adopted from Sayers et al, 2005).  This primer pair was employed to amplify the 
second exon of the Ovar-DRB1 gene. The primers flank on the exon 2 region as the 
forward primer is located in intron 1 and the reverse primer in intron 3.  
Amplifications were performed for 30 cycles (1 min denaturation at 94ºC, 1 min 
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Table 6.6  DNA sample concentration used in Ovar DRB*0203 study 




    
Control 
 
1 27.71 1.84 
2 29.23 1.85 
3 21.96 1.75 
4 17.58 1.75 
5 32.83 1.89 
Resistant 
 
6 98.21 1.88 
7 85.42 1.91 
8 91.05 1.86 
9 34.67 1.77 
10 27.49 1.73 
Susceptible 
 
11 31.53 1.86 
12 26.61 1.91 
13 75.14 1.81 
14 33.43 1.91 
15 68.84 1.84 
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6.3.3 Identification of Ovar DRB1*0203 allele in lambs that are resistant 
to T. circumcincta 
PCR amplicons of Ovar DRB1 in 15 lambs were obtained from genomic DNA.  All 
PCR products were purified and sequenced as described in Section 1.2.4.  A 
consensus sequence of Ovar DRB1*0203 from three independent sequences for each 
sample was generated using CLC Sequence Viewer.  It was not possible to generate 
the full nucleotide bases for the target amplicon in all but samples 9 and 13.  This 
may possibly be due to mutationsthat could be present in the DNA of the  samples or 
the presence of inhibitor in the DNA used.  Sequence alignments, translations, and 
comparisons were carried out using ClustalW2.  The BLAST algorithm was used to 
search the NCBI GenBank database for homologous sequences.   
Figure 6.10 displays the alignments of nucleotide bases for each sample with the 
archetypal DRB1 and the published Ovar DRB1*0203.  Alignment scores for these 
comparisons are shown Table 6.6.  None of the 15 lambs across the three groups 
carry the Ovar DRB*0203 allele. However, it is worth noting that the nucleic acid 
sequences of the resistant animals have close similarities with DRB*0203 which 
ranged from 83-98% compared to the susceptible group with similarities between 83-
93%.  This holds true in the translated sequences with 80-96% and 79-86% matched 
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Ovar-DRB01      --AGTATACTAAGAAAGAGTGTCGTTTCTCCAACGGGACGGAGCGGGTGCGGTTCCTGGA 58 
Ovar-DRB1*0203  GGAGTATTCTACGAGCGAGTGTCATTTCTTCAACGGGACGGAGCGGGTGCGGTTCCTGGA 60 
Ovar-DRB1_1     ---------------------------------CGGGACGGAGCGGGTGCGGTTCCTGGA 27 
Ovar-DRB1_2     -------------------------TTCTCCAACGGGACGGAGCGGGTGCGGTTCCTGGA 35 
Ovar-DRB1_3     ---------------------------------CGGGACGGAGCGGGTGCGGTTCCTGGA 27 
Ovar-DRB1_4     --------------------------------ACGGGACGGAGCGGGTGCGGTTCCTGGA 28 
Ovar-DRB1_5     -----------------------------------GGACGGAGCGGGTGCGGTTCCTGGA 25 
Ovar-DRB1_6     ---------------------------------CGGGACGGAGCGGGTGCGGTTCCTGGA 27 
Ovar-DRB1_7     ---------------------------------CGGGACGGAGCGGGTGCGGTTCCTGGA 27 
Ovar-DRB1_8     --------------------------TCTCCAACGGGACGGAGCGGGTGCGGTTCCTGGA 34 
Ovar-DRB1_9     --AGTATTCTACGAGCGAGTGTCATTTCTTCAACGGGACGGAGCGGGTGCGGTTCCTGGA 58 
Ovar-DRB1_10    ---------------------------------CGGGACGGAGCGGGTGCGGTTCCTGGA 27 
Ovar-DRB1_11    ---------------------------------CGGGACGGAGCGGGTGCGGTTCCTGGA 27 
Ovar-DRB1_12    ---------------------------------CGGGACGGAGCGGGTGCGGTTCCTGGA 27 
Ovar-DRB1_13    --AGTATACTAAGAAAGAGTGTCGTTTCTCCAACGGGACGGAGCGGGTGCGGTTCCTGGA 58 
Ovar-DRB1_14    ----------------------------------GGGACGGAGCGGGTGCGGTTCCTGGA 26 
Ovar-DRB1_15    ---------------------------CTCCAACGGGACGGAGCGGGTGCGGTTCCTGGA 33 
                                                   ************************* 
 
Ovar-DRB01      CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 118 
Ovar-DRB1*0203  CAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 120 
Ovar-DRB1_1     AAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 87 
Ovar-DRB1_2     AAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 95 
Ovar-DRB1_3     CAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 87 
Ovar-DRB1_4     CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 88 
Ovar-DRB1_5     CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 85 
Ovar-DRB1_6     CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 87 
Ovar-DRB1_7     CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 87 
Ovar-DRB1_8     CAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 94 
Ovar-DRB1_9     CAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 118 
Ovar-DRB1_10    CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 87 
Ovar-DRB1_11    NAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 87 
Ovar-DRB1_12    CAGATACTTCTATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 87 
Ovar-DRB1_13    CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 118 
Ovar-DRB1_14    CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 86 
Ovar-DRB1_15    CAGATACTTCCATAATGGAGAAGAGACCCTGCGCTTCGACAGCGACTGGGGCGAGTACCG 93 
                 ********* ************************************************* 
 
Ovar-DRB01      AGCGGTGGCCGAGCTGGGGCGGCCGGACGCTAAGTACTGGAACAGCCAGAAGGACTTCCT 178 
Ovar-DRB1*0203  AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGAGATCCT 180 
Ovar-DRB1_1     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGAGCTCCT 147 
Ovar-DRB1_2     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGAGCTCCT 155 
Ovar-DRB1_3     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACCTCCT 147 
Ovar-DRB1_4     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCTAAGTACTGGAACAGCCAGAAGGACTTCCT 148 
Ovar-DRB1_5     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 145 
Ovar-DRB1_6     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 147 
Ovar-DRB1_7     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 147 
Ovar-DRB1_8     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACNTCCT 154 
Ovar-DRB1_9     AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGAGNTCCT 178 
Ovar-DRB1_10    AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 147 
Ovar-DRB1_11    AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 147 
Ovar-DRB1_12    AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 147 
Ovar-DRB1_13    AGCGGTGGCCGAGCTGGGGCGGCCGGACGCTAAGTACTGGAACAGCCAGAAGGACTTCCT 178 
Ovar-DRB1_14    AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 146 
Ovar-DRB1_15    AGCGGTGGCCGAGCTGGGGCGGCCGGACGCCAAGTACTGGAACAGCCAGAAGGACTTCCT 153 
                ****************************** ***********************  **** 
 
Ovar-DRB01      GGAGCGGGCGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 238 
Ovar-DRB1*0203  GGAGCGGAAGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCGGTGA--- 237 
Ovar-DRB1_1     GGAGCGGAAGCGGGCCAATGTGGACACGTACTGCAGACACAACTACGGGGTCGGTGAGAG 207 
Ovar-DRB1_2     GGAGCGGAAGCGGGCCAATGTGGACACGTACTGCAGACACAACTACGGGGTCGGTGAGAG 215 
Ovar-DRB1_3     GGAGCGGAAGCGGGCCAACGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 207 
Ovar-DRB1_4     GGAGCGGANGCGGGCCGCCGTGNACACGTACTGCAGACACAACTACGGGGTCTTTGAGAG 208 
Ovar-DRB1_5     GGAGCGGACGCGGACCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 205 
Ovar-DRB1_6     GGAGCGGACGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 207 
Ovar-DRB1_7     GGAGCGGAAGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 207 
Ovar-DRB1_8     GGAGCGGAAGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 214 
Ovar-DRB1_9     GGAGCGGAAGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCNGTGAGAG 238 
Ovar-DRB1_10    GGAGCGGGCGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 207 
Ovar-DRB1_11    GGAGCGGACGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 207 
Ovar-DRB1_12    GGAGCGGACGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 207 
Ovar-DRB1_13    GGAGCGGGCGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 238 
Ovar-DRB1_14    GGAGCGGACGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 206 
Ovar-DRB1_15    GGAGCGGAAGCGGGCCGCCGTGGACACGTACTGCAGACACAACTACGGGGTCATTGAGAG 213 
                *******. ****.**.. ***.*****************************  ***    
Figure 6.11  Sequence alignments of Ovar-DRB1 allele in 15 samples: 1 to 5 
(Control), 6 to 10 (Resistant), and 11 to 15 (Susceptible) together with the published 
archetypal Ovar-DRB1 (Accession no. U00204.1) and Ovar-DRB*0203 
(AB017206.1). (*) indicates alignment with Ovar-DRB1. 
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Table 6.7  Identity level of nucleic acid and amino acid sequences of the MHC Class 
II Ovar DRB1 genes of 15 lambs with reference to published sequence of  
Ovar-DRB1*0203. 
Sample Alignment scores (%) 
Nucleic acid Amino acid 
   
Control 1 83 78 
2 86 84 
3 90 86 
4 83 78 
5 89 83 
Resistant 6 87 82 
7 83 80 
8 86 94 
9 98 96 
10 88 83 
Susceptible 11 83 79 
12 90 86 
13 93 83 
14 87 82 
15 86 82 
    
 
 





Ovar-DRB1           GTERVRFLDRYFHNGEETLRFDSDWGEYRAVAELGRPDAKYWNSQKDFL 59 
Ovar-DRB1*0203      ------------Y---------------------------------EI- 60 
Ovar-DRB1_1         ------------------------------------------------- 49 
Ovar-DRB1_2         --------E------------------------------------YEL- 52 
Ovar-DRB1_3         ------------Y----------------------------------L- 49 
Ovar-DRB1_4         ------------------------------------------------- 49 
Ovar-DRB1_5         ------------------------------------------------- 48 
Ovar-DRB1_6         ------------------------------------------------- 49 
Ovar-DRB1_7         ------------------------------------------------- 49 
Ovar-DRB1_8         ------------------------------------------------- 51 
Ovar-DRB1_9         ----------------------------------------------EX- 59 
Ovar-DRB1_10        ------------------------------------------------- 49 
Ovar-DRB1_11        --------X---Y------------------------------------ 49 
Ovar-DRB1_12        ------------Y------------------------------------ 49 
Ovar-DRB1_13        ------------------------------------------------- 52 
Ovar-DRB1_14        ------------------------------------------------- 49 
Ovar-DRB1_15        ------------------------------------------------- 51 
 
Ovar-DRB1      ERARAAVDTYCRHNYGVIESFTVQRRGERGGGRPLWSSVCVCVCVCVCVCVCVCVCVERE 119 
Ovar-DRB1*0203 --K--------------G------------------------------------------ 78 
Ovar-DRB1_1    --X----X---------F--------------L--------------------------- 90 
Ovar-DRB1_2    --K—N------------G------------------------------------------ 90 
Ovar-DRB1_3    --K—N------------------------------------------------------- 73 
Ovar-DRB1_4    --X----X---------F--------------L--------------------------- 90 
Ovar-DRB1_5    --T-T------------------------------------------------------- 72 
Ovar-DRB1_6    --T----------------------R---------------------------------- 75 
Ovar-DRB1_7    --K--------------------------------------------------------- 90 
Ovar-DRB1_8    --K--------------------------------------------------------- 69 
Ovar-DRB1_9    --K--------------X----------------X------------------------- 97 
Ovar-DRB1_10   --A--------------------------------------------------------- 74 
Ovar-DRB1_11   --T--------------------------------------------------------- 78 
Ovar-DRB1_12   ------------------------------------------------------------ 73 
Ovar-DRB1_13   ------------------------------------------------------------ 78 
Ovar-DRB1_14   --T--------------------------------------------------------- 75 
Ovar-DRB1_15   --K--------------------------------------------------------- 81 
Figure 6.12  Protein translation of the second exon of Ovar-DRB1 allele in 15 
samples: 1 to 5 (Control), 6 to 10 (Resistant), and 11 to 15 (Susceptible).     Each 
protein translation is relative to the archetypal Ovar-DRB1 (Accession no. 
U00204.1). Translation of allele Ovar-DRB1*0203 which has been linked to 
resistance to T. circumcincta infection is also shown. Dash indicates identity in the 










The full length 1,596 base sequence of the coding region for ovine IL21R was 
generated. A partial sequence for the ovine IL21 transcript was produced. Their 
genomic organization as to the position of exons and introns was described in 
relation to the ovine genome.  An optimized assay for high resolution melt analysis 
in detecting SNPs in ovine IL21 and IL21R was developed.  A fragment (158 bp 
long) of IL21R coding region showed one nucleotide base substitution from G to A 
in one sheep, with no alteration in the translated protein. 
The allele MHC Class II Ovar DRB*0203 was not identified in the population of 
lambs used in the study.  Therefore, we could not link the resistance of the lambs to 
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To examine the immunology of parasite resistance in sheep, lambs with diversity in 
their predicted genetic resistance to T. circumcincta were exploited to investigate the 
association between the T cell response and phenotypic parameters of parasite 
infection.  Naïve lambs were trickle-infected three times per week over a period of 
three months to simulate a chronic natural infection, which resulted in animals with 
range of susceptibilities that reflected the nature and magnitude of the mature 
immune response.  Expression of protective immunity in the maturation of the 
acquired immune response is thought to have commenced after about 50 days of 
continuous infection as FEC was high in all animals until after this time point 
(Beraldi et al., 2008).  At post mortem, after 13 weeks of continual infection, adult 
worms were highly aggregated in few lambs and absent or low in number in resistant 
lambs.  It is interesting that a population of lambs exposed to similar level of 
infection under identical management systems resulted in clearance of infection in 
some and persistence of infection in others.   
Data pertaining to the histopathology and immunological response were gathered and 
analyzed during the stage when the mature immune response of the resistant animals 
was controlling and/or eliminating recurrent parasite infection.  It was also during 
this stage that other animals in the group did not exhibit control of the infection 
thereby retaining mature adult nematodes and excreting numbers of parasite eggs 
(Beraldi et al., 2008). 
I hypothesized that resistance/susceptibility to T. circumcincta is associated with 
differential activation of Treg and TH17 T cells as well as the interaction between 
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TH1 and TH2 subsets. These four CD4+ T cell subsets were investigated by 
measurement of the transcripts of their characteristic markers and effector cytokines 
and quantitative expression was correlated with individual traits of resistance and 
susceptibility.  Genes that are associated with the immune response linked to 
resistance or susceptibility may be candidates that could be developed as markers for 
selective breeding.  Attempts were made to identify mutations in differentially-
expressed genes of susceptibility to T. circumcincta infection.  
7.2 Development of assay  
Analysis of the immune response required the measurement of ovine transcripts 
particularly for those that were not available from published sequence databases.  
Protein expression as well as functional and immunological assays like FACS, 
immunohistochemistry and western blots are ideal and desirable but are insensitive 
for cytokines, especially within tissues.  Furthermore, these assays are limited by 
lack of antibodies available for sheep and by not being inherently quantitative.   
In order to evaluate the expression of genes associated with T. circumcincta 
infection, I developed real-time RT-qPCR assays for lowly-expressed ovine 
transcripts.   Bovine templates were utilized initially to design primers for these 
genes using stringent criteria (Untergasser et al., 2007) to ensure that only the genes 
of interest were amplified.  Analysis of the generated ovine sequences has verified its 
similarity of at least 95% to closely-related bovine species for all genes included in 
the study.  This gave me more confidence that measurements were made specifically 
on the target transcripts.  This step also conforms to the ‘Minimum information for 
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publication of quantitative real–time experiments (MIQE) guidelines to ensure the 
reliability of assay results (Bustin, 2010; Bustin et al., 2009; Taylor et al., 2010).  
It has been emphasized how primer and magnesium concentration as well as 
annealing temperature affects the melting temperature specificity and overall 
efficiency of the real-time RT-qPCR assay (Eckert and Kunkel, 1991; Mikeska and 
Dobrovic, 2009; Rychlik et al., 1990).  Primer and magnesium optimization steps 
were found to be critical as shortage or an excess of what is optimum results to non-
specific product formation.   The method instituted to determine the optimal primer 
and magnesium concentration for real-time RT-qPCR is in agreement with previous 
assay validation experiments (Bustin, 2004; Bustin et al., 2011; Mikeska and 
Dobrovic, 2009).   
All the parameters mentioned above were optimized, and throughout the conduct of 
the assay various sources of errors due to poor technical skills and slack laboratory 
practice were encountered.  These include minor but equally important steps like 
pipetting errors, reagent preparation and storage, and risks of contamination.  
Problems were addressed by the use of automated liquid handling system as 
described previously (Section 2.5.1) and making aliquots for reagents that require 
frequent freeze-and-thaw.  Use of filter tips and gloves, applying decontaminating 
agents on workbench before setting up experiments, and setting a dedicated room for 
amplified products away from the PCR set-up area reduced contamination.  This was 
done to ensure that only the parameter in question was analyzed in each RT-qPCR 
run.  All RT-qPCR reactions had an efficiency of >90% and r2 of >0.98.  These 
assessment criteria, including melt curve analysis and gel electrophoresis, conform to 
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the requisites of a workable real-time RT-qPCR assay according to MIQE guidelines 
(Bustin et al., 2009).  The developed assay can now be utilized in related studies 
defining biological systems, particularly disease processes in sheep. 
7.3 Inappropriate inflammatory response do not clear worm infection 
The histopathology of resistant and susceptible lambs reflected the differential 
immune response to larval challenge with T. circumcincta.  The pathological 
consequence of T. circumcincta infection consists of tissue injury and local cellular 
changes, which may be to the result of host immune response (McKellar, 1993; Stear 
et al., 2003).  In this study, the extent of tissue damage based on epithelial cell 
hyperplasia could not be determined because tissue blocks were taken from different 
regions of the abomasum where baseline counts differ.  Likewise, the inflammatory 
infiltrates were not quantified by systematic scoring system used in characterizing 
the degree of pathology (Scott et al., 1998).  The cell counts which ranged from zero 
to <10 was deemed too low to draw a quantitative cellular profile (Beard, 2010).  
Mast cell counts could have been useful as these cells have been shown to be 
important in the inhibition of larval establishment (Huntley et al., 1992).  However, 
this could not be possible as the fixative used (zinc salt) was found to be 
incompatible with efficient toluidine blue staining.   
Despite the abovementioned limitations, the histopathological profile of resistant and 
susceptible animals was clearly differentiated.  The abomasal mucosa of resistant 
lambs showed only minor pathological changes, with the gastric glands empty of 
larvae despite uninterrupted, three times weekly infection with ~2000 infective 
larvae.  Resistant lambs with zero to low worm load showed mild inflammation with 
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neutrophils and eosinophils only seen occasionally.  In contrast, susceptible lambs 
showed extensive lymphocytic infiltration characteristic of a chronic inflammatory 
response (Salman and Duncan, 1984).  Although nematodes were not seen in the 
gastric mucosa, the vacuolated areas surrounded by neutrophils, eosinophils and 
cellular debris indicate that larval migration has taken place.   
The mild pathology in resistant animals suggests strongly that the L3 larvae may 
have failed to establish to the adult stage and/or the mature adults may have been 
expelled.  The cellular profile of the abomasal tissue in resistant animals consisting 
of mild lymphocytic infiltrate with few eosinophils and neutrophils may be 
consequent to scantiness of colonizing worms hence, the low level of pathology 
(Smith et al., 1984; Stear et al., 1999a).  Likewise, it seems reasonable to assume that 
susceptible lambs were unable to control parasite colonization/establishment and egg 
production (Miller, 1996; Miller, 1984).   
Worm clearance in resistant animals with little pathology is consistent with the 
generalization that acquired immunity to GI nematodes can be achieved after weeks 
of continuous low-level exposure (Gamble and Zajac, 1992; Seaton et al., 1989; 
Vanimisetti et al., 2004).  On the other hand, persistence of infection with 
consequent tissue damage may be attributed to ineffective or incomplete immunity 
(Meeusen et al., 1995; Meeusen, 1999).   
The present findings suggest that an active immune response is elicited in chronic T. 
circumcincta infection but the inflammatory response for susceptible animals is 
inappropriate to effectively clear the infection.   
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7.4 TH17-related cytokines are up-regulated in susceptible lambs 
It is clear from several studies of mouse models of gastrointestinal nematode 
infection that the type of T helper response is critical to the outcome of infection 
(Else and Finkelman, 1998; Gause et al., 2003; Grencis, 2001).  Protective immunity 
ensues in a predominant TH2 response where cytokines orchestrate effector 
mechanisms to eliminate infection.  On the contrary, protection is compromised 
where TH1 response gains hierarchy.  The cytokines produced in TH2 responses in 
the relative absence of TH1 promote increased number of mast cells, eosinophils and 
elevated levels of IgE and IgG1 in mice (Anthony et al., 2007; Gause et al., 2003).  
Mastocytosis and eosinophilia are also observed in sheep -in addition to the high 
expression of IgA antibody (Harrison et al., 2003; Strain et al.,  2002).  IgA activity 
is thought to be the main immunological mechanism regulating worm length and 
fecundity which translates to reduced gastrointestinal worm infection (Stear et al., 
1999a) in sheep.   
In this study, fold change analysis revealed increased expression of IL6 and IL21 in 
the abomasal lymph node as well as IL6 and TGFB1 in the abomasal mucosa of the 
susceptible group of lambs in comparison to resistant animals. Results of transcript 
copy number measurements in the abomasal lymph node of the full cohort of 55 
animals were consistent with the fold change data on the elevated expression of IL6 
and IL21 in susceptible lambs.  IL23A expression was also significantly increased in 
the susceptible group. 
The cytokine profile in these analyses is consistent with the hypothesis that  
susceptibility to T. circumcincta infection is related to the orchestration of an 
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inflammatory TH17 response (Harrington et al., 2006; Weaver et al., 2007).  
Susceptible animals had the highest level of IL6, IL21 and IL23A transcripts in the 
abomasal lymph node while retaining consistent levels of TGFB1.  The characteristic 
up-regulation of these cytokines is reminiscent of the chronic inflammatory response 
associated with autoimmune inflammatory diseases (Izcue et al., 2009; Kaser et al.,  
2010).  Indeed, high levels of IL6 and IL23 were found in untreated inflamed mucosa 
of patients with inflammatory bowel disease (Olsen et al., 2011). Moreover, an over-
expression of IL21 in inflamed intestine of IBD patients has been reported 
(Monteleone et al., 2009).  These cytokines are primarily involved in the initiation 
and maintenance of the TH17 response and they have all been shown to induce 
STAT3 phosphorylation (Boniface et al., 2008).  The pathology associated with the 
inflammatory response in the abomasum of susceptible lambs may be analogous to 
CD and UC which are two of the most common forms of autoimmune IBD (Weaver 
et al., 2006). 
IL6 expression was consistently high in lymph node and abomasum of susceptible 
animals.  This pro-inflammatory cytokine drives the TGFβ-induced T cells to 
differentiate to TH17 cells in mice (Mangan et al., 2006; Veldhoen et al., 2006).  
Stabilization of the TH17 response is attributed to IL-23 expression relying on IL-
23R which is not expressed in naïve T cells (Parham et al., 2002).  IL-6 enhances the 
activation of IL-23R and works synergistically with IL-23 in further promoting the 
TH17 response (Morishima et al., 2009).   
IL21 has the highest expression in susceptible animals among all transcripts 
measured.  Sustaining the TH17 response is thought to be mediated by IL-21 (Yang 
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et al., 2008b) that amplifies the production of TH17 cells, which in turn selectively 
produce IL-21 (Peluso et al., 2007).  The autocrine production of IL-21 intensifies 
the availability of IL21, which has several downstream functions that maintains the 
TH17 response.  IL-21 not only activates STAT3 (Brenne et al., 2002) but also 
triggers the expression of RORt (Fantini et al., 2007); both important in the lineage 
commitment to the TH17 response.  Furthermore, IL-21 induces the production of 
the key cytokines IL-17A and IL-17F that characterizes the TH17 response  (Mills, 
2008).   
Further expansion of TH17 from naïve T cells also seems to be controlled by IL-23 
released by dendritic cells and macrophages (Collins et al., 2011; Kastelein et al.,  
2007) (Kastelein et al., 2007; Ahern et al., 2010).  This cytokine has been shown to 
be critical for the stability and pathogenicity of TH17 cells (Lexberg et al., 2008; 
McGeachy et al., 2007).  IL-23 is an IL-12-related key inflammatory cytokine 
(Duvallet et al., 2011; Iwakura and Ishigame, 2006; Tang et al., 2011) that is 
involved in the establishment of chronic inflammation and in the development of 
TH17 cells.  The elevated levels of IL-23 in susceptible lambs may be related to the 
massive inflammatory response in the abomasum of these lambs that are carrying a 
high parasite load.   
The participation of IL-23 in the inflammatory response may be attributed to the 
proliferation of TH1 cells as it has heterodimer link with IL-12.   However, its co-
expression with other TH17 cytokines, like IL-6 and IL-21, in susceptible lambs 
suggests that the pathway led to TH17 response.  Recent studies, based on the 
presence of p19 and p40 subunits of IL-23 and not IL-12 p35, have indicated that IL-
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23 is the dominant cytokine controlling inflammation in peripheral tissues (Goldberg 
et al., 2009; Lee et al., 2004).  Evidence shows that IL-23 may induce an autocrine 
loop within the innate immune system leading to production of numerous mediators 
of inflammation (Yen et al., 2006).  The observed inflammatory response is 
consistent with the pathology of IBD (Liu et al., 2011; Olsen et al., 2011) in human 
patients.  In vitro studies show that IL-17A expression is dependent on continued 
expression of IL-23 and a combination of TGFβ/IL6 in mice and TGFβ/IL-21 in 
humans (Lexberg et al.,  2008).   
An argument against the ascendancy of the TH17 response in susceptibility to T. 
circumcincta infection is that IL-17A could not be detected in any sheep in this 
experiment.  IL-17A is the signature TH17 cytokine and was not present in 
detectable amount in tissues examined in this study, which may be due to the fact 
that this cytokine is only produced early after activation and diminishes within a few 
days (Lohr et al., 2009).  It must be noted however that the sheep tissues were from 
persistently infected animals undergoing mature immune responses and had been 
continuously stimulated for 13 weeks.  Tissues were collected 2-3 days after the last 
larval challenge and it is probable that subsequent re-infection failed to induce IL-
17A production, or that it was activated but could only persist for less than 3 days.   
The involvement of inflammatory CD4+ T cells in susceptibility of lambs to T. 
circumcincta is evidenced by the recent digital gene expression experiments showing 
significantly higher expression of H2.0-like homeobox (HLX) and TGFBR1 
transcripts in susceptible lambs (Pemberton et al., 2011).  HLX is a known negative 
regulator of IFNγ through the targeted depletion of STAT4, a key transcription factor 
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for IFNγ mRNA synthesis in NK cells (Becknell et al., 2007) and may signal a 
positive feedback for other TH cells, for example TH17 cells to proliferate.  
However, in mature TH1 cells HLX is induced by T-bet leading to optimum 
production of IFNγ (Mullen et al., 2002). 
TGFβ receptor1 works with TGFβ which is involved in the differentiation of TH17 
and Treg cells. Expression of TGFβ receptor has been associated with inflammatory 
autoimmune disorders (Shimizu et al., 2012).  Additionally, a global transcriptome 
analysis of the ovine immune response to acute T. circumcincta infection revealed 
high expression of transcripts like heat shock proteins, complement factors, and 
chemokines that are involved in direct parasitic effects, immunomodulation, and 
tissue repair (Knight et al., 2011). 
7.5 TH17 versus Treg proliferation 
There are indications that Treg and TH17 cells are not a stable phenotype; mature 
Tregs can re-express RORt and can be converted to IL-17 producing cells (Ariana 
and Elizabeth, 2009; Yang et al., 2008c).  
IL-21 or IL-6 may act as a switch leading to TH17 or Treg differentiation.  
Activation of Treg development from naïve CD4+ T cells occurs in the presence of 
TGFβ, however expression of the same cytokine in combination with IL-21 (Mucida 
et al., 2007; Yang et al., 2008b) or IL-6 (Kimura et al., 2007) directs the 
development of TH17 cells.  Both cytokines prevent the TGFβ-dependent expression 
of FOXP3 promoting the differentiation of TH17 instead of Treg cells (Bettelli et al.,  
2006; Fantini et al., 2007; Fujimoto et al., 2011; Veldhoen et al., 2006). High 
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expression of IL6 and IL21 in susceptible lambs may have triggered the shift to 
TH17 from Treg cells.   
Previous studies suggest that expansion of TH17 and Treg subsets is more dependent 
on TGFβ (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006) than IL-6.  
In my study, TGFB1 was elevated in the abomasal mucosa of susceptible lambs 
compared to the other groups. This cytokine alone could have favoured 
differentiation of Treg cells with consequent down-regulation of TH17 cells (Ivanov 
et al., 2007; Lee et al., 2009).  However, increased IL6 levels may have favourably 
driven the expansion of TH17 cells.  This corroborates studies in mouse models 
showing that the combination of IL-6 and TGFβ is essential to drive TH17 
differentiation (Bettelli et al., 2006; Veldhoen and Stockinger, 2006).  However, the 
participation of TGFβ in TH17 cell differentiation is not clear.  Although it was 
demonstrated that neutralizing antibody against TGFβ almost completely blocked IL-
6 and IL-23 (Morishima et al., 2009) it has also been shown that TGFβ can be 
dispensable in the orchestration of murine TH17 cell development (Ghoreschi et al.,  
2011).  Additionally, it is probable that the measured TGFB1 transcripts do not 
represent the biologically active, mature TGFβ (Barcellos-Hoff, 1996).  TGFβ can 
persist in extracellular components as latent complex that requires stimulation by 
proteolytic, conformational and other factors to be activated (Abe et al., 2002; 
Barcellos-Hoff, 1996; Munger et al., 1999).  Thus, whether TGFβ promotes TH17 
differentiation directly by up-regulating its expression or indirectly by down-
regulating the expression of cytokines related with other TH cell subtypes is not 
clear. 
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The elevated levels of FOXP3 in both infected resistant and susceptible lambs 
compared to uninfected control animals may indicate that immune-regulation is at 
play.  TH17 and Treg cell subsets are both known to play a significant role in 
mucosal immunity by protecting the epithelial cells from invading pathogens 
(Bettelli et al., 2006; Harrington et al., 2005).  The reciprocal relationship of Treg 
and TH17 cells may be reflected in the expression of RORt being inhibited, as 
induced Treg cell differentiation progresses (Zhou et al.,  2008).   
Like in other chronic inflammatory diseases (Olsen et al.,  2011; Wong et al.,  2001), 
either or both IL-6 and IL-21 may have contributed in the differentiation ofTH17 
cells in susceptible lambs with chronic T. circumcincta infection. IL-21 may direct 
the expansion of TH17 cells instead of Treg cells by preventing the TGFβ-dependent 
expression of FOXP3 (Fantini et al.,  2007).  Consequently, autocrine secretion of 
IL-21 is activated which further enhances the TH17 response.  The same mechanism 
applies to IL-6 which blocks FOXP3 thereby preventing Treg differentiation and 
favouring TH17 response (Bettelli et al.,  2006; Fantini et al.,  2007). 
7.6  What tips the balance to TH cell phenotype? 
As I was only able to demonstrate the profile of the immune response at the 
resolution stage of T. circumcincta infection in resistant animals, the series of events 
that took place before this stage can be presumed based on previous related work.  
TH1 may have been orchestrated at the initiation of worm infection (Pernthaner et 
al., 2006) which may have been followed eventually by the development of 
protection, characterized by TH2 response (Andronicos et al., 2010) with continued 
worm challenge.  This effector response may lead to pathology if uncontrolled, 
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prompting Treg cells to suppress the proliferation of TH1 and TH2 cells.  This could 
be the default response in chronic T. circumcincta infection.  However, the results of 
this study suggest that in selected susceptible lambs, the cytokine milieu at the 
maturation of the immune response can inhibit Treg cell development and function, 
in favour of the inflammatory TH17 response.  This concurs with the reported 
adoption of TH17-like phenotype by human and murine Tregs upon activation in an 
inflammatory cytokine milieu (Ayyoub et al., 2012; Radhakrishnan et al., 2008). 
As with other gastrointestinal helminth parasites, protective immunity to T. 
circumcincta seems to be associated with the conventional TH2 response (Craig et 
al., 2007; Finkelman et al., 1991; Lacroux et al., 2006).  However, in the 
experiments reported here, expression levels of transcripts of the classic type 1 
cytokines IL-12 and IFNγ and the type 2 cytokines IL-4, IL-25 and IL-10, did not 
correlate with susceptibility and resistance respectively. Very few IL4 and IL25 
transcripts were detected in any animal; while IL10 and IL12B showed no significant 
changes and IFNG was significantly reduced in susceptible animals. These findings 
are contrary to previous reports on up-regulated expression of IL-4 and IL-10 in 
TH2-mediated protection to GI nematodes in sheep during acute infections (Hein et 
al., 2004; Lacroux et al., 2006; Meeusen et al., 2005).  The low expression of these 
cytokines may be explained by TH2 cells proliferating during acute nematode 
infection, leading to the development of protective IgA antibody. This antibody leads 
to the expulsion of adult worms and inhibits new L3 larval colonization thereby 
obviating continual activation (Pearce et al., 2004; Taylor et al., 2009).  Negligible 
levels of IL4 and IL25 in all study animals and down-regulated IFNG and EBI3 
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expression in susceptible lambs may have also arisen from immune-suppression by 
Treg cells as this were concurrent with high FOXP3 expression.  
Regulation of TH17 cells is consistent with recent observations on blood fluke S. 
mansoni infection in mice, suggesting that lower levels of the TH17-related cytokine 
IL-17A would result in the generation of protective responses associated with IgG 
antibody and eosinophil maturation (Wen et al., 2011).  In addition, an attenuated 
TH17 response to secretory antigens of the liver fluke Fasciola hepatica failed to 
activate a TH2 response (Dowling et al., 2010).   
The majority of studies on T cell immunology of T. circumcincta have focused on 
acute responses in naive and ‘immune’ (infected, then treated) sheep, which 
generally elicits acute protective TH2 responses associated with IgG, IgE and IgA 
antibodies (Balic et al., 2000a; Craig et al., 2007; Gill et al., 2000; Lacroux et al., 
2006; Meeusen et al., 2005; Miller and Horohov, 2006; Pernthaner et al., 2005a; 
Pettit et al., 2005; Shakya et al., 2009; Strain et al., 2002; Terefe et al., 2007b).  It 
was demonstrated in my study that in the development of the mature immune 
response to chronic T. circumcincta infection, immune regulation enables a cytokine 
environment wherein resistance might be the default response and TH17 
proliferation leads to persistent infection (susceptibility).   
TH1 and TH2 cells could inhibit Treg and TH17 differentiation. What tips the 
balance that may determine the effector response is shown in Figure 7.1.  In relation 
to the balance between TH1 and TH17, high levels of the TH1 cytokine IFNγ 
suppress TH17 production (Zhu et al., 2010).  Furthermore, activation of STAT1 by 
IFN can suppress TH17 development by blocking STAT3, a positive regulator of 
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TH17 cells (Tanaka et al., 2007; Yang et al., 2007). In my experiments the 
susceptible lambs had a significantly reduced level of IFNG transcripts.  TH2 lineage 
cells antagonize the TH17 response through forced expression of GATA3, the 
primary TH2 transcriptor, which inhibits IL-17A production (van Hamburg et al.,  
2008). This mechanism depends partially on IL-4 leading to down-regulation of 
other TH17 factors including STAT3, STAT4, and RORt (van Hamburg et al., 
2008).  IL-25, expressed by several cell populations in the mucosa (including 
macrophages, dendritic cells and ‘nuocytes’), drives TH2 activation, suppressing 
TH17 via induction of IL-13 down-regulates IL-23 and IL-6 (Kleinschel et al., 
2007).  IL-25 was not detected in any of my study lambs and raises the possibility 
that other signalling pathways are involved in the development of the TH17 
response.  
7.7 TH17 proliferation is correlated with susceptibility phenotype 
It can be generalized based on published data on protective immunity to T. 
circumcincta that IgA antibody plays a crucial role in control of worm establishment 
and development.  Larval retardation and inhibited worm development have been 
shown to be mediated by IgA antibody (Halliday et al.,2007; Smith et al., 2009b; 
Smith, 2007; Stear et al.,1999a).  The anti-larval excretory/secretory (E/S)-specific 
IgA was negatively correlated with adult T. circumcincta following challenge with 
‘immune’ ewes (Smith et al., 2009b).  A strong negative correlation was also 
demonstrated between IgA levels and worm length/fecundity (Smith et al.,  1985; 
Stear and Bishop, 1999b) in both natural and experimental infection (Strain et al.,  
2002).  However, the question on the exact mechanism by which IgA performs this 
role remains unanswered as these are merely association studies. 
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In selected resistant animals, significantly high IgA antibody production was not 
detected until about 50 days post-infection.  Of note is that from this point until 
animal sacrifice six weeks later, resistant lambs received larval challenge every 2 
days but still had low to zero worm load (Beraldi et al., 2008).  This finding supports 
the hypothesis that the negative correlation of anti-T. circumcincta IgA antibody 
level and low FEC  is a causal relationship (Beraldi et al., 2008; Stear et al., 1999a).  
It is also worth mentioning that the negative correlation did not commence until after 
49 days, implying that it takes this period for ‘resistant’ animals to acquire protective 
immunity.  Unlike resistant lambs, susceptible animals had no/low IgA antibody 
levels with persistently high FEC and post-mortem adult worm numbers.  This offers 
the possibility of developing protection from T. circumcincta infection with repeated 
low-level worm challenge or by vaccination.   
In my studies (Chapter 6) there were highly significant positive correlations of IL6, 
IL21 and IL23A with AWC and FEC and a significant negative correlation of IL23A 
expression with IgA antibody levels.  Therefore I hypothesize that susceptibility to T. 
circumcincta (and persistent infection) is due to inhibited generation of protective 
IgA antibody brought about by the imbalance between the TH17 and Treg subsets 
(Korn et al., 2009; Weaver and Hatton, 2009).  It seems reasonable to assume that 
the high levels of IgA antibody response from day 50 until sacrifice resulted in 
inhibition of larval colonization and/or adult worm elimination following the 
repeated larval challenge in resistant lambs.  
IL-21 plays a decisive role in the control of B cell and plasma cell function 
(Monteleone et al., 2009; Spolski et al., 2009).  Recent human studies have revealed 
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that IL-21 alone can induce immunoglobulin heavy chain switching to IgA but 
concurrent expression with IL-4 can stop IL-21-induced switching to IgA (Avery et 
al., 2008) .  However, in my studies, neither IL-4 nor IL-21 alone is associated with 
IgA antibody levels as IL4 transcripts could not be detected in abomasal lymph 
nodes and IL21 transcript levels was not correlated with IgA expression (there was a 
non-significant 0.135 negative correlation).  Furthermore, excessive IL-21 
production is known to activate multiple signalling pathways that enhance and 
sustain mucosal inflammation (De Nitto et al., 2010) which may explain the 
inflammatory response in susceptible lambs.  
IL-6 is a multifunctional cytokine (Van Snick, 1990) mediating the physiological and 
pathological processes in disease by its involvement in granulocyte development 
(Liu et al., 1997), T cell differentiation (Bettelli et al., 2006), acute phase protein 
production (Gabay, 2006) and development of plasma cells (Beagley et al., 1989; 
Weaver et al., 2006).  IL-6 is crucial in the transition from neutrophil to monocyte 
recruitment in acute and chronic infection respectively (Ferraccioli and Zizzo,  
2011).  The pathway of T cell activation driven by IL-6 and its receptor contribute to 
the perpetuation of chronic intestinal inflammation (Kopf et al., 1994).  It is critically 
involved in the maintenance of autoimmune inflammatory diseases including IBD 
(Bettelli et al., 2006; Mudter and Neurath, 2007).  
The massive lymphocytic infiltration in the abomasal mucosa of susceptible lambs is 
suggestive of a chronic inflammatory response mediated by IL-6.  The inflammatory 
element of T. circumcincta infection has been demonstrated with up-regulated 
expression of IL-6 and IL-1β 5 days post-infection (Craig et al., 2007).  In this study, 
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protective TH2 response was established 3 weeks after trickle infection.  In my 
study, susceptible lambs had elevated IL6 levels at 12 weeks post-infection.  The 
positive correlation of IL6 with FEC and AWC confirms the non-protective 
consequence of the inflammatory response.IL-6 and TGFβ have symmetrical links 
with B cell maturation and antibody class switching for mucosal immunity (Weaver 
et al., 2006).  Both cytokines have been shown to mediate the terminal differentiation 
of stimulated B cells to IgA-secreting plasma cells (Beagley et al.,  1989; Kono et 
al., 1991; Ramsay et al., 1994a).  However, IgA antibody was not significantly 
correlated with IL-6 in the study lambs, which discounts the role of IL-6 in 
enhancing the production of IgA antibody in a predominantly TH17 type of response.   
IL-23 plays a key role in the pathogenesis of several autoimmune and inflammatory 
diseases. It orchestrates innate and T cell-mediated inflammatory pathways as well as 
promotes the differentiation of TH17 cells (Duvallet et al., 2011), Inflammatory 
macrophages express IL-23R and are activated by IL-23 to produce other 
inflammatory cytokines such as IL-1β, TNFα, and IL-23 itself (Tang et al., 2011).  
Naïve T cells do not express IL-23R but this receptor is induced by IL-6 (Morishima 
et al., 2009).  Its participation in a pro-inflammatory context is further enhanced in 
the presence of TGFβ and IL-17A (Langrish et al., 2005). IL-23 is not only 
associated with inflammatory autoimmune diseases (Duvallet et al., 2011) but also 
non-autoimmune inflammatory disorders (Cornellisen, 2009).  Indeed, mice deficient 
of IL-23p19 and IL-10 spontaneously developed IBD (Yen et al., 2006).  In the same 
study, it was shown that IL-23 is essential for accelerating development of chronic 
intestinal inflammation by promoting IL-6 and IL-17A production, key cytokines for 
the inflammatory TH17 response.   
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Our investigation on the mature immune response supports the hypothesis that 
immunological control of these parasites is not simply a consequence of a stereotypic 
TH2 response; TH2 cytokines were not significantly raised in resistant lambs and 
none of the archetypal TH1 and TH2 cytokines were differentially expressed 
between resistant and susceptible lambs. 
An alternative pathway in susceptibility to T. circumcincta infection is proposed.  
Figure 7.1 depicts the initiation and proliferation signals as well as the known 
components of the immune response with corresponding worm burden parameters.  
It must be noted that the direct effector mechanisms of cytokines and antibodies on 
worm clearance and inhibited development are still unclear.   
Several possible mechanisms in the development of protective immunity to GI worm 
infection have been published.  Antibody-mediated worm exclusion or elimination is 
largely associated with hypersensitivity reactions (Greer et al., 2008b; Huntley et al.,  
2001; Jackson et al., 2004; Kemp et al., 2009; Robinson et al., 2010b; Scott and 
McKellar, 1998).  Eosinophil-mediated larval killing has been demonstrated in vitro 
(Rainbird et al., 1998).  The secreted chymases of activated mast cells are thought to 
target epithelial junctional complex proteins, thereby causing increased mucosal 
permeability (Miller, 1996).  Recently, there are indications that abomasal proteins 
e.g. galectins and intelectins in animals previously exposed to T. circumcincta have 
protective properties (Jackson et al., 2004a; Pemberton et al.,  2012).  Indeed, there 
is still a wide area of research to be uncovered in order for us to arrive at more 
defined mechanisms of protection to gastrointestinal nematodes given the diversity 
of the immune response in a host-parasite relationship.  





Figure 7.1  Alternative pathway for susceptibility to T. circumcincta in sheep.  The 
classical protective immunity to T. circumcincta involves a TH2 response 
characterized by up-regulated expression of IL-4, IL-5 and IL-13 and increased 
numbers of eosinophils, mast cells, and globule leucocytes.  The effector 
mechanisms result in larval exclusion and diminished worm development as 
reflected by low FEC and AWC, and reduced worm fecundity.  Susceptibility is 
generally associated with TH1 response resulting in high worm burden through 
elevated levels of IFN and IL-12.  The TH17 response is a proposed pathway by 
which susceptibility is favoured with up-regulation of pro-inflammatory cytokines 
IL-6, IL-21, TGFβ and IL-23A.  This cytokine environment elicits an inflammatory 
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7.8 Genetic basis of differential immune response to susceptibility 
Cytokine expression analysis of a range of gene transcripts and correlation data with 
phenotype has revealed the involvement of TH17-related cytokines in susceptibility 
of sheep to T. circumcincta infection.  The final stage of the study planned to identify 
SNPs associated with susceptibility and/or resistance.   
From the immunological studies three candidate genes were selected that were 
differentially expressed between resistant and susceptible (IL-6, IL-21, and IL-23).  
Only IL-21 and its receptor IL-21R were examined for the presence of SNPs due to 
time constraints.  IL-21R was included in the SNPs analysis based on its reported 
genetic variation in regulating IgE production, specifically in females (Hecker et al.,  
2003).  IL-21 levels showed the strongest significant correlation with FEC and AWC 
in the study lambs; and from the studies reported here is associated with a TH17 
chronic inflammatory response and susceptibility.  IL-21 is considered a key T cell 
growth factor in innate and adaptive immune system (Ferrari-Lacraz et al., 2008).  
The observed up-regulation of IL21 in susceptible lambs may be attributed to IL-21 
being an inflammatory cytokine (Pelletier et al., 2004) that promotes further 
proliferation and maintenance of TH17 cell responses (Korn et al., 2009; Yang et al., 
2008b).  The role of IL-21 in chronic inflammatory diseases is supported by the 
identification of a genetic risk marker for IBD in IL21 region at the same 
chromosome where other human autoimmune inflammatory diseases were linked 
(Festen et al.,  2009).  A genome-wide association study associated polymorphism in 
chromosome 4q27 containing IL-2 and IL-21 to IBD susceptibility (Glas et al.,  
2009).  However expression of IL-21 did not differ between normal and un-inflamed 
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mucosa of IBD patients suggesting that up-regulated IL-21 in IBD is mainly 
attributed to mucosal inflammation. 
One SNP within the coding region of IL21R was identified in one lamb from the 
susceptible group and no polymorphisms were identified in IL21 gene.  It was not 
possible to run HRM analysis on the entire length of the coding region due to limited 
time availability, as the assay also requires optimization.  HRM could optimally 
detect mutations in small gene fragments (~150 bp); hence, only one fragment each 
of IL21 and IL21R was analyzed.  The SNP identified was from one out of fifteen 
samples in the susceptible group only.  The substitution from A to G did not alter the 
predicted amino acid sequence.  Therefore, it is considered unlikely that the SNP 
identified could explain the differential expression of susceptibility to T. 
circumcincta infection.  In addition, the sample size in this experiment is too small to 
arrive at a definite conclusion. 
Recent findings on the association of Ovar DRB*0203 allele with reduced FEC in T. 
circumcincta infection (Hassan et al., 2011)led me to determine if this allele was 
expressed in resistant lambs in this study.  Much work has been done showing the 
association of MHC class II aleles to resistance.   Demonstration of resistance-
associated alleles in MHC Class II is not a remote possibility considering their role in 
immune response activation (Buitkamp et al., 1996; Cresswell, 1994a).  The allele 
MHC Class II Ovar DRB*0203 was not found in any of the resistant and susceptible 
lambs.  But having shown that there was resistance to T. circumcincta in the lambs, 
other genes within the same locus may be involved in the differential immune 
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response.  Furthermore, the immune response is a complex mechanism and other 
genes are probably involved in the development of protective immunity. 
Some SNPs of genes have been associated with resistance to GI nematode infection.   
Polymorphisms in the first intron of IFNG have been associated with low FEC in T. 
circumcincta infection (Coltman et al., 2001b; Matika et al., 2011; Sayers et al., 
2005a).  IL-4 gene (Benavides et al., 2009a) and another allele of gene CSRD2138 
proximal to IL4 have also been associated with reduced FEC in H. contortus 
infections (Maddox et al., 2001).  These findings were confirmed by combined gene 
expression and signalling pathway analysis (Sayre and Harris, 2012) showing 
differential expression of genes related to immune response and resistance to 
parasites.   
QTLs related to GI worm resistance have been identified at the genome- or 
chromosome-wide level. Regions of the ovine genome in Ch 3 was consistently 
associated with resistance to sheep strongyles (Beraldi et al., 2007; Davies et al.,  
2006; Dominik et al., 2010; Marshall et al., 2009).  Loci in Ch 4 (Matika et al.,  
2011) and 6 (Beh et al., 2002; Beraldi et al., 2007) were also linked to worm 
resistance.  Probably the most relevant QTLs associated with worm resistance, which 
may also be related to T cell differentiation, are those found in Ch 1 and 11 
(Coppieters et al., 2009; Marshall et al., 2009).  RORC (RORγ) and STAT3, 
transcription factors of TH17 cells, are both on Ch 1 and 11.  Likewise, TBX21 and 
STAT5 transcription factors for TH1 and TH2 respectively are both located in Ch 11.  
In addition, Ch 20, which contains MHC Class II, has been suggested to influence 
resistance to strongyle worms (Coppieters et al., 2009; Davies et al., 2006).  QTLs 
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controlling a particular trait may hypothetically be unique for one disease or shared 
among different diseases.  Since production of IgA may be stimulated by TH2 cells, 
and there is previous evidence that such cells promote resistance to T. circumcincta, 
it is possible that the phenotype of resistance/susceptibility is controlled by genes 
regulating TH differentiation.    
The present study has led to the identification of candidate genes associated with 
susceptibility to T. circumcincta infection.  Of particular interest is IL-23 which 
activates JAK2 and STAT3; polymorphisms of the genes encoding these signalling 
molecules may be linked to autoimmunity (Danoy et al., 2010) or other chronic 
inflammatory diseases (Kebir et al., 2007; Yen et al., 2006).  Chronic T. 
circumcincta infection signals an inflammatory TH17 response reminiscent of the 
human IBD.  Mutations in IL23R gene have been associated with susceptibility to 
CD (Duerr et al., 2006).  The SNP found was also correlated with the expression of 
IL-22 (Schmechel et al., 2008) a TH17 cytokine thought to interact synergistically 
with IL-17A (Chung et al., 2006).  Mutations in IL21 have also been shown as 
susceptibility markers for IBD (Glas et al., 2009).  Hence, these studies support the 
possible association of susceptibility to T. circumcincta with polymorphisms in these 
genes. 
7.9 Conclusion 
In summary, my study has described the T cell response and its correlation with 
phenotype, as well as histopathology of lambs with predicted genetic variation in 
resistance/susceptibility to T. circumcincta infection.  It can be concluded that there 
is immunological basis of resistance and susceptibility of lambs to persistent 
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infection with T. circumcincta.  Histopathology showed only mild pathological 
changes to the abomasal mucosa of resistant lambs but excessive lymphoid 
infiltration and inflammation in the mucosa and sub-mucosa of infected susceptible 
animals.  Associated with these inflammatory changes are significantly higher levels 
of IL6, IL21 and IL23A transcripts in the abomasal lymph nodes, and TGFB1 in the 
mucosa.  IL6, IL21 and IL23A are correlated with FEC and AWC in the abomasal 
lymph node, and TGFB1 in the abomasal mucosa of susceptible lambs; IL23A was 
negatively correlated with IgA and these data are consistent with the hypothesis that 
susceptibility, and therefore inability to control parasite colonization and egg 
production, is associated with increased levels of activation of the inflammatory 
TH17 T cell subset. 
High resolution melt analysis failed to identify single nucleotide polymorphisms in 
the coding regions of IL21 and IL21R.  Nucleotide substitution from G to A at 
position 1135 in IL21R from susceptible lambs was identified in one sample.  The 
SNP did not alter the translated protein product.  Whilst this finding is considered 
inconclusive due to the low number of samples analysed, the preliminary results may 
serve as a basis for future related work.  
7.10 Future work  
Interesting data have been generated from the study that may be utilized in exploring 
signalling network pathways of the TH17 and other T cell responses.  We know that 
dysregulation of the T cell response is associated with chronic inflammatory 
pathology (and worm susceptibility).  Similar gene expression studies may involve 
the known upstream and downstream players of the TH17 response which include 
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STAT3, RORC, and IL22.  Imbalance of genes involved in TH cell differentiation is 
thought to have led to TH17 differentiation.  To elucidate further the immunological 
and genetic basis of this differential response, examination of the genes involved in 
the signalling pathway for all four TH sets is also worth looking at.   In which case, 
identification of SNPs in STAT3, STAT4 and STAT6, RORA and RORC, GATA3 
and TBX21 will be useful, and which is now underway.   
As this is the first time that TH17 response was associated with susceptibility to GI 
worm infection in sheep, more detailed functional studies may be conducted in 
mouse models.  In which case, manipulation of the experiment for an anticipated 
response is more feasible.   
Identification of SNPs in susceptible lamb was inconclusive hence this information 
could not be adopted in the practical application of breeding for selection at this 
stage.  Have I been given another year of laboratory work, I could have optimized 
and performed HRM analysis on fragments of the entire coding regions of IL21 and 
IL21R.  It could have yielded more generous data from which I could derive a more 
conclusive evidence of SNP identification.  
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R260/280 R260/230 RIN 
11 0 Abomasum 1546.79 2.13 1.88 8.1 
39 0 Abomasum 1192.85 2.12 1.25 9.1 
47 0 Abomasum 1199.36 2.14 1.29 8.9 
57 0 Abomasum 1736.93 2.12 2.14 8.5 
81 0 Abomasum 1093.72 2.13 2.11 8.2 
124 0 Abomasum 1156.37 2.17 1.66 9.3 
130 0 Abomasum 678.12 2.16 1.35 9.2 
146 0 Abomasum 1162.99 2.16 1.53 8.9 
182 0 Abomasum 879.46 2.12 1.97 7.5 
192 0 Abomasum 1188.06 2.11 1.82 7.7 
11 0 LymphNode 1452.47 2.15 2.04 7.5 
39 0 LymphNode 819.64 2.16 1.96 8.1 
47 0 LymphNode 867.00 2.14 1.82 8.5 
57 0 LymphNode 998.13 2.14 1.93 9 
81 0 LymphNode 1475.24 2.18 2.05 9 
124 0 LymphNode 1448.90 2.14 2.12 8.3 
130 0 LymphNode 1120.05 2.15 2.12 8.5 
146 0 LymphNode 1403.14 2.14 1.74 9.1 
182 0 LymphNode 1427.94 2.14 1.66 8.4 
192 0 LymphNode 1681.71 2.14 1.71 8.9 
92 1 Abomasum 1667.44 2.15 2.08 7 
92 1 LymphNode 1055.75 2.17 1.93 8.4 
100 2 Abomasum 
1129.19 
2.15 2.02 4 
 
 







R260/280 R260/230 RIN 
100 2 LymphNode 1706.54 2.11 2.08 8.7 
21 3 Abomasum 1031.17 2.12 2.09 8.5 
21 3 LymphNode 1069.86 2.14 1.85 7.5 
20 4 Abomasum 714.43 2.14 2.03 8 
20 4 LymphNode 609.22 2.12 1.39 8.2 
147 5 Abomasum 1457.72 2.14 1.83 5.8 
147 5 LymphNode 1317.57 2.14 2.03 8.8 
58 6 Abomasum 1444.79 2.12 2.14 7.7 
58 6 LymphNode 1207.80 2.16 2.03 8.6 
50 7 Abomasum 727.48 2.15 1.87 7.5 
50 7 LymphNode 1019.01 2.13 2.08 8.5 
110 8 Abomasum 1434.66 2.17 2.12 7.8 
110 8 LymphNode 1555.20 2.11 2.03 8.2 
54 9 Abomasum 1463.23 2.13 1.91 7.6 
54 9 LymphNode 1345.91 2.17 2.07 8.8 
116 10 Abomasum 1003.51 2.15 2.08 7.8 
116 10 LymphNode 1358.93 2.12 2.04 8.1 
25 11 Abomasum 1102.07 2.16 2 7.7 
25 11 LymphNode 1151.63 2.15 2.07 9.1 
155 12 Abomasum 1123.42 2.15 1.81 6.3 
155 12 LymphNode 1144.59 2.14 1.76 9 
52 13 Abomasum 1159.92 2.13 2.12 7.7 
52 13 LymphNode 1050.26 2.13 1.99 8.8 
34 14 Abomasum 
1430.71 
2.12 2.06 8.2 
 
 







R260/280 R260/230 RIN 
34 14 LymphNode 453.47 2.13 1.98 8 
184 15 Abomasum 1168.96 2.13 1.92 6.3 
184 15 LymphNode 1173.92 2.14 2 8.5 
123 16 Abomasum 1625.11 2.16 1.98 7.5 
123 16 LymphNode 1427.56 2.12 1.95 8.7 
10 17 Abomasum 1282.46 2.11 2.11 7.7 
10 17 LymphNode 1149.05 2.14 2.01 7.7 
193 18 Abomasum 1350.77 2.12 2.09 5.9 
193 18 LymphNode 1316.08 2.15 1.69 9 
102 19 Abomasum 1187.48 2.15 2.05 7.7 
102 19 LymphNode 1546.92 2.12 1.7 8.4 
40 20 Abomasum 1493.15 2.13 1.32 6.6 
40 20 LymphNode 1135.32 2.15 1.84 8.8 
12 21 Abomasum 957.02 2.11 2.06 7.7 
12 21 LymphNode 1316.46 2.15 1.9 6.9 
125 22 Abomasum 1436.03 2.15 2.02 7.6 
125 22 LymphNode 1383.64 2.15 2.11 8.3 
62 23 Abomasum 1722.09 2.12 2.03 8.8 
62 23 LymphNode 1296.37 2.15 1.93 6.9 
36 24 Abomasum 832.39 2.14 2.09 8.8 
36 24 LymphNode 1220.66 2.14 1.93 7.3 
172 25 Abomasum 1078.69 2.16 1.52 6.8 
172 25 LymphNode 1349.51 2.15 2.05 9 
 
181 26 Abomasum 
1030.73 
2.13 1.78 6.6 
 
 







R260/280 R260/230 RIN 
181 26 LymphNode 1295.66 2.15 1.96 8.2 
165 27 Abomasum 1105.28 2.15 1.75 8.1 
165 27 LymphNode 1445.32 2.15 2.01 8.8 
19 28 Abomasum 1023.45 2.13 2.11 8.5 
19 28 LymphNode 1447.77 2.14 2.09 7.7 
8 29 Abomasum 1268.77 2.13 2.1 8.8 
8 29 LymphNode 1025.19 2.14 2.03 8.3 
138 30 Abomasum 1024.12 2.17 1.7 8.7 
138 30 LymphNode 1542.84 2.13 1.82 8.8 
48 31 Abomasum 639.44 2.1 1.14 8.7 
48 31 LymphNode 1159.74 2.15 1.73 8.9 
30 32 Abomasum 1187.02 2.13 2.05 8.1 
30 32 LymphNode 1242.51 2.13 1.96 7.6 
82 33 Abomasum 1221.72 2.12 2.12 8.9 
82 33 LymphNode 1264.25 2.17 1.74 8.9 
190 34 Abomasum 1337.98 2.11 1.88 8 
190 34 LymphNode 1465.29 2.13 2.05 8.7 
178 35 Abomasum 743.68 2.11 1.88 7.5 
178 35 LymphNode 1499.27 2.14 2.03 8 
59 36 Abomasum 1049.92 2.13 2.12 8.6 
59 36 LymphNode 1425.46 2.15 2.01 8.7 
191 37 Abomasum 1306.90 2.11 2.01 7.4 
191 37 LymphNode 1650.67 2.13 2.1 8 
 
65 38 Abomasum 
1260.98 
2.14 1.47 8.8 
 
 







R260/280 R260/230 RIN 
65 38 Abomasum 1260.98 2.14 1.47 8.8 
65 38 LymphNode 1337.89 2.16 1.86 7.7 
60 39 Abomasum 1491.04 2.13 2.08 8.6 
60 39 LymphNode 1296.37 2.15 1.93 8.6 
119 40 Abomasum 1381.35 2.15 2.08 8.2 
119 40 LymphNode 1597.57 2.12 2.09 7.4 
131 41 Abomasum 1386.54 2.15 1.85 8.5 
131 41 LymphNode 1158.71 2.14 1.63 9.1 
28 42 Abomasum 748.89 2.12 1.97 7.9 
28 42 LymphNode 1200.05 2.14 2.02 7.5 
114 43 Abomasum 397.11 2.12 1.66 9.3 
114 43 LymphNode 1379.32 2.12 2.05 8.4 
38 44 Abomasum 999.54 2.14 2 8.6 
38 44 LymphNode 1320.75 2.13 1.96 7.8 
173 45 Abomasum 1244.41 2.16 1.73 7.6 
173 45 LymphNode 1305.27 2.15 1.83 8.7 
183 46 Abomasum 872.69 2.11 1.79 7.7 
183 46 LymphNode 1615.43 2.13 2.05 8.1 
109 47 Abomasum 1625.61 2.16 2.11 8.7 
109 47 LymphNode 1339.43 2.11 2.06 8.4 
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SHEEP v1   -------------------------ATGTACCAGGCGATGGCGTTCTTGGCAGTGGTCAT 35 
SHEEP v2   -------------------------------------ATGGCGTTCTTGGCAGTGGTCAT 23 
CATTLE     CAGGAGCAGTTTTCTCACTAGCCTTTTCCTACAGGCAATGGCATTCTTGGCAATGGTCAT 110 
HORSE      -------------------------ATGTACCAGGTGGTTGTGTTTTTGGCAATGGTCAT 35 
PIG        G-GGAGCAGTTTTCTCACTGGCCTTTTCTTGCAGGCGGTTGCGTTCTTGGCAATGGTCAT 179 
DOG        -------------------------ATGAATCAGGTGATCGTGTTCTTGGTAATGGCCAT 35 
HUMAN v1   TGAGGACAGTTCTCTCATTAGCCTTTTCCTACAGGTGGTTGCATTCTTGGCAATGGTCAT 83 
HUMAN v2   ------ATGTAC-------------------CAGGTGGTTGCATTCTTGGCAATGGTCAT 35 
RAT        -------------------------ATGTACCAGGCTGTTGCGTTCTTGGCAATGGTTGT 35 
MOUSE      -------------------------ATGTACCAGGCTGTTGCATTCTTGGCAATGATCGT 35 
                                                .* * .** **** *.**.  .* 
 
SHEEP v1   GGGAACCCACACCCTCTGTTTGGGGTCCCAGAGGCGTTGCACCCACTGGCCCGGCTGCTG 95 
SHEEP v2   GGGAACCCACACCCTCTGTTTGGGGTCCCAGAGGCGTTGCACCCACTGGCCCGGCTGCTG 83 
CATTLE     GGGAACCCACACCCTCTGTTTGGGGTCCCAGAGGTGTTGCACCCACTGGCCCAGCTGCTG 170 
HORSE      GGGAACCCCCACCCTCAGTTTGTGG---CACAAGGAATGCACCCATTGGCCCAGCTGCTG 92 
PIG        GGGAACCCACACCTTCCATTTGTGGTCCCAGAAGGGCTGTCCCCACTGGCCCAACTGCTG 239 
DOG        GGGAACCCACACCCTCAATTTTCGGATCCGGAAGGACTGCACCCACTGGCCTAACTGCTG 95 
HUMAN v1   GGGAACCCACACCTACAG------------------------CCACTGGCCCAGCTGCTG 119 
HUMAN v2   GGGAACCCACACCTACAG------------------------CCACTGGCCCAGCTGCTG 71 
RAT        GGGAACCCACACCGTCAGTTTGCGGATCCAGGAGGACTGCAGCCACTTACCCAGATGCTG 95 
MOUSE      GGGAACCCACACCGTCAGCTTGCGGATCCAGGAGGGCTGCAGTCACTTGCCCAGCTGCTG 95 
           ********.**** :* .                         ** * .** ...***** 
 
SHEEP v1   CCCCAGCGAAGGACAGAACCCCACTGAGGAGTGGCTGAAGTGGAACAGTGTGCTCATGCC 155 
SHEEP v2   CCCCAGCGAAGGACAGAACCCCACTGAGGAGTGGCTGAAGTGGAACAGTGTGCTCATGCC 143 
CATTLE     CCCCAGCAAAGGACAGAATTCCACTGAGGAGTGGCTGAAGTGGAACAGTGTGCTCATGCC 230 
HORSE      CCCCAAGAAAGGACAGGACCCCATTGAGGAGTGGCTGAAGTGGAGCACTGCGCACGTGCC 152 
PIG        CCCCAGCAAAGGACAGAACCCCATAGAAGAGTGGCTGAAGCAGAATGCTGTGCTCATGCC 299 
DOG        TCCCAGCAAAAGGCAGGACCCCACTCATGAGTGGCTGAAGCGGGACACTGTGCTCAAGTT 155 
HUMAN v1   CCCCAGCAAAGGGCAGGACACCTCTGAGGAGCTGCTGAGGTGGAGCACTGTGCCTGTGCC 179 
HUMAN v2   CCCCAGCAAAGGGCAGGACACCTCTGAGGAGCTGCTGAGGTGGAGCACTGTGCCTGTGCC 131 
RAT        TCCCAGCAAACAACAAGAATTCCCCGAGGAGTGGCTGAAGTGGAACCCTGCACCTGTGTC 155 
MOUSE      CCCCAGCAAAGAGCAAGAACCCCCGGAGGAGTGGCTGAAGTGGAGCTCTGCATCTGTGTC 155 
            ****. .** ..**..*   *    * ***  *****.* .*..   ** .   .:*   
 
SHEEP v1   TCCCCCAGAGACCACCAGCCTCGCCCACCACTCAGAATCCTGCAGTTCCAGCAAGGATGG 215 
SHEEP v2   TCCCCCAGAGACCACCAGCCTCGCCCACCACTCAGAATCCTGCAGTTCCAGCAAGGATGG 203 
CATTLE     TCCCCCAGAGACCACCAGCCTCGCCCACCACCCAGAACCCTGCAGTTCCAGCAGGGATGG 290 
HORSE      TCCCCCAGAGACTGCTAACCTCGCCCACCACCCAGAATCCTGCAGGGCCAGCGAAGACGG 212 
PIG        TCCTCTGGAGATGGCCAGCCCCACTCCCCACCCAGAATCCTGCAAGGCGAGTGAAGACGG 359 
DOG        CCCCGGAGAGACCACTAGCCTCACCCACCACCCAGAATCCTGCAAAGCCAGTGAAGACGG 215 
HUMAN v1   TCCCCTAGAGCCTGCTAGGCCCAACCGCCACCCAGAGTCCTGTAGGGCCAGTGAAGATGG 239 
HUMAN v2   TCCCCTAGAGCCTGCTAGGCCCAACCGCCACCCAGAGTCCTGTAGGGCCAGTGAAGATGG 191 
RAT        TCCCCCAGAGCCTCTGAGGCACACCCACCACCCAGAATCCTGCAGGGCCAGCAAGGACGG 215 
MOUSE      CCCCCCAGAGCCTCTGAGCCACACCCACCACGCAGAATCCTGCAGGGCCAGCAAGGATGG 215 
            **   .***.     *. * *.. * **** ****. **** *.  * ** ...** ** 
 
Figure 1  Nucleotide alignments of sheep IL25 cDNA transcript variant 1 (FR670343) 
and transcript variant 2 (FR670344) aligned with cattle (XM_605190.2), horse 
(XM_001918325.1), pig (XM_001926286.1), dog (XM_537375.2), human transcript variant 
1 (NM_022789.2) and human transcript variant 2 (NM_172314.1), rat (XM_001054877.1) 
and mouse (NM_080729.2) sequences.  Alignments were done using using ClustalW2.  (*) 
denotes that nucleotides are identical in all sequences    
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SHEEP v1   ACCCCTCAACAGCCGTTCCATCGCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCG 275 
SHEEP v2   ACCCCTCAACAGCCGTTCCATCGCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCG 263 
CATTLE     ACCCCTCAACAGCCGCTCCATCGCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCG 350 
HORSE      ACCTCTCAACAGCAGGTCCATCTCCCCCTGGCGATATGAGTTGGACAGGGACTTGAACCG 272 
PIG        ACCCCTCAACAGCAGATCCATTGCCCCTTGGAGATACGAGTTGGACAGAGACTTGAACCG 419 
DOG        ACCGCTCAACAGCAGGTCTATCTCCCCCTGGAAATATGAGTTGGACAGGGACTTGAACCG 275 
HUMAN v1   ACCCCTCAACAGCAGGGCCATCTCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCG 299 
HUMAN v2   ACCCCTCAACAGCAGGGCCATCTCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCG 251 
RAT        CCCTCTCAACAGCAGGGCCATCTCTCCTTGGAGCTATGAGTTGGACAGGGACTTGAATCG 275 
MOUSE      CCCCCTCAACAGCAGGGCCATCTCTCCTTGGAGCTATGAGTTGGACAGGGACTTGAATCG 275 
           .** *********.*  * **  * ** ***...** ***********.******** ** 
 
SHEEP v1   GCTCCCGCAGGATCTGTACCACGCACGCTGCCTGTGTCCACACTGTGTCAGCCTCCAGAC 335 
SHEEP v2   GCTCCCGCAGGATCTGTACCACGCACGCTGCCTGTGTCCACACTGTGTCAGCCTCCAGAC 323 
CATTLE     GCTCCCGCAGGATCTGTACCACGCACGTTGCCTGTGTCCACACTGTGTCAGCCTGCAGAC 410 
HORSE      GCTCCCCCAGGACCTGTACCACGCCCGGTGCCTATGTCCGCACTGCGTCAGCCTGCAGAC 332 
PIG        GCTGCCCCAGGACTTGTACCACGCTCGTTGCCTGTGTCCACACTGTGTCAGCCTCCGGAC 479 
DOG        GCTCCCCCAGGACCTGTACCACGCCCGTTGCCTGTGTCAACACTGTGTCAGCCTACAGAC 335 
HUMAN v1   GCTCCCCCAGGACCTGTACCACGCCCGTTGCCTGTGCCCGCACTGCGTCAGCCTACAGAC 359 
HUMAN v2   GCTCCCCCAGGACCTGTACCACGCCCGTTGCCTGTGCCCGCACTGCGTCAGCCTACAGAC 311 
RAT        GGTCCCCCAGGATCTGTACCATGCTCGATGCCTGTGCCCACACTGCGTCAGCCTACAGAC 335 
MOUSE      GGTCCCCCAGGACCTGTACCACGCTCGATGCCTGTGCCCACACTGCGTCAGCCTACAGAC 335 
           * * ** *****  ******* ** ** *****.** *..***** ******** *.*** 
 
SHEEP v1   GGGCTCCCACATGGACCCCCTGGGAAACTCAGAGCTGCTCTACCACAACCAGACCGTTTT 395 
SHEEP v2   GGGCTCCCACATGGACCCCCTGGGAAACTCAGAGCTGCTCTACCACAACCAGACCGTTTT 383 
CATTLE     GGGCTCCCACATGGACCCCCTGGGAAACTCAGAGCTGCTCTACCACAACCAGACCGTCTT 470 
HORSE      AGGCTCCCACATGGACCCCCTGGGCAACTCGGAGCTGCTCTACCACAACCAGACCGTCTT 392 
PIG        GGGTTCCCACATGGATCCCCTGGGTAACTCAGAGCTGCTGTACCACAACCAGACCGTCTT 539 
DOG        GGGCTCCCACATGGACCCCCTGGGCAACTCGGAGTTGCTCTACCACAACCAAACCGTCTT 395 
HUMAN v1   AGGCTCCCACATGGACCCCCGGGGCAACTCGGAGCTGCTCTACCACAACCAGACTGTCTT 419 
HUMAN v2   AGGCTCCCACATGGACCCCCGGGGCAACTCGGAGCTGCTCTACCACAACCAGACTGTCTT 371 
RAT        AGGATCTCACATGGACCCAATGGGCAACTCAGTACCACTCTACCACAACCAGACAGTCTT 395 
MOUSE      AGGCTCCCACATGGACCCGCTGGGCAACTCCGTCCCACTTTACCACAACCAGACGGTCTT 395 
           .** ** ******** ** . *** ***** *:   .** ***********.** ** **
 
Figure 1  cont’n.  
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SHEEP v1   CTACCGGCGGCCATGCCCTGGACAGCAGGGCGCCCACCATGGCTACTGCCTGGAACGCAG 455 
SHEEP v2   CTACCGGCGGCCATGCCCTGGACAGCAGGGCGCCCACCATGGCTACTGCCTGGAACGCAG 443 
CATTLE     CTACCGGCGGCCGTGCCCTGGACAGCAGGGCGACCACCATGGCTACTGCCTGGAACGCAG 530 
HORSE      CTACCGGCGGCCGTGCCCTGGGAAGCGGGGCGCCCACGATGGCTACTGCCTGGAACGCAG 452 
PIG        CTACCGGCGGCCGTGCCCTGGACAGCAGGGCGCCCATGATAGCTACTGTCTGGAGCCCAG 599 
DOG        CTACCGGCGGCCGTGCCCTGGAGAGCAGGGTGCCCCTGATGGTTACTGTTTGGAACAAAG 455 
HUMAN v1   CTACCGGCGGCCATGCCATGGCGAGAAGGGCACCCACAAGGGCTACTGCCTGGAGCGCAG 479 
HUMAN v2   CTACCGGCGGCCATGCCATGGCGAGAAGGGCACCCACAAGGGCTACTGCCTGGAGCGCAG 431 
RAT        CTACCGGCGGCCATGCCACGGCGAGCAAGGTGCCCACGGCCGTTACTGCTTGGAGCGCAG 455 
MOUSE      CTACCGGCGGCCATGCCATGGCGAGGAAGGTACCCATCGCCGCTACTGCTTGGAGCGCAG 455 
           ************.****. **  ** ..** ..**.  .  * *****  ****.* .** 
 
SHEEP v1   GCTCTACCGTGTCTCCTTGGCTTGCGTGTGCGTGCGGCCCCGTGTGATGGCCTAG 510 
SHEEP v2   GCTCTACCGTGTCTCCTTGGCTTGCGTGTGCGTGCGGCCCCGTGTGATGGCCTAG 498 
CATTLE     GCTCTACCGTGTCTCCTTGGCTTGCGTGTGCGTGCGGCCCCGTGTGATGGCCTAG 585 
HORSE      GCTCTACCGCGTCTCCTTGGCTTGCGTGTGTGTGCGGCCCCGTGTGATGGCCTAG 507 
PIG        GCTCTACCAAGTCTCCCTGGCTTGCGTGTGTGTGCGGCCCCGTGTGATGGCCTAA 654 
DOG        ACTCTACCGTGTCTCCCTGGCTTGTGTGTGTGTGCGGCCCCGAGTGATGGCCTAG 510 
HUMAN v1   GCTGTACCGTGTTTCCTTAGCTTGTGTGTGTGTGCGGCCCCGTGTGATGGGCTAG 534 
HUMAN v2   GCTGTACCGTGTTTCCTTAGCTTGTGTGTGTGTGCGGCCCCGTGTGATGGGCTAG 486 
RAT        GCTCTACCGAGTCTCCTTGGCTTGTGTGTGTGTGCGGCCCCGTATGATGGCTTAG 510 
MOUSE      GCTCTACCGAGTCTCCTTGGCTTGTGTGTGTGTGCGGCCCCGGGTCATGGCTTAG 510 
           .** ****. ** *** *.***** ***** *********** .* ****  **. 
 
Figure 1. cont’n 
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Materials used in the study  
Ampicillin stock solution (50 mg/ml) 
Ampicillin stock solution was made by mixing 500 mg of Ampicillin Na salt (> 98% 
titration) into 10 ml molecular biology grade water (AccuGENE®).  The solution was 
sterilized by passing through a 0.22 m filter.  Aliquots of the solution in 1 ml were 
stored in -20C, and then diluted to the working concentration of 100 g/ml (1:500). 
Glycerol storage buffer 
Glycerol storage buffer was prepared by mixing 65 ml glycerol, 22.5 ml molecular 
biology grade water, 2.5 ml of 1 M Tris (pH 6.0), and 10 ml of 0.1 M filter-sterilized 
MgSO4. 
Isopropyl--D-1-thiogalactopyranoside (IPTG) stock solution (0.1 M) 
IPTG stock solution (0.1 M) was prepared by adding 48.8 ml of molecular biology 
grade water to 1.2 g of IPTG (Melford).  The solution was filter-sterilized then stored 
at -20C in 1 ml aliquots. 
Luria Bertani (LB) broth 
LB broth was made by dissolving 10 g Tryptone (Oxoid), 5 g Yeast extract (Oxoid) 
and 5 g NaCl in 1 L distilled water using a magnetic stirrer.  The solution was 
sterilized by autoclaving. 
 
 




LB agar was made by adding 7.5 g bacteriological agar to 500 ml of LB broth 
(Section 1.1.4).  The solution was mixed thoroughly and sterilized by autoclaving. 
LB/Ampicillin/IPTG/X-Gal plates 
LB/Ampicillin/IPTG/X-Gal plates were made by heating previously prepared LB 
agar medium (Section 1.1.5) to melt, then allowed to cool to about 50C before 
adding in the following: a) ampicillin to a final concentration of 100 g/ml (Section 
4.1.1), b) 0.5 mM IPTG (Section 4.1.3) and 80 g/ml X-Gal (Section 4.1.6).  
Approximately 30 ml of agar medium was poured into 90 mm petri dishes and 
allowed to set. 
5-Bromo-4-chloro-3-indolyl--D galactoside (X-Gal) solution 
X-Gal solution was prepared by dissolving 100 mg X-Gal in 2 ml N,N’- 
dimethylformamide.  The bottle was wrapped in aluminum foil and stored at -20C. 
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Cambridge  
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United Kingdom 
  
Corbett Life Science / Corbett Robotics Unit 1, Terek House 
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Phoenix Business Park 
Eaton Socon, St Neots 
Cambridgeshire 
PE19 8EP  UK 
 
Invitrogen Ltd 3 Fountain Drive  
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Nanodrop Technologies, Inc 3411 Silverside Rd 
Bancroft Building  
Wilmington  
DE 19810 USA 
 




SG4 0TY  UK 
 
Promega UK Delta House 





Qiagen QIAGEN HOUSE  
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Crawley  
West Sussex  
RH10 9NQ UK 
 
Roche Applied Science Charles Avenue  
Burgess Hill  
RH15 9RY  
UK 
 
Sigma-Aldrich Company Ltd Sigma-Aldrich Company Ltd. 
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